Document:

EX-10.1

 EXHIBIT 10.1 

 
  

 
 PLEDGE AND SECURITY AGREEMENT

 dated as of 
 August 27, 2020

 among 
 SABRE GLBL INC., 

as the Company 
 SABRE HOLDINGS
CORPORATION, 
 as Holdings 
 THE
SUBSIDIARY GUARANTORS 
 AS IDENTIFIED IN THE INDENTURE 

and 
 WELLS FARGO BANK, NATIONAL
ASSOCIATION, 
 as Collateral Agent 

NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE LIEN AND SECURITY INTEREST GRANTED TO THE COLLATERAL AGENT, FOR THE BENEFIT OF THE SECURED PARTIES,
PURSUANT TO THIS AGREEMENT AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE COLLATERAL AGENT AND THE OTHER SECURED PARTIES HEREUNDER ARE SUBJECT TO THE PROVISIONS OF THE INTERCREDITOR AGREEMENT. IN THE EVENT OF ANY CONFLICT OR INCONSISTENCY BETWEEN
THE PROVISIONS OF THE INTERCREDITOR AGREEMENT AND THIS AGREEMENT, THE PROVISIONS OF THE INTERCREDITOR AGREEMENT SHALL CONTROL. 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I	  

	DEFINITIONS	  

			
	 Section 1.01.
	 	Indenture	  	 	1	 
			
	 Section 1.02.
	 	Other Defined Terms	  	 	1	 
	
	ARTICLE II	  

	PLEDGE OF SECURITIES	  

			
	 Section 2.01.
	 	Pledge	  	 	8	 
			
	 Section 2.02.
	 	Delivery of the Pledged Collateral	  	 	8	 
			
	 Section 2.03.
	 	Representations, Warranties and Covenants	  	 	9	 
			
	 Section 2.04.
	 	Certification of Limited Liability Company and Limited Partnership Interests	  	 	10	 
			
	 Section 2.05.
	 	Registration in Nominee Name, Denominations	  	 	10	 
			
	 Section 2.06.
	 	Voting Rights; Dividends and Interest	  	 	11	 
			
	 Section 2.07.
	 	Collateral Agent Not a Partner or Limited Liability Company Member	  	 	12	 
	
	ARTICLE III	  

	SECURITY INTERESTS IN PERSONAL PROPERTY	  

			
	 Section 3.01.
	 	Security Interest	  	 	13	 
			
	 Section 3.02.
	 	Representations and Warranties	  	 	14	 
			
	 Section 3.03.
	 	Covenants	  	 	16	 
			
	 Section 3.04.
	 	Other Actions	  	 	20	 
	
	ARTICLE IV	  

	REMEDIES	  

			
	 Section 4.01.
	 	Remedies upon Default	  	 	21	 
			
	 Section 4.02.
	 	Application of Proceeds	  	 	23	 
			
	 Section 4.03.
	 	Grant of License to Use Intellectual Property; Power of Attorney	  	 	23	 
	
	ARTICLE V	  

	INDEMNITY, SUBROGATION AND SUBORDINATION	  

			
	 Section 5.01.
	 	Indemnity	  	 	24	 
			
	 Section 5.02.
	 	Contribution and Subrogation	  	 	24	 
			
	 Section 5.03.
	 	Subordination	  	 	25	 

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	ARTICLE VI	  

	INTERCREDITOR AGREEMENT	  

			
	 Section 6.01.
	 	Intercreditor Agreement	  	 	25	 
			
	 Section 6.02
	 	Obligations of Grantors	  	 	25	 
			
	 Section 6.03
	 	Delivery of Collateral	  	 	25	 
	
	ARTICLE VII	  

	MISCELLANEOUS	  

			
	 Section 7.01.
	 	Notices	  	 	26	 
			
	 Section 7.02.
	 	Waivers; Amendment	  	 	26	 
			
	 Section 7.03.
	 	Collateral Agent’s Fees and Expenses	  	 	26	 
			
	 Section 7.04.
	 	Successors and Assigns	  	 	27	 
			
	 Section 7.05.
	 	Survival of Agreement	  	 	27	 
			
	 Section 7.06.
	 	Counterparts; Effectiveness; Successors and Assigns; Several Agreement	  	 	27	 
			
	 Section 7.07.
	 	Severability	  	 	28	 
			
	 Section 7.08.
	 	Governing Law; Jurisdiction; Consent to Service of Process	  	 	28	 
			
	 Section 7.09.
	 	WAIVER OF RIGHT TO TRIAL BY JURY	  	 	28	 
			
	 Section 7.10.
	 	Headings	  	 	29	 
			
	 Section 7.11.
	 	Security Interest Absolute	  	 	29	 
			
	 Section 7.12.
	 	Reserved	  	 	29	 
			
	 Section 7.13.
	 	Termination or Release	  	 	29	 
			
	 Section 7.14.
	 	Additional Grantors	  	 	30	 
			
	 Section 7.15.
	 	Collateral Agent Appointed Attorney-in-Fact	  	 	30	 
			
	 Section 7.16.
	 	General Authority of the Collateral Agent	  	 	31	 
			
	 Section 7.17.
	 	Recourse; Limited Obligations	  	 	31	 

  
 -ii- 

			
	ANNEX A	  	List of Subsidiary Guarantors
		
	Schedules	  	
		
	SCHEDULE I	  	Pledged Equity; Pledged Debt
	SCHEDULE II	  	Commercial Tort Claims
		
	Exhibits	  	
		
	EXHIBIT I	  	Form of Security Agreement Supplement
	EXHIBIT II	  	Form of Perfection Certificate
	EXHIBIT III	  	Form of Patent Security Agreement
	EXHIBIT IV	  	Form of Trademark Security Agreement
	EXHIBIT V	  	Form of Copyright Security Agreement

 PLEDGE AND SECURITY AGREEMENT (this “Agreement”) dated as of
August 27, 2020, among SABRE HOLDINGS CORPORATION, a Delaware corporation (“Holdings”), SABRE GLBL INC., a Delaware corporation (the “Company”), the Subsidiary Guarantors party hereto and WELLS FARGO BANK,
NATIONAL ASSOCIATION, as Collateral Agent for the Secured Parties (as defined below). 
 Reference is made to the Indenture dated as of
August 27, 2020 (as amended, supplemented or otherwise modified from time to time, the “Indenture”), among the Company, Holdings, the Subsidiary Guarantors and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee and as
Collateral Agent, pursuant to which the Company has agreed to issue 7.375% senior secured notes due 2025 (the “Notes”). Each of Holdings and each Subsidiary party hereto is an affiliate of the Company and will derive substantial
benefits from the issuance of the Notes by the Company pursuant to the Indenture. In order to secure the payment of all principal of and interest and premium, if any, on the Notes, and the payment and performance of all other Obligations under the
Indenture and all of the Grantors’ obligations and liabilities hereunder and in connection herewith, each Grantor is willing to execute and deliver this Agreement. Accordingly, the parties hereto agree as follows: 

ARTICLE I 
 Definitions

 SECTION 1.01. Indenture. (a) Capitalized terms used in this Agreement and not otherwise defined herein have the meanings
specified in the Indenture. All terms defined in the New York UCC (as defined herein) and not defined in this Agreement have the meanings specified therein; the term “instrument” shall have the meaning specified in Article 9 of
the New York UCC. 
 (b) The rules of construction specified in Article I of the Indenture also apply to this Agreement. 

SECTION 1.02. Other Defined Terms. As used in this Agreement, the following terms have the meanings specified below: 

“Account Debtor” means any Person who is or who may become obligated to any Grantor under, with respect to or on account of
an Account. 
 “Accounts” has the meaning specified in Article 9 of the New York UCC. 

“Agreement” means this Pledge and Security Agreement. 

“Article 9 Collateral” has the meaning assigned to such term in Section 3.01(a). 

“Claiming Party” has the meaning assigned to such term in Section 5.02. 

“Collateral” means the Article 9 Collateral and the Pledged Collateral. 

 “Commercial Tort Claim” has the meaning specified in Article 9 of the New
York UCC. 
 “Copyright License” means any written agreement, now or hereafter in effect, granting any right to any third
party under any copyright now or hereafter owned by any Grantor or that such Grantor otherwise has the right to license, or granting any right to any Grantor under any copyright now or hereafter owned by any third party, and all rights of such
Grantor under any such agreement. 
 “Copyrights” means all of the following now owned or hereafter acquired by any
Grantor: (a) all copyrights in any work subject to the copyright laws of the United States or any other country, whether as author, assignee, transferee or otherwise, and (b) all registrations and applications for registration of any such
copyrights in the United States or any other country, including registrations, recordings, supplemental registrations and pending applications for registration in the USCO or any foreign equivalent office. 

“Contributing Party” has the meaning assigned to such term in Section 5.02. 

“Dollar Amount” means, with respect to any Indebtedness denominated in United States dollars, the principal amount thereof
then outstanding. 
 “Domestic Subsidiary” means a Subsidiary of Holdings which owns a Principal Domestic Property and
transacts substantially all of its business or maintains substantially all of its property within the United States, excluding its territories, possessions and Puerto Rico, but in any case excluding any Subsidiary which is engaged primarily in
financing operations outside of the United States or in leasing personal property or financing inventory receivables or other property. 

“Excluded Assets” means: 

(a) any Principal Domestic Property (but only to the extent that and for so long as any such Principal Domestic Property is not subject to a
Lien securing any other First Lien Obligation); 
 (b) any
letter-of-credit rights; 
 (c) any Securitization Assets;

 (d) any motor vehicles and other assets subject to certificates of title; 

(e) any real property that is not a Material Real Property; 

(f) any leasehold interests; 
 (g)
any LC Assets; 

  
 2 

 (h) any assets or properties that are acquired in a transaction not prohibited by the
Indenture, so long as such assets or properties are subject to a Lien permitted under paragraphs 8 or 9 of the definition of Permitted Liens in the Indenture, which Liens secure Indebtedness that is permitted by the Indenture to be incurred or
assumed in connection with such transaction; 
 (i) any Intellectual Property whose pledge would result in the forfeiture of any of the
Grantors’ rights in such property; 
 (j) any Trademark applications filed in the USPTO on the basis of such Grantor’s “intent-to-use” such Trademark, unless and until an amendment to such application or an acceptable evidence of use of such Trademark has been filed with the USPTO
pursuant to Section 1(c) or Section 1(d) of the Lanham Act (15 U.S.C. 1051, et seq.), as applicable, to the extent that granting a lien in or assigning such Trademark application prior to such filing would adversely affect the
enforceability or validity of such Trademark application or any registration that issues therefrom; 
 (k) any General Intangible, Investment
Property or other rights of a Grantor arising under any contract, lease, instrument, license or other document or any assets subject thereto if but only to the extent that and so long as the grant of a security interest therein would
(x) constitute a violation or abandonment of, or render unenforceable, a valid and enforceable restriction in respect of such General Intangible, Investment Property or other such rights in favor of a third party or under any law, regulation,
permit, order or decree of any Governmental Authority (for the avoidance of doubt, the restrictions described herein shall not include negative pledges or similar undertakings in favor of a lender or other financial counterparty), or
(y) expressly give any other party in respect of any such contract, lease, instrument, license or other document, the right to terminate its obligations thereunder, provided, however, that the limitation set forth in this
clause (j) shall not affect, limit, restrict or impair the grant by a Grantor of a security interest pursuant to this Agreement in any such Collateral to the extent that an otherwise applicable prohibition or restriction on such grant is
rendered ineffective pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the Uniform
Commercial Code of any relevant jurisdiction or any other applicable law or principles of equity and provided, further, that, at such time as the condition causing the conditions in subclauses (x) and (y) of this
clause (j) shall be remedied, whether by contract, change of law or otherwise, the contract, lease, instrument, license or other documents shall immediately cease to be an Excluded Asset, and any security interest that would otherwise be
granted herein shall attach immediately to such contract, lease, instrument, license or other document, or to the extent severable, to any portion thereof that does not result in any of the conditions in (x) or (y) above; 

(l) any assets the pledge of which is prohibited by law or by agreements containing anti-assignment clauses not overridden by the Uniform
Commercial Code or other applicable law; and 
 (m) any asset with respect to which the Company has reasonably determined in writing that the
costs of providing a security interest in such asset or perfection thereof is excessive in view of the benefits to be obtained by the Collateral Agent (but only to the extent that and for so long as any such asset is not subject to a Lien securing
any other First Lien Obligations). 

  
 3 

 “Excluded Security” means 

(a) any shares of stock or debt of any Domestic Subsidiary (but only to the extent that and for so long as any such stock or debt is not
pledged to secure any other First Lien Obligations); 
 (b) more than 65% of the issued and outstanding voting Equity Interests of any
Material Foreign Subsidiary that is a direct Subsidiary of the Company or a Guarantor; 
 (c) any Equity Interests of any Foreign Subsidiary
that is not a Material Foreign Subsidiary; 
 (d) any Equity Interests of any Unrestricted Subsidiary (until such time as any Unrestricted
Subsidiary becomes a Restricted Subsidiary in accordance with the Indenture); 
 (e) any Equity Interests of any Subsidiary that are not
directly held by the Company or a Guarantor; 
 (f) any Equity Interests of any Subsidiary that are acquired in a transaction not prohibited
by the Indenture, so long as such Equity Interests are subject to a Lien permitted under paragraphs 8 or 9 of the definition of Permitted Liens in the Indenture, which Liens secure Indebtedness that is permitted by the Indenture to be incurred or
assumed in connection with such transaction; 
 (g) any shares of stock or debt whose pledge is prohibited by law or by agreements containing
anti-assignment clauses not overridden by applicable law; and 
 (h) any Equity Interests of any Subsidiary with respect to which the Company
has reasonably determined in writing that the costs of providing a pledge of such Equity Interests or perfection thereof is excessive in view of the benefits to be obtained by the Collateral Agent (but only to the extent that and for so long as any
such Equity Interests are not pledged to secure any other First Lien Obligations). 
 “General Intangibles” has the meaning
specified in Article 9 of the New York UCC and includes for the avoidance of doubt corporate or other business records, indemnification claims, contract rights (including rights under leases, whether entered into as lessor or lessee, Hedging
Obligations and other agreements), goodwill, Intellectual Property, registrations, franchises, tax refund claims and any letter of credit, guarantee, claim, security interest or other security held by or granted to any Grantor, as the case may be,
to secure payment by an Account Debtor of any of the Accounts. 
 “Governmental Authority” means any nation or government,
any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, administrative tribunal, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative
powers or functions of or pertaining to government. 
 “Grantor” means each of Holdings, the Company, and the Subsidiary
Guarantors. 

  
 4 

 “Holdings’ Consolidated Net Assets” means the aggregate amount of
assets, less reserves and other deductible items, after deducting current liabilities, as shown on Holdings’ most recent consolidated balance sheet and prepared in accordance with generally accepted accounting principles. 

“Indemnitee” means each Secured Party and each director, officer or employee thereof. 

“Indenture” has the meaning assigned to such term in the preliminary statement of this Agreement. 

“Intellectual Property” means all intellectual and similar property of every kind and nature now owned or hereafter acquired
by any Grantor, including inventions, designs, Patents, Copyrights, Licenses, Trademarks, trade secrets, confidential or proprietary technical and business information, know-how,
show-how, or other data or information, the intellectual property rights in software and databases and related documentation, domain names and all additions, improvements and accessions to, and books and
records describing any of the foregoing, together with all causes of action arising prior to or after the date hereof for infringement of any of the foregoing, or unfair competition claims regarding the same. 

“Intellectual Property Security Agreements” means the short-form Patent Security Agreement, short-form Trademark Security
Agreement, and short-form Copyright Security Agreement, each substantially in the form attached hereto as Exhibits III, IV and V, respectively. 

“Investment Property” has the meaning specified in Article 9 of the New York UCC, but shall not include any Pledged
Collateral. 
 “Laws” means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules,
guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration
thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority. 

“License” means any Patent License, Trademark License, Copyright License or other Intellectual Property license or sublicense
agreement to which any Grantor is a party, together with any and all (i) renewals, extensions, supplements and continuations thereof, (ii) income, fees, royalties, damages, claims and payments now and hereafter due and/or payable
thereunder and with respect thereto including damages and payments for past, present or future infringements or violations thereof, and (iii) rights to sue for past, present and future violations thereof. 

“Material Adverse Effect” means a circumstance or condition affecting the business, operations, assets, liabilities (actual
or contingent) or financial condition of Holdings and its Subsidiaries, taken as a whole, that would materially adversely affect (a) the ability of the Company, Holdings and the Subsidiary Guarantors (taken as a whole) to perform their
respective obligations under the Indenture or (b) the rights and remedies of the Trustee or the Collateral Agent under the Indenture or any Security Document. 

  
 5 

 “Material Foreign Subsidiary” means, at any date of determination, each of
the Company’s Foreign Subsidiaries (a) whose total assets at the last day of the most recent Test Period were equal to or greater than 2.5% of the Total Assets of Holdings, the Company and the Restricted Subsidiaries at such date or
(b) whose gross revenues for such Test Period were equal to or greater than 2.5% of the consolidated gross revenues of Holdings, the Company and the Restricted Subsidiaries for such period, in each case determined in accordance with GAAP. 

“Material Real Property” means any real property owned by any Grantor with a fair market value (as determined by the Company
in good faith) in excess of $15,000,000; provided that, notwithstanding the foregoing, the Headquarters will not constitute a Material Real Property for so long as any 2016 Notes or the Headquarters Financing remains outstanding. 

“New York UCC” means the Uniform Commercial Code as from time to time in effect in the State of New York. 

“Notes” has the meaning assigned to such term in the preliminary statement of this Agreement. For all purposes hereunder, the
Notes shall include the Initial Notes and any Additional Notes (each as defined in the Indenture). 
 “Obligations” means
“Notes Obligations” as defined in the Indenture. 
 “Patent License” means any written agreement, now or
hereafter in effect, granting to any third party any right to make, use or sell any invention claimed in a Patent that is now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, or granting to any Grantor any
right to make, use or sell any invention claimed in a Patent that is now or hereafter owned by any third party, and all rights of any Grantor under any such agreement. 

“Patents” means all of the following now owned or hereafter acquired by any Grantor: (a) all letters Patent of the
United States or the equivalent thereof in any other country in or to which any Grantor now or hereafter has any right, title or interest therein, all registrations and recordings thereof, and all applications for letters Patent of the United States
or the equivalent thereof in any other country, including registrations, recordings and pending applications in the USPTO or any similar offices in any other country, and (b) all reissues, continuations, divisions, continuations-in-part, renewals or extensions thereof, and the inventions claimed therein, including the right to make, use and/or sell the inventions claimed therein. 

“Perfection Certificate” means a certificate substantially in the form of Exhibit II, completed and supplemented with
the schedules and attachments contemplated thereby, and as amended, updated, modified or supplemented from time to time, and duly executed as of the date hereof, and as of any subsequent delivery date as required pursuant to the Security Documents,
by the chief financial officer or the chief legal officer of each of Holdings and the Company. 
 “Pledged Collateral” has
the meaning assigned to such term in Section 2.01. 

  
 6 

 “Pledged Debt” has the meaning assigned to such term in Section 2.01.

 “Pledged Equity” has the meaning assigned to such term in Section 2.01. 

“Pledged Securities” means any promissory notes, stock certificates or other securities now or hereafter included in the
Pledged Collateral, including all certificates, instruments or other documents representing or evidencing any Pledged Collateral. 

“Principal Domestic Property” means any building, structure or other facility, together with the land on which it is erected
and fixtures comprising a part of it, used primarily for information processing, research or housing hardware or software required for information processing, located in the United States, excluding its territories, possessions and Puerto Rico,
owned or leased by Holdings or one of Holdings’ Subsidiaries and having a net book value in excess of 1% of Holdings’ Consolidated Net Assets, other than any such building, structure or other facility or a portion which the Company’s
principal executive officer, president and principal financial officer determine in good faith is not of material importance to the total business conducted or assets owned by the Company and its Subsidiaries as an entirety. 

“Secured Parties” means, collectively, the Trustee, the Collateral Agent and the Holders of the Notes. 

“Security Agreement Supplement” means an instrument in the form of Exhibit I hereto. 

“Security Interest” has the meaning assigned to such term in Section 3.01(a). 

“Test Period” in effect at any time shall mean the most recent period of four consecutive fiscal quarters of the Company
ended on or prior to such time (taken as one accounting period) in respect of which financial statements for each quarter or fiscal year in such period have been or are required to be delivered. 

“Trademark License” means any written agreement, now or hereafter in effect, granting to any third party any right to use any
trademark now or hereafter owned by any Grantor or that any Grantor otherwise has the right to license, or granting to any Grantor any right to use any trademark now or hereafter owned by any third party, and all rights of any Grantor under any such
agreement. 
 “Trademarks” means all of the following now owned or hereafter acquired by any Grantor: (a) all
trademarks, service marks, trade names, corporate names, trade dress, logos, fictitious business names and other source or business identifiers, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all
registration applications filed in connection therewith, including registrations and registration applications in the USPTO or any similar offices in any State of the United States or any other country or any political subdivision thereof, and all
extensions or renewals thereof, as well as any unregistered trademarks and service marks used by a Grantor and (b) all goodwill connected with the use of and symbolized thereby. 

“USCO” means the United States Copyright Office. 

“USPTO” means the United States Patent and Trademark Office. 

  
 7 

 ARTICLE II 

Pledge of Securities 

SECTION 2.01. Pledge. As security for the payment or performance, as the case may be, in full of the Obligations, including the
Guarantee, each Grantor hereby pledges to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, and hereby grants to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, a
security interest in and lien on all of such Grantor’s right, title and interest in, to and under (i) all Equity Interests held by it, including without limitation those Equity Interests listed on Schedule I and any other Equity Interests
obtained in the future by such Grantor and, to the extent certificated, the certificates representing all such Equity Interests (the “Pledged Equity”); provided that the Pledged Equity shall not include any Excluded Security;
(ii) the debt securities owned by it, including without limitation those debt securities listed opposite the name of such Grantor on Schedule I, any debt securities obtained in the future by such Grantor and the promissory notes and any other
instruments evidencing any debt (the “Pledged Debt”); provided that the Pledged Debt shall not include any Excluded Security; (iii) subject to Section 2.06, all payments of principal or interest, dividends, cash,
instruments and other property from time to time received, receivable or otherwise distributed in respect of, in exchange for or upon the conversion of, and all other Proceeds received in respect of, the Pledged Equity and Pledged Debt;
(iv) subject to Section 2.06, all rights and privileges of such Grantor with respect to the securities and other property referred to in clauses (i), (ii), and (iii) above; and (v) all Proceeds of any of the foregoing (the
items referred to in clauses (i) through (v) above being collectively referred to as the “Pledged Collateral”); provided, however, that in no event shall Pledged Collateral include any property with respect
to which a Grantor is treated as having a security entitlement within the meaning of Article 8 of any applicable Uniform Commercial Code. 

TO HAVE AND TO HOLD the Pledged Collateral, together with all right, title, interest, powers, privileges and preferences pertaining or
incidental thereto, unto the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, forever, subject, however, to the terms, covenants and conditions hereinafter set forth. 

SECTION 2.02. Delivery of the Pledged Collateral. (a) Each Grantor agrees to deliver or cause to be delivered as promptly as
practicable to the Collateral Agent, for the benefit of the Secured Parties, any and all Pledged Securities (other than any uncertificated securities, but only for so long as such securities remain uncertificated) to the extent such Pledged
Securities, in the case of promissory notes or other instruments evidencing Indebtedness, are required to be delivered pursuant to paragraph (b) of this Section 2.02. 

(b) Each Grantor will cause (i) any Indebtedness for borrowed money owed to such Grantor by any Person (other than intercompany
Indebtedness between Grantors and intercompany Indebtedness referred to in the following clause (ii)) having an aggregate principal amount in excess of the Dollar Amount of $5,000,000, to be evidenced by a duly executed promissory note, and
(ii) any intercompany Indebtedness made by such Grantor to a Subsidiary of the Company that is not a Grantor to be evidenced by (x) a duly executed global promissory note to which such Subsidiary of the Company that is not a Grantor is a
signatory, or (y) at the option of the Grantor, to the extent such Indebtedness is in an aggregate principal amount in excess of the Dollar Amount of $15,000,000, a duly executed promissory note; in each case (i) and (ii) that is delivered
to the Collateral Agent, for the benefit of the Secured Parties, pursuant to the terms hereof. 

  
 8 

 (c) Upon delivery to the Collateral Agent, (i) any Pledged Securities shall be
accompanied by stock or security powers duly executed in blank or other instruments of transfer reasonably satisfactory to the Collateral Agent and by such other instruments and documents as the Collateral Agent may reasonably request and
(ii) all other property comprising part of the Pledged Collateral shall be accompanied by proper instruments of assignment or transfer duly executed by the applicable Grantor and such other instruments or documents as the Collateral Agent may
reasonably request. Each delivery of Pledged Securities shall be accompanied by a schedule describing the securities, which schedule shall be attached hereto as Schedule I and made a part hereof; provided that failure to attach any such
schedule hereto shall not affect the validity of such pledge of such Pledged Securities. Each schedule so delivered shall supplement any prior schedules so delivered. 

SECTION 2.03. Representations, Warranties and Covenants. Holdings and the Company jointly and severally represent, warrant and
covenant, as to themselves and the other Grantors, to the Collateral Agent, for the benefit of the Secured Parties, that: 
 (a) Schedule I
correctly sets forth the percentage of the issued and outstanding units of each class of the Equity Interests of the issuer thereof represented by the Pledged Equity and includes all Equity Interests, debt securities and promissory notes required to
be pledged hereunder in accordance with the terms of the Indenture; 
 (b) the Pledged Equity and Pledged Debt (solely with respect to
Pledged Debt issued by a Person other than the Company or a subsidiary of the Company, to the best of Holdings’ and the Company’s knowledge) have been duly and validly authorized and issued by the issuers thereof and (i) in the case
of Pledged Equity, are fully paid and nonassessable and (ii) in the case of Pledged Debt (solely with respect to Pledged Debt issued by a Person other than the Company or a subsidiary of the Company, to the best of Holdings’ and the
Company’s knowledge), are legal, valid and binding obligations of the issuers thereof; 
 (c) except for the security interests granted
hereunder, each of the Grantors (i) is and, subject to any transfers made in compliance with the Indenture, will continue to be the direct owner, beneficially and of record, of the Pledged Securities indicated on Schedule I as owned by such
Grantors, (ii) holds the same free and clear of all Liens, other than (A) Liens created by the Security Documents and (B) Liens permitted pursuant to Section 4.12 of the Indenture, (iii) will make no assignment, pledge,
hypothecation or transfer of, or create or permit to exist any security interest in or other Lien on, the Pledged Collateral, other than (A) Liens created by the Security Documents and (B) Liens permitted pursuant to Section 4.12 of
the Indenture, and (iv) will defend its title or interest thereto or therein against any and all Liens (other than the Liens permitted pursuant to this Section 2.03(c)), however arising, of all Persons whomsoever; 

  
 9 

 (d) except for restrictions and limitations imposed by the Indenture or the Security
Documents or securities laws generally and except as described in the Perfection Certificate, the Pledged Collateral is and will continue to be freely transferable and assignable, and none of the Pledged Collateral is or will be subject to any
option, right of first refusal, shareholders agreement, charter or by-law provisions or contractual restriction of any nature that might prohibit, impair, delay or otherwise affect in any manner material and
adverse to the Secured Parties the pledge of such Pledged Collateral hereunder, the sale or disposition thereof pursuant hereto or the exercise by the Collateral Agent of rights and remedies hereunder; 

(e) each of the Grantors has the power and authority to pledge the Pledged Collateral pledged by it hereunder in the manner hereby done or
contemplated; 
 (f) no consent or approval of any Governmental Authority, any securities exchange or any other Person was or is necessary to
the validity of the pledge effected hereby (other than such as have been obtained and are in full force and effect); 
 (g) by virtue of the
execution and delivery by the Grantors of this Agreement, when any Pledged Securities are delivered to the Collateral Agent in accordance with this Agreement, the Collateral Agent will obtain a legal, valid and perfected first priority lien upon and
security interest in such Pledged Securities as security for the payment and performance of the Obligations, to the extent such perfection is governed by the Uniform Commercial Code subject to Liens permitted pursuant to Section 4.12 of the
Indenture; and 
 (h) the pledge effected hereby is effective to vest in the Collateral Agent, for the benefit of the Secured Parties, the
rights of the Collateral Agent in the Pledged Collateral as set forth herein. 
 SECTION 2.04. Certification of Limited Liability
Company and Limited Partnership Interests. Any limited liability company and any limited partnership controlled by any Grantor shall either (a) not have in its operative documents any provision that any Equity Interests in such limited
liability company or such limited partnership be a security as defined under Article 8 of the Uniform Commercial Code, or (b) certificate any Equity Interests in any such limited liability company or such limited partnership. To the extent
an interest in any limited liability company or limited partnership controlled by any Grantor and pledged under Section 2.01 is certificated or becomes certificated, each such certificate shall be delivered to the Collateral Agent, pursuant to
Section 2.02(a) and such Grantor shall fulfill all other requirements under Section 2.02 applicable in respect thereof. 

SECTION 2.05. Registration in Nominee Name; Denominations. If an Event of Default shall occur and be continuing,
(a) the Collateral Agent, on behalf of the Secured Parties, shall have the right (in its sole and absolute discretion) to hold the Pledged Securities in its own name as pledgee, the name of its nominee (as pledgee or as sub-agent) or the name of the applicable Grantor, endorsed or assigned in blank or in favor of the Collateral Agent, and each Grantor will promptly give to the Collateral Agent copies of any notices or other
communications received by it with respect to Pledged Securities registered in the name of such Grantor and (b) the Collateral Agent shall have the right to exchange the certificates representing Pledged Securities for certificates of smaller
or larger denominations for any purpose consistent with this Agreement; provided, that the Collateral Agent shall give the Company prior notice of its intent to exercise such rights unless an Event of Default under paragraphs 8 or 9 of
Section 6.01 of the Indenture shall have occurred and be continuing in which case no notice shall be required. 

  
 10 

 SECTION 2.06. Voting Rights; Dividends and Interest. (a) Unless and
until an Event of Default shall have occurred and be continuing and the Collateral Agent shall have notified the Company that the rights of the Grantors under this Section 2.06 are being suspended: 

(i) Each Grantor shall be entitled to exercise any and all voting and/or other consensual rights and powers inuring to an owner
of Pledged Securities or any part thereof for any purpose consistent with the terms of the Indenture, this Agreement and the other Security Documents; provided that such rights and powers shall not be exercised in any manner, except as may be
expressly permitted under the Indenture, this Agreement or the other Security Documents, that would materially and adversely affect the rights inuring to a holder of any Pledged Securities or the rights and remedies of any of the Collateral Agent or
the other Secured Parties under the Indenture, this Agreement or any other Security Document or the ability of the Secured Parties to exercise the same. 

(ii) The Collateral Agent shall execute and deliver to each Grantor, or cause to be executed and delivered to each Grantor, all
such proxies, powers of attorney and other instruments as each Grantor may reasonably request in writing for the purpose of enabling such Grantor to exercise the voting and/or consensual rights and powers it is entitled to exercise pursuant to
subparagraph (i) above. 
 (iii) Each Grantor shall be entitled to receive and retain any and all dividends, interest,
principal and other distributions paid on or distributed in respect of the Pledged Securities to the extent and only to the extent that such dividends, interest, principal and other distributions are permitted by, and otherwise paid or distributed
in accordance with, the terms and conditions of the Indenture, the Security Documents and applicable Laws; provided that any noncash (and non-cash equivalent) dividends, interest, principal or other
distributions that would constitute Pledged Equity or Pledged Debt, whether resulting from a subdivision, combination or reclassification of the outstanding Equity Interests of the issuer of any Pledged Securities or received in exchange for Pledged
Securities or any part thereof, or in redemption thereof, or as a result of any merger, consolidation, acquisition or other exchange of assets to which such issuer may be a party or otherwise, shall be and become part of the Pledged Collateral, and,
if received by any Grantor, shall not be commingled by such Grantor with any of its other funds or property but shall be held separate and apart therefrom, shall be held in trust for the benefit of the Collateral Agent and the Secured Parties and
shall be forthwith delivered to the Collateral Agent in the same form as so received (with any necessary endorsement reasonably requested by the Collateral Agent). 

  
 11 

 (b) Upon the occurrence and during the continuance of an Event of Default, after the
Collateral Agent shall have notified the Company of the suspension of the rights of the Grantors under paragraph (a)(iii) of this Section 2.06, then all rights of any Grantor to dividends, interest, principal or other distributions that
such Grantor is authorized to receive pursuant to paragraph (a)(iii) of this Section 2.06 shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall have the sole and exclusive right and authority
to receive and retain such dividends, interest, principal or other distributions. All dividends, interest, principal or other distributions received by any Grantor contrary to the provisions of this Section 2.06 shall be held in trust for the
benefit of the Collateral Agent, shall be segregated from other property or funds of such Grantor and shall be forthwith delivered to the Collateral Agent upon demand in the same form as so received (with any necessary endorsement reasonably
requested by the Collateral Agent). Any and all money and other property paid over to or received by the Collateral Agent pursuant to the provisions of this paragraph (b) shall be retained by the Collateral Agent in an account to be established
by the Collateral Agent upon receipt of such money or other property and shall be applied in accordance with the provisions of Section 4.02 hereof. After all Events of Default have been cured or waived, the Collateral Agent shall promptly repay
to each Grantor (without interest) all dividends, interest, principal or other distributions that such Grantor would otherwise be permitted to retain pursuant to the terms of paragraph (a)(iii) of this Section 2.06 and that remain in such
account. 
 (c) Upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent shall have notified the
Company of the suspension of the rights of the Grantors under paragraph (a)(i) of this Section 2.06, then all rights of any Grantor to exercise the voting and consensual rights and powers it is entitled to exercise pursuant to
paragraph (a)(i) of this Section 2.06, and the obligations of the Collateral Agent under paragraph (a)(ii) of this Section 2.06, shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall
have the sole and exclusive right and authority to exercise such voting and consensual rights and powers; provided that, unless otherwise directed by Holders of a majority in aggregate principal amount of the then outstanding Notes, the
Collateral Agent shall have the right from time to time following and during the continuance of an Event of Default to permit the Grantors to exercise such rights at the discretion of the Collateral Agent. After all Events of Default have been cured
or waived, each Grantor shall have the exclusive right to exercise the voting and/or consensual rights and powers that such Grantor would otherwise be entitled to exercise pursuant to the terms of paragraph (a)(i) of this Section 2.06.

 (d) Any notice given by the Collateral Agent to the Company suspending the rights of the Grantors under paragraph (a) of this
Section 2.06 (i) shall be given in writing, (ii) may be given with respect to one or more of the Grantors at the same or different times and (iii) may suspend the rights of the Grantors under paragraph (a)(i) or
paragraph (a)(iii) of this Section 2.06 in part without suspending all such rights (as specified by the Collateral Agent in its sole and absolute discretion) and without waiving or otherwise affecting the Collateral Agent’s rights to
give additional notices from time to time suspending other rights so long as an Event of Default has occurred and is continuing. 

SECTION 2.07. Collateral Agent Not a Partner or Limited Liability Company Member. Nothing contained in this
Agreement shall be construed to make the Collateral Agent or any other Secured Party liable as a member of any limited liability company or as a partner of any partnership and neither the Collateral Agent nor any other Secured Party by virtue of
this Agreement or otherwise (except as referred to in the following sentence) shall have any of the duties, obligations or liabilities of a member of any limited liability company or as a partner in any partnership. The parties hereto expressly
agree that this Agreement shall not be construed as creating a partnership or joint venture among the Collateral Agent, any other Secured Party, any Grantor and/or any other Person. 

  
 12 

 ARTICLE III 

Security Interests in Personal Property 

SECTION 3.01. Security Interest. (a) As security for the payment or performance, as the case may be, in full of the
Obligations, including the Guarantees, each Grantor hereby grants to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, a security interest (the “Security Interest”) in and lien on all
right, title or interest in or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest
(collectively, the “Article 9 Collateral”): 
 (i) all Accounts; 

(ii) all Chattel Paper; 

(iii) all Commercial Tort Claims listed on Schedule II hereto; 

(iv) all Deposit Accounts; 

(v) all Documents; 

(vi) all Equipment; 

(vii) all General Intangibles; 

(viii) all Goods; 

(ix) all Instruments; 

(x) all Inventory; 

(xi) all Investment Property; 

(xii) all books and records pertaining to the Article 9 Collateral; and 

(xiii) to the extent not otherwise included, all Proceeds and products of any and all of the foregoing and all supporting
obligations, collateral security and guarantees given by any Person with respect to any of the foregoing; 
 provided that
notwithstanding anything to the contrary in this Agreement, this Agreement shall not constitute a grant of a security interest in any Excluded Asset (which Excluded Assets, for the avoidance of doubt, shall not constitute “Article 9
Collateral”). 

  
 13 

 (b) Each Grantor hereby irrevocably authorizes the Collateral Agent for the benefit of the
Secured Parties at any time and from time to time to file in any relevant jurisdiction any initial financing statements (including fixture filings) with respect to the Article 9 Collateral or any part thereof and amendments thereto that
(i) indicate the Collateral as all assets of such Grantor or words of similar effect as being of an equal or lesser scope or with greater detail, and (ii) contain the information required by Article 9 of the Uniform Commercial Code or
the analogous legislation of each applicable jurisdiction for the filing of any financing statement or amendment, including (A) whether such Grantor is an organization, the type of organization and, if required, any organizational
identification number issued to such Grantor and (B) in the case of a financing statement filed as a fixture filing, a sufficient description of the real property to which such Article 9 Collateral relates; provided, however,
that the right of the Collateral Agent to file financing statements hereunder shall not be construed as a duty to do so. Each Grantor agrees to provide such information to the Collateral Agent promptly upon any reasonable request. Each Grantor shall
file on behalf of the Collateral Agent, for the benefit of the Secured Parties, any financing statements in the relevant jurisdiction necessary to perfect the security interests in the Article 9 Collateral granted hereunder. 

(c) The Security Interest is granted as security only and shall not subject the Collateral Agent or any other Secured Party to, or in any way
alter or modify, any obligation or liability of any Grantor with respect to or arising out of the Article 9 Collateral. 
 (d) The
Collateral Agent is authorized to file with the USPTO or the USCO (or any successor office in the United States or any applicable office in any other country) such documents as may be necessary or advisable for the purpose of perfecting, confirming,
continuing, enforcing or protecting the Security Interest in United States Intellectual Property that constitutes Article 9 Collateral granted by each Grantor, without the signature of any Grantor, and naming any Grantor or the Grantor as debtors
and the Collateral Agent as a secured party; provided, however, that such authorization shall not be construed as a duty on the part of the Collateral Agent to file such documents. 

(e) Notwithstanding anything to the contrary in the Indenture, none of the Grantors shall be required to enter into any deposit account control
agreement or securities account control agreement with respect to any deposit account or securities account. 
 SECTION 3.02.
Representations and Warranties. Holdings and the Company jointly and severally represent and warrant, as to themselves and the other Grantors, to the Collateral Agent and the Secured Parties that: 

(a) Each Grantor has good and valid rights in and title to the material Article 9 Collateral with respect to which it has purported to
grant a Security Interest hereunder and has full power and authority to grant to the Collateral Agent the Security Interest in such Article 9 Collateral pursuant hereto and to execute, deliver and perform its obligations in accordance with the
terms of this Agreement, without the consent or approval of any other Person other than any consent or approval that has been obtained. 

  
 14 

 (b) The information set forth in the Perfection Certificate, including the exact legal name
of each Grantor, is correct and complete in all material respects as of the date hereof. The Uniform Commercial Code financing statements (including fixture filings, as applicable) or other appropriate filings, recordings or registrations prepared
based upon the information provided to the Collateral Agent in the Perfection Certificate for filing in each governmental, municipal or other office specified in Schedule 6 to the Perfection Certificate (or specified by notice from the Company to
the Collateral Agent after the date hereof in the case of filings, recordings or registrations (other than filings required to be made in the USPTO and the USCO in order to perfect the Security Interest in Article 9 Collateral consisting of United
States Patents, Trademarks and Copyrights) required by Section 10.03 of the Indenture), are all the filings, recordings and registrations that are necessary to establish a legal, valid and perfected security interest in favor of the Collateral
Agent (for the benefit of the Secured Parties) in respect of all Article 9 Collateral (other than Article 9 Collateral consisting of Intellectual Property) in which the Security Interest may be perfected by filing, recording or registration in the
United States (or any political subdivision thereof) and its territories and possessions, and no further or subsequent filing, refiling, recording, rerecording, registration or reregistration is necessary in any such jurisdiction, except as provided
under applicable law with respect to the filing of continuation statements. 
 (c) Each Grantor represents and warrants that short-form
Intellectual Property Security Agreements containing a description of all Article 9 Collateral consisting of United States Patents, United States registered Trademarks (and Trademarks for which United States registration applications are
pending, unless it constitutes an Excluded Asset) and United States registered Copyrights, respectively, have been delivered to the Collateral Agent for recording by the USPTO and the USCO pursuant to 35 U.S.C. § 261, 15 U.S.C. § 1060 or
17 U.S.C. § 205 and the regulations thereunder, as applicable, as may be necessary to establish a valid and perfected security interest in favor of the Collateral Agent (for the benefit of the Secured Parties) in respect of all Article 9
Collateral consisting of Patents, Trademarks and Copyrights in which a security interest may be perfected by filing, recording or registration in the USPTO and the USCO, as applicable, in the United States (or any political subdivision thereof) and
its territories and possessions under the Federal intellectual property laws, and no further or subsequent filing, refiling, recording, rerecording, registration or reregistration is necessary (other than (i) such filings and actions as are
necessary to perfect the Security Interest with respect to any Article 9 Collateral consisting of Patents, Trademarks and Copyrights (or registration or application for registration thereof) acquired or developed by any Grantor after the date
hereof, (ii) as may be required under the laws of jurisdictions outside the United States with respect to Article 9 Collateral created under such laws, and (iii) the UCC financing and continuation statements contemplated in
Section 3.02(b)). 
 (d) The Security Interest constitutes (i) a legal and valid security interest in all the Article 9 Collateral
securing the payment and performance of the Obligations; (ii) subject to the filings described in Section 3.02(b), a perfected security interest in all Article 9 Collateral in which a security interest may be perfected by filing, recording
or registering a financing statement or analogous document in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Uniform Commercial Code in the relevant jurisdiction and (iii) subject to
the filings described in Section 3.02(c), a perfected security interest in all Intellectual Property in which a security interest may be perfected upon the receipt and recording of fully executed short-form Intellectual Property Security
Agreements with the USPTO and the USCO, as applicable. The Security Interest is and shall be prior to any other Lien on any of the Article 9 Collateral, other than (i) any nonconsensual Lien that is permitted pursuant to Section 4.12 of
the Indenture and has priority as a matter of law and (ii) Liens permitted pursuant to Section 4.12 of the Indenture. 

  
 15 

 (e) The material Article 9 Collateral is owned by the Grantors free and clear of any Lien,
except for Liens permitted pursuant to Section 4.12 of the Indenture. None of the Grantors has filed or consented to the filing of (i) any financing statement or analogous document under the New York UCC or any other applicable United
States laws covering any Article 9 Collateral, (ii) any assignment in which any Grantor assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with the USPTO or the USCO or
(iii) any assignment in which any Grantor assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with any foreign governmental, municipal or other office, which financing statement or
analogous document, assignment, security agreement or similar instrument is still in effect, except, in each case, for Liens permitted pursuant to Section 4.12 of the Indenture. 

SECTION 3.03. Covenants. (a) The Company agrees promptly (and in any event within 60 days of such change) to notify the
Collateral Agent in writing of any change in (i) the legal name, (ii) the identity or type of organization or corporate structure, (iii) the jurisdiction of organization, (iv) the chief executive office or (v) the
organizational identification number, of any Grantor. In addition, if any Grantor does not have an organizational identification number on the date hereof (or the date such Grantor becomes a party to this Agreement) and later obtains one, the
Company shall promptly (and in any event within 60 days of such change) thereafter notify the Collateral Agent of such organizational identification number and shall take all actions reasonably requested by the Collateral Agent to the extent
necessary to maintain the security interests (and the priority thereof) of the Collateral Agent in the Article 9 Collateral intended to be granted hereby fully perfected and in full force and effect. 

(b) Upon becoming aware of any defect in the security interests (and the priority thereof, except as permitted pursuant to Section 4.12 of
the Indenture) of the Collateral Agent in the Article 9 Collateral intended to be granted hereby, the Company agrees promptly (and in any event within 60 days of such knowledge) to notify the Collateral Agent in writing of such defect. 

(c) Each year, at the time of delivery of annual financial statements with respect to the preceding fiscal year pursuant to Section 4.03
of the Indenture, the Company shall deliver to the Collateral Agent an updated Perfection Certificate executed by the chief financial officer or the chief legal officer of each of Holdings and the Company, setting forth any information required
therein that has changed or confirming that there has been no change in such information since the date of such certificate or the date of the most recent certificate delivered pursuant to this Section 3.03(c) and certifying that all UCC
financing statements, Intellectual Property Security Agreements and other appropriate filings, recordings or registrations have been filed of record in each governmental, municipal or other appropriate office in each jurisdiction necessary to
protect and perfect the Security Interests and Liens in the United States under this Agreement. 

  
 16 

 (d) The Company agrees, on its own behalf and on behalf of each other Grantor, at its own
expense, to execute, acknowledge, deliver and cause to be duly filed all such further instruments and documents and take all such actions required from time to time to assure, preserve, protect and perfect the Security Interest and the rights and
remedies created hereby, including the payment of any fees and taxes required in connection with the execution and delivery of this Agreement, the granting of the Security Interest and the filing of any financing statements (including fixture
filings) or other documents in connection herewith or therewith. 
 (e) At its option, the Collateral Agent may discharge past due taxes,
assessments, charges, fees, Liens, security interests or other encumbrances at any time levied or placed on the Article 9 Collateral and not permitted pursuant to Section 4.12 of the Indenture, and may pay for the maintenance and preservation
of the Article 9 Collateral to the extent any Grantor fails to do so as required by the Indenture or this Agreement and within a reasonable period of time after the Collateral Agent has requested that it do so, and each Grantor jointly and severally
agrees to reimburse the Collateral Agent within 10 Business Days after demand for any payment made or any reasonable expense incurred by the Collateral Agent pursuant to the foregoing authorization; provided, however, Grantors shall
not be obligated to reimburse the Collateral Agent with respect to any Article 9 Collateral consisting of Intellectual Property which any Grantor has failed to maintain or pursue, or otherwise allowed to lapse, terminate or be put into the public
domain, in accordance with Section 3.03(i)(ix). Nothing in this paragraph shall be interpreted as excusing any Grantor from the performance of, or imposing any obligation on the Collateral Agent or any Secured Party to cure or perform, any
covenants or other promises of any Grantor with respect to taxes, assessments, charges, fees, Liens, security interests or other encumbrances and maintenance as set forth herein, in the Indenture or in any other Security Document. 

(f) If at any time any Grantor shall take a security interest in any property of an Account Debtor or any other Person, the value of which is
in excess of $10,000,000, to secure payment and performance of an Account, such Grantor shall promptly assign such security interest to the Collateral Agent for the benefit of the Secured Parties. Such assignment need not be filed of public record
unless necessary to continue the perfected status of the security interest against creditors of and transferees from the Account Debtor or other Person granting the security interest. 

(g) Each Grantor (rather than the Collateral Agent or any Secured Party) shall remain liable (as between itself and any relevant counterparty)
to observe and perform all the conditions and obligations to be observed and performed by it under each contract, agreement or instrument relating to the Article 9 Collateral, all in accordance with the terms and conditions thereof, and each
Grantor jointly and severally agrees to indemnify and hold harmless the Collateral Agent and the Secured Parties from and against any and all liability for such performance. 

(h) If any Grantor shall at any time hold or acquire a Commercial Tort Claim with a value in excess of $10,000,000 and for which such Grantor
(or predecessor in interest) has filed a complaint in a court of competent jurisdiction, such Grantor shall promptly notify the Collateral Agent in writing signed by such Grantor of the brief details thereof and grant to the Collateral Agent a
security interest therein and in the Proceeds thereof, all upon the terms of this Agreement pursuant to a document in form and substance reasonably satisfactory to the Collateral Agent. 

  
 17 

 (i) Intellectual Property Covenants, Representations and Warranties: 

(i) Other than to the extent permitted herein or in the Indenture or with respect to registration and applications no longer
used, and except to the extent failure to act would not, as deemed by the Company in its reasonable business judgment, be reasonably expected to have a Material Adverse Effect, with respect to registration or pending application of each item of its
Article 9 Collateral consisting of Intellectual Property for which such Grantor has standing to do so, each Grantor agrees to take, at its expense, all reasonable steps, including, without limitation, in the USPTO, the USCO and any other
governmental authority located in the United States, to diligently pursue the registration and maintenance of each Patent, Trademark, or Copyright registration or application and shall not abandon any such application prior to exhaustion of all
administrative and judicial remedies, now or hereafter included in such Article 9 Collateral consisting of Intellectual Property of such Grantor where reasonable to do so. Each Grantor shall take all reasonable steps to maintain its trade secrets
under applicable law and to preserve the secrecy of its confidential information. 
 (ii) Other than to the extent permitted
herein or in the Indenture, or with respect to registration and applications no longer used, or except as would not, as deemed by the Company in its reasonable business judgment, be reasonably expected to have a Material Adverse Effect, no Grantor
shall do or permit any act or knowingly omit to do any act whereby any of its Article 9 Collateral consisting of Intellectual Property may lapse, be terminated, or become invalid or unenforceable or placed in the public domain (or in the case of a
trade secret, become publicly known). 
 (iii) Other than as excluded or as permitted herein or in the Indenture, or with
respect to Patents, Copyrights or Trademarks which are no longer used or useful in the Grantor’s business operations or except where failure to do so would not, as deemed by the applicable Grantor in its reasonable business judgment, be
reasonably expected to have a Material Adverse Effect, each Grantor shall take all reasonable steps to preserve and protect each item of its Article 9 Collateral consisting of Intellectual Property, including, without limitation,
(A) maintaining the quality of any and all products or services used or provided in connection with any of the Trademarks of such Grantor, at least consistent with the quality of such products and services as of the date hereof, (B) taking
all reasonable steps necessary to ensure that all licensed users of any of the Trademarks abide by the applicable license’s terms with respect to standards of quality and (C) using the Trademarks which are material to such Grantor’s
business in interstate commerce during the time in which this Agreement is in effect and taking all reasonable steps to preserve such Trademarks under the laws of the relevant jurisdiction. Each Grantor agrees to renew those of its domain name
registrations that are material to such Grantor’s business. 

  
 18 

 (iv) Each Grantor represents and warrants that it is the lawful owner of all
of its material Article 9 Collateral consisting of Intellectual Property (excluding Intellectual Property granted pursuant to Licenses), including (i) the Patents listed in the Perfection Certificate for such Grantor, and that said Patents
include all the material United States patents and applications that such Grantor owns as of the date hereof, and (ii) the Copyrights listed in the Perfection Certificate for such Grantor, and that said Copyrights include all the United States
copyrights registered and applied for with the USCO for material United States copyrights that such Grantor owns as of the date hereof. 

(v) Each Grantor further represents and warrants that the Trademarks and domain names listed in the Perfection Certificate
include all material United States registered marks and applications for United States registered marks in the USPTO and all material domain names that such Grantor owns in connection with its business as of the date hereof. Each Grantor represents
and warrants that it is the lawful owner of all U.S. trademark registrations and applications and domain name registrations listed in the Perfection Certificate and that said registrations are subsisting and have not been canceled, and that such
Grantor has not received any written third-party claim that any of said registrations is invalid or unenforceable, other than as would not, either individually or in the aggregate, in the Grantor’s reasonable opinion, be reasonably expected to
have a Material Adverse Effect. 
 (vi) Each Grantor agrees, promptly upon learning thereof, to notify the Collateral Agent
in writing of the name and address of, and to furnish such pertinent information that may be available with respect to, any party who such Grantor learns is likely to be infringing, contributorily infringing, actively inducing infringement,
misappropriating or otherwise violating any of such Grantor’s rights in and to any Intellectual Property in any manner that would, in the Grantor’s reasonable opinion, reasonably be expected to have a Material Adverse Effect, or with
respect to any party claiming that such Grantor’s use of any Intellectual Property material to such Grantor’s business violates in any material respect any property right of such party. Each Grantor further agrees to take appropriate
actions diligently against, including but not limited to prosecution of, in accordance with reasonable business practices, any Person infringing any of such Grantor’s Intellectual Property rights in any manner that would, in the Grantor’s
reasonable opinion, reasonably be expected to, either individually or in the aggregate, have a Material Adverse Effect. 

(vii) If any Grantor acquires, makes an application for, or is issued a registration for Intellectual Property before the
USPTO, the USCO, or an equivalent thereof in any state of the United States, such Grantor shall, at its own expense, deliver to the Collateral Agent a grant of a security interest in such application or registration, within sixty (60) days of
the submission of such application or receipt of registration (twenty (20) days in the case of Copyrights) confirming the grant of a security interest in such Intellectual Property to the Collateral Agent hereunder. Such Security Interest must
be substantially in the form of Exhibit III hereto in the case of Patents, Exhibit IV hereto in the case of Trademarks, or Exhibit V hereto in the case of Copyrights, or in such other form as may be reasonably satisfactory to the Collateral Agent.

  
 19 

 (viii) Concurrently with the delivery of the Perfection Certificate pursuant
to Section 3.03(c), and upon reasonable request by the Collateral Agent (but in any event, not more than three times per fiscal year), if a United States Patent or an application for a United States Patent, a registered United States Copyright,
or an application for a United States Copyright is issued or acquired by a Grantor, the relevant Grantor shall deliver to the Collateral Agent a copy of said Copyright or Patent, or certificate or registration of, or application therefor, as the
case may be, and shall update, through amendment or by other written document executed by and reasonably acceptable to the Collateral Agent and such Grantor, the relevant schedules of any Intellectual Property Security Agreement filed with the USPTO
or USCO, as applicable, pursuant to this Agreement, such that any such update may be filed with the USPTO or USCO, as applicable. 

(ix) Nothing in this Agreement, in the Indenture or in any other Security Document prevents any Grantor from disposing of,
discontinuing the use or maintenance of, failing to pursue, or otherwise allowing to lapse, terminating or putting into the public domain, any of its Article 9 Collateral consisting of Intellectual Property to the extent permitted by the Indenture
if such Grantor determines in its reasonable business judgment that such discontinuance is desirable in the conduct of its business. 

SECTION 3.04. Other Actions. In order to further insure the attachment, perfection and priority of, and the ability of the
Collateral Agent to enforce, the Security Interest, each Grantor agrees, in each case at such Grantor’s own expense, to take the following actions with respect to the following Article 9 Collateral: 

(a) Instruments. If any Grantor shall at any time hold or acquire any Instruments constituting Article 9 Collateral and evidencing
an amount in excess of $10,000,000, such Grantor shall forthwith endorse, assign and deliver the same to the Collateral Agent for the benefit of the Secured Parties, accompanied by such instruments of transfer or assignment duly executed in blank as
the Collateral Agent may from time to time reasonably request. 
 (b) Investment Property. Except to the extent otherwise provided in
Article II, if any Grantor shall at any time hold or acquire any certificated securities, such Grantor shall forthwith endorse, assign and deliver the same to the Collateral Agent for the benefit of the Secured Parties, accompanied by such
instruments of transfer or assignment duly executed in blank as the Collateral Agent may from time to time reasonably request. If any securities now or hereafter acquired by any Grantor are uncertificated and are issued to such Grantor or its
nominee directly by the issuer thereof, following the occurrence of an Event of Default such Grantor shall promptly notify the Collateral Agent thereof and, at the Collateral Agent’s reasonable request, pursuant to an agreement in form and
substance reasonably satisfactory to the Collateral Agent, either (i) cause the issuer to agree to comply with instructions from the Collateral Agent as to such securities, without further consent of any Grantor or such nominee, or
(ii) arrange for the Collateral Agent to become the registered owner of such securities. If any securities, whether certificated or uncertificated, or other investment property are held by any Grantor or its nominee through a securities
intermediary or commodity intermediary, following the occurrence of an Event of Default, such Grantor shall immediately notify the Collateral Agent thereof and at the Collateral Agent’s request and option, pursuant to an agreement in form and
substance reasonably satisfactory to the Collateral Agent shall either (i) cause such securities intermediary or (as the case may be) commodity intermediary to agree to comply with entitlement orders or other instructions from the Collateral
Agent to such securities 

  
 20 

 
intermediary as to such security entitlements, or (as the case may be) to apply any value distributed on account of any commodity contract as directed by the Collateral Agent to such commodity
intermediary, in each case without further consent of any Grantor or such nominee, or (ii) in the case of financial assets or other Investment Property held through a securities intermediary, arrange for the Collateral Agent to become the
entitlement holder with respect to such Investment Property, with the Grantor being permitted, only with the consent of the Collateral Agent, to exercise rights to withdraw or otherwise deal with such Investment Property. The Collateral Agent agrees
with each of the Grantors that the Collateral Agent shall not give any such entitlement orders or instructions or directions to any such issuer, securities intermediary or commodity intermediary, and shall not withhold its consent to the exercise of
any withdrawal or dealing rights by any Grantor, unless an Event of Default has occurred and is continuing. The provisions of this paragraph shall not apply to any financial assets credited to a securities account for which the Collateral Agent is
the securities intermediary. 
 ARTICLE IV 

Remedies 
 SECTION 4.01.
Remedies upon Default. Upon the occurrence and during the continuance of an Event of Default, it is agreed that the Collateral Agent shall have the right to exercise any and all rights afforded to a secured party with respect to the
Obligations under the Uniform Commercial Code or other applicable law and also may (i) require each Grantor to, and each Grantor agrees that it will at its expense and upon request of the Collateral Agent forthwith, assemble all or part of the
Collateral as directed by the Collateral Agent and make it available to the Collateral Agent at a place and time to be designated by the Collateral Agent that is reasonably convenient to both parties; (ii) occupy any premises owned or, to the
extent lawful and permitted, leased by any of the Grantors where the Collateral or any part thereof is assembled or located for a reasonable period in order to effectuate its rights and remedies hereunder or under law, without obligation to such
Grantor in respect of such occupation; provided that the Collateral Agent shall provide the applicable Grantor with notice thereof prior to or promptly after such occupancy; (iii) declare the entire right, title, and interest of such
Grantor in each of the Patents, Trademarks, domain names and Copyrights vested in the Collateral Agent for the benefit of the Secured Parties (in which event such right, title, and interest shall immediately vest in the Collateral Agent for the
benefit of the Secured Parties, and the Collateral Agent shall be entitled to exercise the power of attorney referred to below in Section 4.03 hereof to execute, cause to be acknowledged and notarized and to record said absolute assignment with
the applicable agency); (iv) exercise any and all rights and remedies of any of the Grantors under or in connection with the Collateral, or otherwise in respect of the Collateral; provided that the Collateral Agent shall provide the
applicable Grantor with notice thereof prior to or promptly after such exercise; and (v) subject to the mandatory requirements of applicable law and the notice requirements described below, sell or otherwise dispose of all or any part of the
Collateral securing the Obligations at a public or private sale or at any broker’s board or on any securities exchange, for cash, upon credit or for future delivery as the Collateral Agent shall deem appropriate. The Collateral Agent shall be
authorized at any such sale of securities (if it deems it advisable to do so) to restrict the prospective bidders or purchasers to Persons who will represent and agree that they are purchasing the Collateral for their own account for investment and
not with a view to the distribution or sale thereof, and upon 

  
 21 

 
consummation of any such sale the Collateral Agent shall have the right to assign, transfer and deliver to the purchaser or purchasers thereof the Collateral so sold. Each such purchaser at any
sale of Collateral shall hold the property sold absolutely, free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by law) all rights of redemption, stay and appraisal which such Grantor now
has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted. Upon the occurrence and during the continuance of an Event of Default, the Grantors agree to execute such further documents as the
Collateral Agent may reasonably request to transfer ownership of the Patents, Trademarks, domain names and Copyrights to the Collateral Agent for the benefit of the Secured Parties. 

The Collateral Agent shall give the applicable Grantors 10 days’ written notice (which each Grantor agrees is reasonable notice within
the meaning of Section 9-611 of the New York UCC or its equivalent in other jurisdictions) of the Collateral Agent’s intention to make any sale of Collateral. Such notice, in the case of a public
sale, shall state the time and place for such sale and, in the case of a sale at a broker’s board or on a securities exchange, shall state the board or exchange at which such sale is to be made and the day on which the Collateral, or portion
thereof, will first be offered for sale at such board or exchange. Any such public sale shall be held at such time or times within ordinary business hours and at such place or places as the Collateral Agent may fix and state in the notice (if any)
of such sale. At any such sale, the Collateral, or portion thereof, to be sold may be sold in one lot as an entirety or in separate parcels, as the Collateral Agent may (in its sole and absolute discretion) determine. The Collateral Agent shall not
be obligated to make any sale of any Collateral if it shall determine not to do so, regardless of the fact that notice of sale of such Collateral shall have been given. The Collateral Agent may, without notice or publication, adjourn any public or
private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for sale, and such sale may, without further notice, be made at the time and place to which the same was so adjourned. In case any sale of
all or any part of the Collateral is made on credit or for future delivery, the Collateral so sold may be retained by the Collateral Agent until the sale price is paid by the purchaser or purchasers thereof, but the Collateral Agent shall not incur
any liability in case any such purchaser or purchasers shall fail to take up and pay for the Collateral so sold and, in case of any such failure, such Collateral may be sold again upon like notice. At any public (or, to the extent permitted by law,
private) sale made pursuant to this Agreement, any Secured Party may bid for or purchase, free (to the extent permitted by law) from any right of redemption, stay, valuation or appraisal on the part of any Grantor (all said rights being also hereby
waived and released to the extent permitted by law), the Collateral or any part thereof offered for sale and may make payment on account thereof by using any claim then due and payable to such Secured Party from any Grantor as a credit against the
purchase price, and such Secured Party may, upon compliance with the terms of sale, hold, retain and dispose of such property without further accountability to any Grantor therefor. For purposes hereof, a written agreement to purchase the Collateral
or any portion thereof shall be treated as a sale thereof; the Collateral Agent shall be free to carry out such sale pursuant to such agreement and no Grantor shall be entitled to the return of the Collateral or any portion thereof subject thereto,
notwithstanding the fact that after the Collateral Agent shall have entered into such an agreement all Events of Default shall have been remedied and the Obligations paid in full. As an alternative to exercising the power of sale herein conferred
upon it, the Collateral Agent may proceed by a suit or suits at law or in equity to foreclose this Agreement and to sell the Collateral or any portion thereof pursuant to a judgment or decree of a court or courts having competent jurisdiction or
pursuant to a proceeding by a court appointed receiver. Any sale pursuant to the provisions of this Section 4.01 shall be deemed to conform to the commercially reasonable standards as provided in
Section 9-610(b) of the New York UCC or its equivalent in other jurisdictions. 

  
 22 

 Each Grantor irrevocably makes, constitutes and appoints the Collateral Agent (and all
officers, employees or agents designated by the Collateral Agent) as such Grantor’s true and lawful agent (and attorney-in-fact) during the continuance of an Event
of Default and after notice to the Company of its intent to exercise such rights, for the purpose of (i) making, settling and adjusting claims in respect of Article 9 Collateral under policies of insurance, endorsing the name of such
Grantor on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance and (ii) making all determinations and decisions with respect thereto. 

SECTION 4.02. Application of Proceeds. (a) The Collateral Agent shall apply the proceeds of any collection or
sale of Collateral, including any Collateral consisting of cash, in accordance with Section 6.10 of the Indenture. 
 (b) The Collateral
Agent shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Agreement and the Indenture. Upon any sale of Collateral by the Collateral Agent (including pursuant to a power of
sale granted by statute or under a judicial proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers
shall not be obligated to see to the application of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable in any way for the misapplication thereof. 

(c) In making the determinations and allocations required by this Section 4.02, the Collateral Agent may conclusively rely upon
information supplied by the Collateral Agent as to the amounts of unpaid principal and interest and other amounts outstanding with respect to the Obligations, and the Collateral Agent shall have no liability to any of the Secured Parties for actions
taken in reliance on such information, provided that nothing in this sentence shall prevent any Grantor from contesting any amounts claimed by any Secured Party in any information so supplied. All distributions made by the Collateral Agent
pursuant to this Section 4.02 shall be (subject to any decree of any court of competent jurisdiction) final (absent manifest error), and the Collateral Agent shall have no duty to inquire as to the application by the Collateral Agent of any
amounts distributed by it. It is understood and agreed that the Grantors shall remain jointly and severally liable to the extent of any deficiency between the amount of the proceeds of the Collateral and the aggregate amount of the Obligations. 

SECTION 4.03. Grant of License to Use Intellectual Property; Power of Attorney. For the exclusive purpose of
enabling the Collateral Agent to exercise rights and remedies under this Agreement at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, each Grantor shall, upon prior written request by the Collateral
Agent at any time during the continuance of an Event of Default, grant to the 

  
 23 

 
Collateral Agent a non-exclusive, irrevocable, royalty-free, limited license (until the termination or cure of the Event of Default) to use, license or
sublicense any of the Intellectual Property Collateral now owned or hereafter acquired by such Grantor, and wherever the same may be located, and including in such license reasonable access to all media in which any of the licensed items may be
recorded or stored and to all computer software and programs used for the compilation or printout thereof; provided, however, that nothing in this Section 4.03 shall require Grantors to grant any license that is prohibited by any
rule of law, statute or regulation, or is prohibited by, or constitutes a breach or default under or results in the termination of any contract, license, agreement, instrument or other document with respect to such property or otherwise unreasonably
prejudices the value thereof to the relevant Grantor; provided, further, that such licenses to be granted hereunder with respect to Trademarks shall be subject to the maintenance of quality standards with respect to the goods and
services on which such Trademarks are used sufficient to preserve the validity of such Trademarks. For the avoidance of doubt, the use of such license by the Collateral Agent may be exercised, at the option of the Collateral Agent, only during the
continuation of an Event of Default. Furthermore, each Grantor hereby grants to the Collateral Agent an absolute power of attorney to sign, upon the occurrence and during the continuance of any Event of Default, any document which may be required by
the USPTO or the USCO in order to effect an absolute assignment of all right, title and interest in each Patent, Trademark or Copyright, and to record the same. 

ARTICLE V 
 Indemnity,
Subrogation and Subordination 
 SECTION 5.01. Indemnity. In addition to all such rights of indemnity and subrogation as the
Grantors may have under applicable law (but subject to Section 5.03), the Company agrees that, in the event any assets of any Grantor shall be sold pursuant to this Agreement or any other Security Document to satisfy in whole or in part an
Obligation owed to any Secured Party, the Company shall indemnify such Grantor in an amount equal to the greater of the book value or the fair market value of the assets so sold. 

SECTION 5.02. Contribution and Subrogation. Each Grantor (a “Contributing Party”) agrees (subject to
Section 5.03) that, in the event assets of any other Grantor shall be sold pursuant to any Security Document to satisfy any Obligation owed to any Secured Party, and such other Grantor (the “Claiming Party”) shall not have been
fully indemnified by the Company as provided in Section 5.01, the Contributing Party shall indemnify the Claiming Party in an amount equal to the greater of the book value or the fair market value of such assets, in each case multiplied by a
fraction of which the numerator shall be the net worth of the Contributing Party on the date hereof and the denominator shall be the aggregate net worth of all the Contributing Parties together with the net worth of the Claiming Party on the date
hereof (or, in the case of any Grantor becoming a party hereto pursuant to Section 7.14, the date of the Security Agreement Supplement hereto executed and delivered by such Grantor). Any Contributing Party making any payment to a Claiming Party
pursuant to this Section 5.02 shall be subrogated to the rights of such Claiming Party to the extent of such payment. 

  
 24 

 SECTION 5.03. Subordination. Notwithstanding any provision of this Agreement to
the contrary, all rights of the Grantors under Sections 5.01 and 5.02 and all other rights of indemnity, contribution or subrogation under applicable law or otherwise shall be fully subordinated to the indefeasible payment in full in cash of the
Obligations, provided that if any amount shall be paid to such Grantor on account of such subrogation rights at any time prior to the irrevocable payment in full in cash of all the Obligations, such amount shall be held in trust for the
benefit of the Secured Parties and shall forthwith be paid to the Collateral Agent to be credited and applied against the Obligations, whether matured or unmatured, in accordance with Section 6.10 of the Indenture. No failure on the part of the
Company or any Grantor to make the payments required by Sections 5.01 and 5.02 (or any other payments required under applicable law or otherwise) shall in any respect limit the obligations and liabilities of any Grantor with respect to its
obligations hereunder, and each Grantor shall remain liable for the full amount of the obligations of such Grantor hereunder. 
 ARTICLE
VI 
 Intercreditor Agreement 

SECTION 6.01. Intercreditor Agreement. Notwithstanding anything herein to the contrary, the lien and security interest granted to
the Collateral Agent pursuant to this Agreement and the exercise of any right or remedy by the Collateral Agent hereunder are subject to the provisions of the Intercreditor Agreement. In the event of any conflict between the terms of the
Intercreditor Agreement and this Agreement, the terms of the Intercreditor Agreement shall govern and control. The Trustee, by its acceptance hereof, and the Collateral Agent, each in its capacity as an Additional Senior Class Debt
Representative (under and as defined in the Intercreditor Agreement), and each Holder of the Notes, by its acceptance hereof, acknowledges and agrees that upon the Additional Senior Class Debt Representatives’ entry into the Intercreditor
Joinder Agreement, the Additional Senior Class Debt Representatives and each Holder of the Notes will be subject to and bound by the provisions of the Intercreditor Agreement as Additional First-Lien Secured Parties (as defined therein). 

SECTION 6.02. Obligations of Grantors. To the extent that the obligations of any Grantor hereunder shall conflict, or shall be
inconsistent, with the obligations of such Grantor under the Intercreditor Agreement, the provisions of the Intercreditor Agreement shall control. 

SECTION 6.03. Delivery of Collateral. Notwithstanding anything herein to the contrary, prior to the Discharge of Credit Agreement
Obligations (as defined in the Intercreditor Agreement), to the extent any Grantor is required hereunder to indorse, assign or deliver Collateral to the Collateral Agent for any purpose and is unable to do so as a result of having previously
indorsed, assigned or delivered such Collateral to the Applicable Collateral Agent (as defined in the Intercreditor Agreement) in accordance with the terms of the Intercreditor Agreement, such Grantor’s obligations hereunder with respect to
such indorsement, assignment or delivery shall be deemed satisfied by the indorsement, assignment or delivery in favor of or to the Applicable Collateral Agent (as defined in the Intercreditor Agreement), acting as a gratuitous bailee of the
Collateral Agent. 

  
 25 

 ARTICLE VII 

Miscellaneous 

SECTION 7.01. Notices. All communications and notices hereunder shall (except as otherwise expressly permitted herein) be in
writing and given as provided in Section 13.01 of the Indenture. All communications and notices hereunder to any Grantor shall be given to it in care of the Company as provided in Section 13.01 of the Indenture. 

SECTION 7.02. Waivers; Amendment. (a) No failure or delay by the Collateral Agent or any other Secured Party in exercising
any right or power hereunder or under the Indenture shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any
other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Collateral Agent and any other Secured Party hereunder and under the Indenture are cumulative and are not exclusive of any rights or
remedies that they would otherwise have. No waiver of any provision of this Agreement or consent to any departure by any Grantor therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this
Section 7.02, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice or demand on any Grantor in any case shall entitle any Grantor to any other or further notice or
demand in similar or other circumstances. 
 (b) Neither this Agreement nor any provision hereof may be waived, amended or modified except
pursuant to an agreement or agreements in writing entered into by the Collateral Agent and the Grantor or Grantors with respect to which such waiver, amendment or modification is to apply, subject to any consent required in accordance with Article 9
of the Indenture. 
 SECTION 7.03. Collateral Agent’s Fees and Expenses. (a) The parties hereto
agree that the Collateral Agent shall be entitled to reimbursement of its expenses incurred hereunder as provided in Section 7.06 of the Indenture as if named therein. 

(b) Without limitation of its indemnification obligations under the Indenture, the Company agrees to indemnify the Collateral Agent and the
other Indemnitees against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including the reasonable fees, charges and disbursements of any counsel for any Indemnitee, incurred by or
asserted against any Indemnitee arising out of, in connection with, or as a result of, the execution, delivery or performance of this Agreement or any claim, litigation, investigation or proceeding relating to the Indenture or this Agreement or any
of the instruments contemplated thereby or hereby, whether or not any Indemnitee is a party thereto; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or
related expenses are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or of any director, officer or employee thereof. 

  
 26 

 (c) Any such amounts payable as provided hereunder shall be additional Obligations secured
hereby and by the other Security Documents. The provisions of this Section 7.03 shall remain operative and in full force and effect regardless of the termination of this Agreement pursuant to Section 7.13, the Indenture or any other
Security Document, the consummation of the transactions contemplated hereby or thereby, the repayment of any of the Obligations, the invalidity or unenforceability of any term or provision of this Agreement, the Indenture or any other Security
Document, or any investigation made by or on behalf of the Collateral Agent or any other Secured Party. All amounts due under this Section 7.03 shall be payable within 10 days of written demand therefor. 

SECTION 7.04. Successors and Assigns. Whenever in this Agreement any of the parties hereto is referred to, such reference shall be
deemed to include the permitted successors and assigns of such party; and all covenants, promises and agreements by or on behalf of any Grantor or the Collateral Agent that are contained in this Agreement shall bind and inure to the benefit of their
respective successors and assigns, to the extent permitted under Article 5 of the Indenture. 
 SECTION 7.05. Survival of
Agreement. All representations and warranties made hereunder and in the Indenture or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such
representations and warranties have been or will be relied upon by the Collateral Agent and each other Secured Party, regardless of any investigation made by the Collateral Agent or any other Secured Party and shall continue in full force and effect
as long as any Obligation under the Indenture or any Security Document shall remain unpaid or unsatisfied. 
 SECTION 7.06.
Counterparts; Effectiveness; Successors and Assigns; Several Agreement. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Delivery by facsimile transmission or other electronic communication of an executed counterpart of a signature page to this Agreement shall be effective as delivery of an original executed counterpart of this Agreement. The Collateral
Agent may also require that any such documents and signatures delivered by facsimile transmission or other electronic communication be confirmed by a manually signed original thereof; provided that the failure to request or deliver the same
shall not limit the effectiveness of any document or signature delivered by facsimile transmission or other electronic communication. This Agreement shall become effective as to any Grantor when a counterpart hereof executed on behalf of such
Grantor shall have been delivered to the Collateral Agent and a counterpart hereof shall have been executed on behalf of the Collateral Agent, and thereafter shall be binding upon such Grantor and the Collateral Agent and their respective successors
and assigns permitted thereby, and shall inure to the benefit of such Grantor, the Collateral Agent and the other Secured Parties and their respective successors and assigns permitted thereby, except that no Grantor shall have the right to assign or
transfer its rights or obligations hereunder or any interest herein or in the Collateral (and any such assignment or transfer shall be void) except as expressly contemplated by this Agreement or the Indenture. This Agreement shall be construed as a
separate agreement with respect to each Grantor and may be amended, modified, supplemented, waived or released with respect to any Grantor without the approval of any other Grantor and without affecting the obligations of any other Grantor
hereunder. 

  
 27 

 SECTION 7.07. Severability. If any provision of this Agreement, any other
Security Document or the Indenture is held to be illegal, invalid or unenforceable, the legality, validity and enforceability of the remaining provisions thereof shall not be affected or impaired thereby. The invalidity of a provision in a
particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 
 SECTION 7.08.
Governing Law; Jurisdiction; Consent to Service of Process. (a) THIS AGREEMENT, THE INDENTURE AND EACH OTHER SECURITY DOCUMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (EXCEPT AS OTHERWISE
EXPRESSLY PROVIDED THEREIN). 
 (b) ANY LEGAL ACTION OR PROCEEDING ARISING UNDER ANY SECURITY DOCUMENT OR IN ANY WAY CONNECTED WITH OR
RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THE INDENTURE, THE NOTES, OR THE TRANSACTIONS RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, MAY BE BROUGHT IN THE COURTS OF THE
STATE OF NEW YORK SITTING IN NEW YORK CITY OR OF THE UNITED STATES FOR THE SOUTHERN DISTRICT OF SUCH STATE, AND BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH OF THE COMPANY, HOLDINGS, THE SUBSIDIARY GUARANTORS, THE TRUSTEE AND THE COLLATERAL
AGENT CONSENTS, FOR ITSELF AND IN RESPECT OF ITS PROPERTY, TO THE NONEXCLUSIVE JURISDICTION OF THOSE COURTS. EACH OF THE COMPANY, HOLDINGS, THE SUBSIDIARY GUARANTORS, THE TRUSTEE AND THE COLLATERAL AGENT IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING
ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, WHICH IT MAY NOW OR HEREAFTER HAVE TO THE BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THE INDENTURE OR OTHER DOCUMENT RELATED THERETO.

 (c) Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 7.01.
Nothing in this Agreement or in the Indenture will affect the right of any party to this Agreement to serve process in any other manner permitted by law. 

SECTION 7.09. WAIVER OF RIGHT TO TRIAL BY JURY. EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO
TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING UNDER THE INDENTURE OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THE INDENTURE, OR THE TRANSACTIONS
RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER FOUNDED IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT
TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 7.09 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE SIGNATORIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

  
 28 

 SECTION 7.10. Headings. Article and Section headings and the Table of
Contents used herein are for convenience of reference only, are not part of this Agreement and are not to affect the construction of, or to be taken into consideration in interpreting, this Agreement. 

SECTION 7.11. Security Interest Absolute. All rights of the Collateral Agent hereunder, the Security Interest, the grant of a
security interest in the Collateral and all obligations of each Grantor hereunder shall be absolute and unconditional irrespective of (a) any lack of validity or enforceability of the Indenture, any agreement with respect to any of the
Obligations or any other agreement or instrument relating to any of the foregoing, (b) any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any
consent to any departure from the Indenture or any other agreement or instrument, (c) any exchange, release or non-perfection of any Lien on other collateral, or any release or amendment or waiver of or
consent under or departure from any guarantee, securing or guaranteeing all or any of the Obligations or (d) any other circumstance that might otherwise constitute a defense available to, or a discharge of, any Grantor in respect of the
Obligations or this Agreement. 
 SECTION 7.12. Reserved. 

SECTION 7.13. Termination or Release. (a) This Agreement, the Security Interest and all other security interests granted
hereby shall terminate with respect to all Obligations and any Liens arising therefrom shall be automatically released when all the outstanding Obligations (in each case other than contingent indemnification obligations not yet accrued and payable)
have been indefeasibly satisfied and discharged in accordance with Section 12.01 of the Indenture. 
 (b) A Grantor shall automatically
be released from its obligations hereunder and the Security Interest in the Collateral of such Grantor shall be automatically released upon the consummation of any transaction permitted by the Indenture as a result of which such Grantor ceases to be
a Subsidiary or is designated as an Unrestricted Subsidiary of the Company in accordance with the Indenture. 
 (c) Upon any disposition by
any Grantor of any Collateral that is not prohibited by the Indenture, or upon the effectiveness of any written consent to the release of the Security Interest granted hereby in any Collateral pursuant to Section 10.04 of the Indenture, the
Security Interest in such Collateral shall be automatically released. 
 (d) A Grantor (other than Holdings and the Company) shall
automatically be released from its obligations hereunder and the Security Interest in the Collateral of such Grantor shall be automatically released if such Grantor ceases to be a Restricted Subsidiary pursuant to the terms of the Indenture. 

  
 29 

 (e) In connection with any termination or release pursuant to paragraph (a), (b), (c)
or (d) of this Section 7.13, the Collateral Agent shall execute and deliver to any Grantor, at such Grantor’s expense, all documents that such Grantor shall reasonably request to evidence such termination or release. Any execution and
delivery of documents pursuant to this Section 7.13 shall be without recourse to or warranty by the Collateral Agent. 
 (f) At any time
that the respective Grantor desires that the Collateral Agent take any action described in the immediately preceding paragraph (e), it shall, upon request of the Collateral Agent, deliver to the Collateral Agent an officer’s certificate
certifying that the release of the respective Collateral is permitted pursuant to paragraph (a), (b), (c) or (d). The Collateral Agent shall have no liability whatsoever to any Secured Party as a result of any release of Collateral by it
as permitted (or which the Collateral Agent in good faith believes to be permitted) by this Section 7.13. 
 SECTION 7.14.
Additional Grantors. If at any time a Subsidiary of the Company executes and delivers a supplemental indenture to the Indenture to become a Guarantor in accordance with Section 4.17 of the Indenture, contemporaneously with the execution
and delivery of any such supplemental indenture, such Subsidiary shall execute and deliver a Security Agreement Supplement in the form of Exhibit I hereto by the Collateral Agent and such Subsidiary. Upon such execution and delivery, such Subsidiary
shall become a Grantor hereunder with the same force and effect as if originally named as a Grantor herein. The execution and delivery of any such instrument shall not require the consent of any other Grantor hereunder. The rights and obligations of
each Grantor hereunder shall remain in full force and effect notwithstanding the addition of any new Grantor as a party to this Agreement. 

SECTION 7.15. Collateral Agent Appointed
Attorney-in-Fact. Each Grantor hereby appoints the Collateral Agent the
attorney-in-fact of such Grantor for the purpose of carrying out the provisions of this Agreement and taking any action and executing any instrument that the Collateral
Agent may deem necessary or advisable to accomplish the purposes hereof at any time after and during the continuance of an Event of Default, which appointment is irrevocable (until termination of the Indenture) and coupled with an interest. Without
limiting the generality of the foregoing, the Collateral Agent shall have the right, upon the occurrence and during the continuance of an Event of Default and notice by the Collateral Agent to the Company of its intent to exercise such rights, with
full power of substitution either in the Collateral Agent’s name or in the name of such Grantor (a) to receive, endorse, assign and/or deliver any and all notes, acceptances, checks, drafts, money orders or other evidences of payment
relating to the Collateral or any part thereof; (b) to demand, collect, receive payment of, give receipt for and give discharges and releases of all or any of the Collateral; (c) to sign the name of any Grantor on any invoice or bill of
lading relating to any of the Collateral; (d) to send verifications of Accounts to any Account Debtor; (e) to commence and prosecute any and all suits, actions or proceedings at law or in equity in any court of competent jurisdiction to
collect or otherwise realize on all or any of the Collateral or to enforce any rights in respect of any Collateral; (f) to settle, compromise, compound, adjust or defend any actions, suits or proceedings relating to all or any of the
Collateral; (g) to notify, or to require any Grantor to notify, Account Debtors to make payment directly to the Collateral Agent; (h) subject to the terms of the Intercreditor Agreement, to make, settle and adjust claims in respect of
Article 9 Collateral under policies of insurance, including endorsing the name of any Grantor on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance, making all determinations and decisions with
respect thereto and obtaining or maintaining 

  
 30 

 
policies of insurance or paying any premium in whole or in part relating thereto; and (i) to use, sell, assign, transfer, pledge, make any agreement with respect to or otherwise deal with
all or any of the Collateral, and to do all other acts and things necessary to carry out the purposes of this Agreement, as fully and completely as though the Collateral Agent were the absolute owner of the Collateral for all purposes;
provided that nothing herein contained shall be construed as requiring or obligating the Collateral Agent to make any commitment or to make any inquiry as to the nature or sufficiency of any payment received by the Collateral Agent, or to
present or file any claim or notice, or to take any action with respect to the Collateral or any part thereof or the moneys due or to become due in respect thereof or any property covered thereby. The Collateral Agent and the other Secured Parties
shall be accountable only for amounts actually received as a result of the exercise of the powers granted to them herein, and neither they nor their officers, directors, employees or agents shall be responsible to any Grantor for any act or failure
to act hereunder, except for their own gross negligence or willful misconduct or that of any of their Affiliates, directors, officers, employees, counsel, agents or
attorneys-in-fact. All sums disbursed by the Collateral Agent in connection with this paragraph, including reasonable attorneys’ fees, court costs, expenses and
other charges relating thereto, shall be payable, within 10 days of demand, by the Grantors to the Collateral Agent and shall be additional Obligations secured hereby. 

SECTION 7.16. General Authority of the Collateral Agent. By acceptance of the benefits of this Agreement and any
other Security Documents, each Secured Party (whether or not a signatory hereto) shall be deemed irrevocably (a) to consent to the appointment of the Collateral Agent as its agent hereunder and under such other Security Documents, (b) to
confirm that the Collateral Agent shall have the authority to act as the exclusive agent of such Secured Party for the enforcement of any provisions of this Agreement and such other Security Documents against any Grantor, the exercise of remedies
hereunder or thereunder and the giving or withholding of any consent or approval hereunder or thereunder relating to any Collateral or any Grantor’s obligations with respect thereto, (c) to agree that it shall not take any action to
enforce any provisions of this Agreement or any other Security Document against any Grantor, to exercise any remedy hereunder or thereunder or to give any consents or approvals hereunder or thereunder except as expressly provided in this Agreement
or any other Security Document and (d) to agree to be bound by the terms of this Agreement and any other Security Documents. 

SECTION 7.17. Recourse; Limited Obligations. This Agreement is made with full recourse to each Grantor and pursuant to and upon
all the warranties, representations, covenants and agreements on the part of such Grantor contained herein, in the Indenture and otherwise in writing in connection herewith or therewith. It is the desire and intent of each Grantor and the Secured
Parties that this Agreement shall be enforced against each Grantor to the fullest extent permissible under the laws applied in each jurisdiction in which enforcement is sought. Notwithstanding anything to the contrary contained herein, and in
furtherance of the foregoing, it is noted that the obligations of each Grantor that is a Guarantor have been limited as expressly provided in the Guarantee and are limited hereunder as and to the same extent provided therein. 

[Signatures on following page] 

  
 31 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and
year first above written. 
  

			
	SABRE HOLDINGS CORPORATION,
	         as Holdings

		
	         By
	 	 /s/ Brian Evans

		 	 Name: Brian Evans

		 	 Title: Treasurer

	
	SABRE GLBL INC.,
	         as the Company

		
	         By
	 	 /s/ Brian Evans

		 	 Name: Brian Evans

		 	 Title: Treasurer

	
	 EACH OF THE SUBSIDIARY GUARANTORS LISTED ON ANNEX A HERETO,

		
	         By
	 	 /s/ Steven W. Milton

		 	 Name: Steven W. Milton

		 	 Title: Corporate Secretary

	
	 WELLS FARGO BANK, NATIONAL ASSOCIATION,

        as Collateral Agent

		
	         By
	 	 /s/ Patrick Giordano

		 	 Name: Patrick Giordano

		 	 Title: Vice President

 Signature Page for 

Pledge and Security Agreement 

 Annex A 

List Of Subsidiary Guarantors 
  

	1.	 GetThere Inc. 

	2.	 GetThere L.P. 

	3.	 lastminute.com LLC 

	4.	 lastminute.com Holdings, Inc. 

	5.	 PRISM Group, Inc. 

	6.	 PRISM Technologies, LLC 

	7.	 Sabre International Newco, Inc. 

	8.	 SabreMark G.P., LLC 

	9.	 SabreMark Limited Partnership 

	10.	 TVL Holdings I, LLC 

	11.	 TVL Holdings, Inc. 

	12.	 TVL LLC 

	13.	 TVL LP 

	14.	 TVL Common, Inc. 

	15.	 IHS US Inc. 

	16.	 Innlink, LLC 

	17.	 Nexus World Services, Inc. 

	18.	 TravLynx LLC 

	19.	 RSI Midco, Inc. 

	20.	 Radixx Solutions International, Inc. 

  
 A-1 

 SCHEDULE I 

Pledged Equity 
  

															
	 Issuer
	  	 Interest

Issued
 (if not

stock)
	  	 Record and Beneficial
Owner
	  	 Total Shares
Outstanding
	  	Voting
or Non-
Voting
Interests
?	  	Total Shares
Pledged	 	% age
Owner-
ship	 	Certificated
	 EB2 International Limited
	  		  	Sabre GLBL Inc.	  	160,278 Ordinary and 242,697 Preference	  	V	  	N/A	 	100%	 	N/A
	 FlightLine Data Services, Inc.
	  		  	Sabre GLBL Inc.	  	200 Common Stock	  	V	  	200	 	100%	 	Yes
	 GetThere Inc.
	  		  	Sabre GLBL Inc.	  	 1,000 Common
 Stock
	  	V	  	100	 	100%	 	Yes
	 GetThere L.P.
	  	Limited Partnership	  	Sabre GLBL Inc.	  	N/A	  	V	  	100%	 	13.5%	 	No
	  	Limited Partnership	  	GetThere Inc.	  	N/A	  	V	  	100%	 	85.5%
	  	General Partnership	  	GetThere Inc.	  	N/A	  	V	  	100%	 	1%
	 lastminute.com LLC
	  	Limited Liability Company	  	TVL Holdings, Inc.	  	N/A	  	V	  	9.0511	 	9.0511%	 	Yes
	  	TVL LP	  	N/A	  	V	  	90.9489	 	90.9489%	 	Yes
	 lastminute.com Holdings, Inc.
	  		  	TVL LLC	  	1 Common Stock	  	V	  	1	 	100%	 	Yes
	 Lastminute (Cyprus) Ltd
	  		  	lastminute.com LLC	  	555 Ordinary	  	V	  	360.1	 	100%	 	Yes
	 PRISM Group, Inc.
	  		  	Sabre GLBL Inc.	  	1,000 Common Stock	  	V	  	1,000	 	100%	 	Yes
	 PRISM Technologies, LLC
	  		  	Sabre GLBL Inc.	  	N/A	  	V	  	100%	 	100%	 	No
	 Sabre Digital Limited
	  		  	Sabre GLBL Inc.	  	400,002 Ordinary	  	V	  	260,001	 	100%	 	Yes
	 Sabre Headquarters, LLC
	  	Limited Liability Company	  	Sabre GLBL Inc.	  	N/A	  	V	  	N/A	 	100%	 	No

  
 S-1-1 

															
	 Issuer
	 	 Interest

Issued
 (if not

stock)
	 	 Record and Beneficial
Owner
	 	 Total Shares
Outstanding
	  	Voting
or Non-
Voting
Interests
?	 	Total Shares
Pledged	 	% age
Owner-
ship	 	Certificated
	 Sabre GLBL Inc.
	 		 	Marlins Acquisition Corp.	 	1,000 Common Stock	  	V	 	100%	 	100%	 	No
	 		 	Sabre Holdings Corporation	 	1,000 Common Stock	  	V	 	1,000	 	100%	 	Yes
	 Sabre International Newco, Inc.
	 		 	Sabre GLBL Inc.	 	1,000 Common Stock	  	V	 	991	 	99%	 	Yes
	 	GetThere L.P.	  	V	 	9	 	1%	 	Yes
	 Sabre Holdings (Luxembourg)

    S.á r.l.
	 		 	Sabre International Newco, Inc.	 	45,731 Shares	  	V	 	27,936	 	100%	 	No
	 SabreMark G.P., LLC
	 	Limited Liability Company	 	Sabre GLBL Inc.	 	N/A	  	V	 	100%	 	100%	 	No
	 SabreMark Limited Partnership
	 	Limited Partnership General Partnership	 	Sabre GLBL Inc.	 	99% Limited Partnership Interest	  	V	 	100%	 	99%	 	No
	 	SabreMark G.P., LLC	 	1% General Partnership Interest	  	V	 	100%	 	1%
	 TVL Travel Limited (f/k/a Travelocity.co.uk Limited)
	 		 	Lastminute.com LLC	 	1 Ordinary	  	V	 	0.65	 	100%	 	Yes
	 TVL Australia Pty Ltd. (f/k/a Travelocity Australia Pty Ltd.)
	 		 	TVL LP	 	100 Ordinary	  	V	 	65	 	100%	 	Yes
	 TVL Europe (f/k/a Travelocity Europe Limited)
	 		 	lastminute.com LLC	 	1 Ordinary	  	V	 	0.65	 	99%	 	Yes
	 		 	TVL Travel Limited (f/k/a Travelocity.co.uk Limited)	 	1 Ordinary	  	V	 	N/A	 	1%	 	Yes

  
 S-1-2 

															
	 Issuer
	  	 Interest

Issued
 (if not

stock)
	  	 Record and Beneficial
Owner
	  	 Total Shares
Outstanding
	  	Voting
or Non-
Voting
Interests
?	  	Total Shares
Pledged	  	% age
Owner-
ship	 	Certificated
	 TVL International B.V. (f/k/a Travelocity International B.V.)1
	  		  	lastminute.com Holdings, Inc.	  	18,000 Ordinary	  	V	  	11,700	  	100%	 	No
	 TVL Holdings, Inc.
	  		  	Sabre GLBL Inc.	  	1,000 Common Stock	  	V	  	1,000	  	100%	 	Yes
	 TVL Holdings I, LLC
	  	 Limited
 Liability Company
	  	TVL LLC	  	N/A	  	V	  	N/A	  	100%	 	No
	 TVL LLC
	  	 Limited
 Liability Company
	  	TVL Holdings, Inc.	  	N/A	  	V	  	N/A	  	100%
 Preferred
	 	Yes
	  	 Limited
 Liability Company
	  	TVL Holdings, Inc.	  	N/A	  	NV	  	N/A	  	5%
 Common
	 	Yes
	  	 TVL
 Common, Inc.
	  	95%
 Common

	 TVL LP
	  	Limited Partnership	  	TVL LLC	  	N/A	  	V	  	N/A	  	89% LP	 	No
	  	TVL Holdings I, LLC	  	N/A	  	V	  	N/A	  	1% LP
	  	General Partnership	  	TVL LLC	  	N/A	  	V	  	N/A	  	10% GP
	 TVL Common, Inc.
	  		  	Sabre GLBL Inc.	  	1 Common Stock	  	V	  	1	  	100%	 	Yes
	 Zuji Holdings Ltd.
	  		  	TVL LP	  	 76,772,000
 Ordinary
	  	V	  	49,901,800	  	100%	 	Yes
	 IHS US Inc.
	  		  	Sabre GLBL Inc.	  	100 Common	  	V	  	N/A	  	100%	 	Yes
	 Innlink, LLC
	  	Limited Liability Company	  	IHS US Inc.	  	N/A	  	V	  	N/A	  	100%	 	No
	 Nexus World Services, Inc.
	  		  	Sabre GLBL Inc.	  	1,500 Common	  	V	  	N/A	  	100%	 	Yes

  

	1 	 Note: TVL International B.V. is in liquidation. As of July 1, 2019, TVL Sabre GmbH has been
dissolved. 

  
 S-1-3 

															
	 Issuer
	  	 Interest

Issued
 (if not

stock)
	  	 Record and Beneficial
Owner
	  	 Total Shares
Outstanding
	  	Voting
or Non-
Voting
Interests
?	  	Total Shares
Pledged	 	% age
Owner-
ship	 	Certificated
	 TravLynx, LLC
	  	Limited Liability Company	  	IHS US Inc.	  	N/A	  	V	  	N/A	 	100%	 	Yes
	 ezy Webwerkstaden AB
	  	N/A	  	Radixx Solutions International, Inc.	  	153,125	  	V	  	0%	 	100%	 	N/A

  
 S-1-4 

 Joint Ventures 

 

							
	 Issuer
	  	 Interest Issued
	  	 Record and Beneficial
Owner
	  	 Percentage

Ownership

	NONE	  		  		  	

 Other Equity Interests 
  

	1.	 Sabre International Newco, Inc. owns 2,056,463 Yield-Free Convertible Preferred Equity Certificates with a
nominal value of $35 issued by Sabre Holdings (Luxembourg) S.á r.l. on December 26, 2012, represented by Certificate N. 4, executed on March 13, 2013. 

  
 S-1-5 

 Pledged Debt 

Indebtedness Summary 
 List of all intercompany promissory notes
and other evidence of indebtedness in excess of $25 million USD in aggregate principal amount at June 30, 2020. 
 The debt instruments listed
below are assets of the Grantor listed (debt that is owed to such Grantor). 
  

													
	 Grantor
	  	Loan	  	Debtor	 	Principal at 06/30/20	 	  	Interest at 6/30/20	 
	Sabre International Newco, Inc.	  	Promissory Note	  	Sabre Holdings
(Luxembourg) S.á r.l.	 	USD $	10,332,869	 	  	USD $	180,993	 
	Sabre International Newco, Inc.	  	Promissory Note	  	Sabre Holdings
(Luxembourg) S.á r.l.	 	USD $	130,420,445	 	  	USD $	1,279,642	 
	Sabre International Newco, Inc.	  	Promissory Note	  	Sabre Holdings
(Luxembourg) S.á r.l.	 	USD $	37,651,229	 	  	USD $	376,885	 
	Sabre GLBL Inc.	  	Promissory Note	  	Sabre Finance
 (Luxembourg)S.á r.l.
	 	USD $	26,748,417	 	  	USD $	358,354	 
		  		  		 	  
	  
	 	  	  
	  
	 
	 Total
	 	USD $	203,305,439	 	  	USD $	1,097,948	 
		  		  		 	  
	  
	 	  	  
	  
	 

 A global note evidencing intercompany debt owed by a Grantor to a Grantor. 

A global note evidencing intercompany debt owed by a Non-Loan Party to a Grantor. 

  
 S-1-6 

 SCHEDULE II 

Commercial Tort Claims 

The following list includes all commercial tort claims of each Grantor, with a value in excess of $10,000,000 and for which such Grantor has
filed a complaint in a court of competent jurisdiction: 
 None as of August 27, 2020. 

  
 S-2-1 

 EXHIBIT I 

SUPPLEMENT NO. dated as of [    ] (this “Supplement”), to the Pledge and Security Agreement dated as of
August 27, 2020 (the “Security Agreement”) among SABRE HOLDINGS CORPORATION (“Holdings”), SABRE GLBL INC. (the “Company”), the Subsidiary Guarantors and WELLS FARGO BANK, NATIONAL ASSOCIATION, as
Collateral Agent for the Secured Parties. 
 A. Reference is made to the Indenture dated as of August 27, 2020 (as amended, supplemented or
otherwise modified from time to time, the “Indenture”), among the Company, Holdings, the Subsidiary Guarantors and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee and as Collateral Agent. 

B. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the Indenture and the
Security Agreement referred to therein. 
 C. Section 7.14 of the Security Agreement provides that additional Restricted Subsidiaries of
the Company may become Grantors under the Security Agreement by execution and delivery of an instrument in the form of this Supplement. The undersigned Restricted Subsidiary (the “New Subsidiary”) is executing this Supplement in
accordance with the requirements of the Indenture to become a Grantor under the Security Agreement. 
 Accordingly, the Collateral Agent and
the New Subsidiary agree as follows: 
 SECTION 1. In accordance with Section 7.14 of the Security Agreement, the New Subsidiary by its
signature below becomes a Grantor under the Security Agreement with the same force and effect as if originally named therein as a Grantor, and the New Subsidiary hereby (a) agrees to all the terms and provisions of the Security Agreement
applicable to it as a Grantor and Grantor thereunder and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct on and as of the date hereof. In furtherance of the foregoing,
the New Subsidiary, as security for the payment and performance in full of the Obligations does hereby create and grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, their successors and assigns, a
security interest in and lien on all of the New Subsidiary’s right, title and interest in and to the Collateral (as defined in the Security Agreement) of the New Subsidiary. Each reference to a “Grantor” in the Security
Agreement shall be deemed to include the New Subsidiary. The Security Agreement is hereby incorporated herein by reference. 
 SECTION 2.
The New Subsidiary represents and warrants to the Collateral Agent and the other Secured Parties that this Supplement has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation, enforceable against
it in accordance with its terms, except as such enforceability may be limited by Bankruptcy Law and by general principles of equity. 

  
 EXHIBIT I 

1 

 SECTION 3. This Supplement may be executed in counterparts (and by different parties hereto
on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Supplement shall become effective when the Collateral Agent shall have received a counterpart of
this Supplement that bears the signature of the New Subsidiary, and the Collateral Agent has executed a counterpart hereof. Delivery of an executed signature page to this Supplement by facsimile transmission or other electronic communication shall
be as effective as delivery of a manually signed counterpart of this Supplement. 
 SECTION 4. The New Subsidiary hereby represents and
warrants that (a) set forth on Schedule I attached hereto is a true and correct schedule of the location of any and all Collateral of the New Subsidiary and (b) set forth under its signature hereto is the true and correct legal name of the
New Subsidiary, its jurisdiction of formation and the location of its chief executive office. Schedule I shall be incorporated into, and after the date hereof be deemed part of, the Perfection Certificate. 

SECTION 5. Except as expressly supplemented hereby, the Security Agreement shall remain in full force and effect. 

SECTION 6. THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

SECTION 7. If any provision of this Supplement is held to be illegal, invalid or unenforceable, the legality, validity and enforceability of
the remaining provisions of this Supplement, the Security Agreement or the Indenture shall not be affected or impaired thereby. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in
any other jurisdiction. 
 SECTION 8. All communications and notices hereunder shall be in writing and given as provided in
Section 7.01 of the Security Agreement. 
 SECTION 9. The New Subsidiary agrees to reimburse the Collateral Agent for its reasonable out-of-pocket expenses in connection with the execution and delivery of this Supplement, including the reasonable fees, other charges and disbursements of counsel for the
Collateral Agent. 
 [Signatures on following page] 
  

 IN WITNESS WHEREOF, the New Subsidiary and the Collateral Agent have duly executed this
Supplement to the Security Agreement as of the day and year first above written. 
  

			
	[NAME OF NEW SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:
	
	Jurisdiction of Formation:
	Address Of Chief Executive Office:
	
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Collateral Agent
		
	By:	 	  

		 	Name:
		 	Title:

 SCHEDULE I 

TO SUPPLEMENT NO. [    ] TO THE 

SECURITY AGREEMENT 
 LOCATION OF
COLLATERAL 
  

			
	Description	  	Location

 EQUITY INTERESTS 
  

									
	 Issuer
	  	 Number of

Certificate
	  	 Registered

Owner
	  	 Number and Class of

Equity Interests
	  	 Percentage of
Equity Interests

DEBT SECURITIES 
  

							
	 Issuer
	  	 Principal Amount
	  	 Date of Note
	  	 Maturity Date

 EXHIBIT II 

Form of Perfection Certificate 

 PERFECTION CERTIFICATE 

Dated: [            ] 

Reference is made to (a) the Indenture dated as of August 27, 2020 (as amended, supplemented or otherwise modified from time to time,
the “Indenture”), among Sabre GLBL Inc. (f/k/a Sabre Inc.), a Delaware corporation (the “Company”), Sabre Holdings Corporation, a Delaware corporation (“Holdings”), the Subsidiary Guarantors party
thereto and Wells Fargo Bank, National Association, as Trustee and as Collateral Agent, and (b) the Pledge and Security Agreement dated as of August 27, 2020 (as amended, supplemented or otherwise modified from time to time, the
“Security Agreement”), among Holdings, the Company, the Subsidiary Guarantors and the Collateral Agent. Capitalized terms used but not defined herein have the meanings assigned in the Indenture or the Security Agreement, as applicable.

 The undersigned Authorized Officer of the Company and Holdings, hereby certifies to the Collateral Agent and each other Secured Party as
follows: 
  

	1.	 Names. (a) The exact legal name of Holdings, the Company, and each Subsidiary Guarantor (each a
“Grantor”), as such name appears in its respective organizational documents, is as follows: 

  

	
	Exact Legal Name of Each Grantor

 (b) Set forth below is each other legal name each Grantor has had in the past five years, together with the
date of the relevant change: 
  

					
	 Grantor
	  	 Other Legal Name(s) in

Past 5 Years
	  	 Date of
Change2

  

 

	2 	 Some prior names are due to other entities merging into the current Grantor. 

 (c) Except as set forth in Schedule 1 hereto, no Grantor has changed its identity or
corporate structure in any way within the past five years. Changes in identity or corporate structure would include mergers, consolidations and acquisitions, as well as any change in the form, nature or jurisdiction of organization. If any such
change has occurred, include in Schedule 1 the information required by Sections 1 and 2 of this certificate as to each acquiree or constituent party to a merger or consolidation. 

(d) The following is a list of all other names (including trade names or similar appellations) used by each Grantor or any of its divisions or
other business units in connection with the conduct of its business or the ownership of its properties at any time during the past five years: 
  

			
	 Grantor
	  	 Other Names

(e) Set forth below is the Organizational Identification Number, if any, issued by the jurisdiction of organization of each Grantor that is a
registered organization: 
  

			
	 Grantor
	  	 Organizational ID Number

(f) Set forth below is the Federal Taxpayer Identification Number of each Grantor: 

 

			
	 Grantor
	  	 Federal Taxpayer ID Number

 

	2.	 Current Locations. (a) the chief executive office of each Grantor is located at the address set
forth opposite its name below: 

  

			
	 Grantor
	  	 Location

 (b) The jurisdiction of organization of each Grantor that is a registered organization is set forth opposite
its name below: 
  

			
	 Grantor
	  	Jurisdiction
		  	

 (c) Set forth below opposite the name of each Grantor are all the domestic locations not identified above where such Grantor
maintains any Equipment or other tangible Collateral in excess of $100,000 fair market value in the aggregate for such location: 
  

					
	 Grantor
	  	Property Address	  	County, State
		  		  	

 (d) Set forth below is a list of all real property in excess of $1,000,000 fair market value or $100,000 annual lease expenses
held by each Grantor, whether owned or leased, the name of the Grantor that owns or leases said property, and the street address for each property: 
  

					
	 Address
	  	Owned/Leased	  	Entity
		  		  	

 (e) Set forth below opposite the name of each Grantor are all the domestic places of business of such Grantor not identified
in paragraphs (a), (b), (c) and (d) above: 
  

					
	 Grantor
	  	Property Address	  	County, State
		  		  	

 (f) Set forth below opposite the name of each Grantor are the names and addresses of all United States Persons other than such
Grantor that have possession of any of the material Collateral consisting of instruments, chattel paper, inventory or equipment of such Grantor in excess of $100,000 for each such Person: 

 

							
	 Grantor
	  	Mailing Address	  	County	  	State
		  		  		  	

	3.	 No Unusual Transactions. Except as otherwise disclosed on Schedule 3 hereto, all Accounts have been
originated by the Grantors and all Inventory has been acquired by the Grantors in the ordinary course of business from a person in the business of selling goods of that kind. 

 

	4.	 File Search Reports. File
search reports have been obtained from (A) each Uniform Commercial Code filing office (i) in each jurisdiction identified with respect to such Grantor in Section 2 hereof with respect to each legal name described in Section 1 and
(ii) in each U.S. jurisdiction, to the extent known, relating to the transactions disclosed on Schedule 3 with respect to each legal name of the person or entity from which each Grantor purchased or otherwise acquired any of the Collateral, and
(B) each filing office in respect of judgment and tax liens, and such search reports reflect either (i) no liens against any of the Collateral other than those permitted under the Credit Agreement or (ii) any liens reported in such
lien searches that are not permitted under the Credit Agreement have subsequently been terminated or released prior to the date hereof. 

  

	5.	 UCC Filings. Financing statements including the indications of the Collateral hereto have been filed in
the proper Uniform Commercial Code filing office in the jurisdiction in which each Grantor is located and, to the extent any of the Collateral is comprised of fixtures, in the proper local jurisdiction, in each case as set forth with respect to such
Grantor in Section 2 hereof. 

  

	6.	 Schedule of Filings. Attached
hereto as Schedule 6 is a schedule setting forth, with respect to the filings described in Section 5 above and the filings described in Schedule 12(A) and Schedule 12(B), each filing and the filing office in which such filing is made. No other
filings, recordings or registration are necessary to establish a legal, valid and perfected security interest in favor of the Collateral Agent in the Article 9 Collateral, pursuant to the Pledge and Security Agreement. 

 

	7.	 Stock Ownership and other Equity Interests. Attached hereto as Schedule 7 is a true and correct list of
all the issued and outstanding stock, partnership interests, limited liability company membership interests or other equity interest of each Grantor and the record and beneficial owners of such stock, partnership interests, membership interests or
other equity interests. Also set forth on Schedule 7 is each equity investment of Holdings, the Company or any Grantor that represents 50% or more of the equity of the entity in which such investment was made. 

 

	8.	 Debt Instruments. Attached hereto as Schedule 8 is a true and correct list of all (a) promissory
notes, tangible chattel paper, electronic chattel paper and other evidence of indebtedness (other than checks to be deposited in the ordinary course of business and other than intercompany indebtedness) held by Holdings, the Company and each
Subsidiary that are required to be pledged under the Security Agreement in excess of $5,000,000 in aggregate principal amount, and (b) all intercompany notes between Holdings and each Subsidiary of Holdings or each Subsidiary of Holdings and
each other such Subsidiary that are required to be pledged under the Security Agreement in excess of $25,000,000 in aggregate principal amount. 

	9.	 Deposit Accounts and
Securities Accounts. Attached hereto as Schedule 9 is a true and correct list of deposit accounts, brokerage accounts or securities investment accounts
maintained by each Grantor, including the name and address of the depository institution, the type of account, and the account number. 

  

	10.	 Advances. Attached hereto as Schedule 10 is (a) a true and correct list of all advances in respect
of Indebtedness made by the Company to any Subsidiary of the Company or made by any Subsidiary of the Company to the Company or to any other Subsidiary of the Company in excess of $10,000,000 in aggregate principal amount (other than those already
identified on Schedule 8), which advances will be on and after the date hereof evidenced by one or more intercompany notes pledged to the Collateral Agent under the Security Agreement, and (b) a true and correct list of all unpaid intercompany
transfers of goods sold and delivered by or to any Grantor in excess of $25,000,000 in the aggregate, except in each case (a) and (b), those advances expected to be settled or paid within 60 days in the normal course of business.

  

	11.	 Mortgage Filings. Attached hereto as Schedule 11 is a schedule setting forth, with respect to any owned
property listed in 2(d) above that is mortgaged, (a) the exact name of the Person that owns such property as such name appears in its Organization Document, (b) if different from the name identified pursuant to clause (a), the exact name
of the current record owner of such property reflected in the records of the filing office for such property identified pursuant to the following clause and (c) the filing office in which a Mortgage with respect to such property must be filed
or recorded in order for the Collateral Agent to obtain a perfected security interest therein. 

  

	12.	 Intellectual Property. Attached hereto as Schedule 12(A) is a true and correct list of all of each
Grantor’s material U.S. patents, patent applications, trademark registrations and applications for registration, copyright registrations and applications for registration, and domain names (collectively, the “Registered Intellectual
Property”), filed with or subject to the United States Patent and Trademark Office or the United States Copyright Office, as applicable, in each case owned by a Grantor in its own name as of the date hereof, indicating for each such item,
as applicable, the application and/or registration number, date and jurisdiction of filing and/or issuance, and the identity of the current applicant or registered owner. 

Attached hereto as Schedule 12(B) is a true and correct list of all of each Grantor’s material Intellectual Property agreements (other
than licenses of commercially available off-the-shelf software) in which a Grantor is, as of the date hereof, the exclusive licensee of any United States patent, patent application, trademark registration or application for registration, copyright
registration or application for registration (collectively, the “Exclusive IP Agreements”). 

	13.	 Commercial Tort
Claims. Attached hereto as Schedule 13 is a true and correct list of commercial tort claims in excess of $10,000,000 held by any Grantor for which a complaint has been filed in a court of competent
jurisdiction, including a brief description thereof. 

  

	14.	 Letter-of-Credit Rights. Attached hereto as Schedule 14 is a true and correct list of all Letters of
Credit in excess of $10,000,000 issued in favor of each Grantor, as beneficiary thereunder. 

 IN WITNESS WHEREOF, the undersigned have
duly executed this certificate as of the date first above written. 
  

			
	SABRE GLBL INC.
		
	By:	 	
                     
        

	Name:
	Its:
	
	SABRE HOLDINGS CORPORATION
		
	By:	 	  

	Name:
	Its:

 SCHEDULE 1 

Changes in Identity or Corporate Structure Within Past Five Years 

 SCHEDULE 3 

Assets Acquired Outside the Ordinary Course of Business in the Past 5 Years 

 

									
	 Company or Assets Acquired
	  	Acquisition Date	 	  	Acquiring Party	 
		  				  			

 SCHEDULE 6 

UCC Filings and Filing Offices 
  

					
	 Jurisdiction
	  	Grantors	 
		  			

 Intellectual Property Filings and Filing Offices 

 

					
	 Jurisdiction
	  	Grantor	 
		  			

 SCHEDULE 7 

Stock Ownership and Other Equity Interests 
  

																					
	 Grantor
	  	Interest Issued	 	  	Record and
Beneficial Owner	 	  	Percentage
Ownership	 	  	Shares
Pledged	 	  	Certificated	 
		  				  				  				  				  			

 Equity Investments of 50% or More of Equity Interests of Issuer 

 

																													
	 Issuer
	  	Interest
Issued
(if not
stock)	 	  	Record and
Beneficial
Owner	 	  	Total Shares
Outstanding	 	  	Voting
or Non-
Voting
Interests
?	 	  	Total Shares
Pledged	 	  	% age
Owner-
ship	 	  	Certificated	 
		  				  				  				  				  				  				  			

 Joint Ventures 

 

							
	 Issuer
	  	 Interest Issued
	  	 Record and Beneficial

Owner
	  	 Percentage

Ownership

		  		  		  	

 Other Equity Interests 

 SCHEDULE 8 

Debt Instruments 

 SCHEDULE 9 

Deposit Accounts 
  

							
	 Depository
	  	 Address
	  	 ABA #
	  	
  Account #  

Securities Investment Accounts 
  

					
	 Investment Bank
	  	 Address
	  	 Account #

 SCHEDULE 10 

Advances 

 SCHEDULE 11 

Mortgage Filings 
  

							
	 Record Owner Pre-Closing
	  	 Record Owner
Post-
 Closing
	  	 Property Address
	  	 Filing Jurisdictions

 SCHEDULE 12 

Patents, Pending Patent Applications, Trademarks and Pending Trademark 

Applications Intellectual Property 

CONFIDENTIAL 
 A. UNITED STATES PATENTS AND
PATENT APPLICATIONS 
  

							
	 Title
	  	 Owner
	  	 (Application

Number) /
 Patent
Number
	  	 (Filing Date) /

Issuance Date

 B. UNITED STATES TRADEMARKS AND TRADEMARK APPLICATIONS 

 

													
	 No.        
	  	MARK	  	SERIAL
NO	  	REG NO	  	FILE DT	  	REG DT	  	OWNER
		  		  		  		  		  		  	

 C. DOMAIN NAMES 

 

			
	 DOMAIN NAME
	 	 REGISTRANT

		 	

 a. UNITED STATES REGISTERED COPYRIGHTS 

 

									
	 No.
	  	TITLE	  	REG NO	  	REG DATE	  	OWNER
		  		  		  		  	

 Schedule 12B – Exclusive IP Agreements 

 SCHEDULE 13 

Commercial Tort Claims 

 SCHEDULE 14 

Letter-of-Credit Rights 
  

									
	 Issuer
	  	Beneficiary	  	Amount	  	Issue Date	  	Expiry Date
		  		  		  		  	

 EXHIBIT III 

Form of Patent Security Agreement 

 FORM OF PATENT SECURITY AGREEMENT 

(SHORT-FORM) 

PATENT SECURITY AGREEMENT (this “Agreement”), dated as of [    ], among SABRE HOLDINGS CORPORATION
(“Holdings”), SABRE GLBL INC. (the “Company”), the Subsidiary Guarantors (each of the foregoing, including the Company, a “Grantor”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Collateral Agent
for the Secured Parties (as defined below). 
 Reference is made to the Pledge and Security Agreement dated as of August 27, 2020 (as
amended, supplemented or otherwise modified from time to time, the “Security Agreement”), among Holdings, the Borrower, the Subsidiary Guarantors and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Collateral Agent. Accordingly, the
parties hereto agree as follows: 
 Section 1. Terms. Capitalized terms used in this Agreement and not otherwise defined herein
have the meanings specified in the Security Agreement. The rules of construction specified in Article I of the Indenture also apply to this Agreement. 

Section 2. Grant of Security Interest. As security for the payment or performance, as the case may be, in full of the Obligations,
each Grantor, pursuant to and in accordance with the Security Agreement, did and hereby does grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, a security interest in, all right, title and interest in
or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the
“Patent Collateral”): 
 All letters Patent of the United States or the equivalent thereof in any other country, all
registrations and recordings thereof, and all applications for letters Patent of the United States or the equivalent thereof in any other country in or to which any Grantor now or hereafter has any right, title or interest therein, including
registrations, recordings and pending applications in the USPTO or any similar offices in any other country, and all reissues, continuations, divisions, continuations-in-part, renewals, improvements or extensions thereof. 

Section 3. Termination. This Agreement is made to secure the satisfactory performance and payment of the Obligations. This
Agreement and the security interest granted hereby shall terminate with respect to all of a Grantor’s Obligations and any Lien arising therefrom shall be automatically released upon termination of the Security Agreement or release of such
Grantor’s obligations thereunder. The Collateral Agent shall, in connection with any termination or release herein or under the Security Agreement, execute and deliver to any Grantor as such Grantor may request, an instrument in writing
releasing the security interest in the Patent Collateral acquired under this Agreement. Additionally, upon such satisfactory performance or payment, the Collateral Agent shall reasonably cooperate with any efforts made by a Grantor to make of record
or otherwise confirm such satisfaction including, but not limited to, the release and/or termination of this Agreement and any security interest in, to or under the Patent Collateral. 

 Section 4. Supplement to the Security Agreement. The security interests granted
to the Collateral Agent herein are granted in furtherance, and not in limitation of, the security interests granted to the Collateral Agent pursuant to the Security Agreement. Each Grantor hereby acknowledges and affirms that the rights and remedies
of the Collateral Agent with respect to the Patent Collateral are more fully set forth in the Security Agreement, the terms and provisions of which are hereby incorporated herein by reference as if fully set forth herein. In the event of any
conflict between the terms of this Agreement and the Security Agreement, the terms of the Security Agreement shall govern. 

Section 5. Representations and Warranties. Holdings and the Company jointly and severally represent and warrant, as to themselves
and the other Grantors, to the Collateral Agent and the Secured Parties, that a true and correct list of all of the existing material Patent Collateral consisting of Patent registrations or applications registered or filed with the USPTO owned by
the Grantor, in whole or in part, is collectively set forth in Schedule I. 
 Section 6. Miscellaneous. The provisions of
Article VII of the Security Agreement are hereby incorporated by reference. 
 NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE LIEN AND SECURITY
INTEREST GRANTED TO THE COLLATERAL AGENT, FOR THE BENEFIT OF THE SECURED PARTIES, PURSUANT TO THIS AGREEMENT AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE COLLATERAL AGENT AND THE OTHER SECURED PARTIES HEREUNDER ARE SUBJECT TO THE PROVISIONS OF THE
INTERCREDITOR AGREEMENT. IN THE EVENT OF ANY CONFLICT OR INCONSISTENCY BETWEEN THE PROVISIONS OF THE INTERCREDITOR AGREEMENT AND THIS AGREEMENT, THE PROVISIONS OF THE INTERCREDITOR AGREEMENT SHALL CONTROL. 

[Signatures on following page] 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and
year first above written. 
  

			
	SABRE HOLDINGS CORPORATION,
	 as Holdings

		
	By:	 	
                     
                

		 	Name:
		 	Title:
	
	SABRE GLBL INC.,
	 as the Company

		
	By:	 	  

		 	Name:
		 	Title:
	
	AS SUBSIDIARY GUARANTOR:
	
	[SUBSIDIARY GUARANTOR]
		
	By:	 	
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Patent Security Agreement Short Form] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	 as Collateral Agent

		
	By:	 	              

		 	Name:
		 	Title:

 [Signature Page to Patent Security Agreement Short Form] 

 Schedule I 

Short Particulars of U.S. Patent Collateral 
  

							
	 Title
	  	Owner	  	(Application Number)
/Patent Number	  	(Filing Date) /
Issuance Date
		  		  		  	

 EXHIBIT IV 

Form of Trademark Security Agreement 

 FORM OF TRADEMARK SECURITY AGREEMENT 

(SHORT-FORM) 

TRADEMARK SECURITY AGREEMENT (this “Agreement”), dated as
of    [                ], among SABRE HOLDINGS CORPORATION (“Holdings”), SABRE GLBL INC. (the “Company”), the
Subsidiary Guarantors (each of the foregoing, including the Company, a “Grantor”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Collateral Agent for the Secured Parties (as defined below). 

Reference is made to the Pledge and Security Agreement dated as of August 27, 2020 (as amended, supplemented or otherwise modified from time
to time, the “Security Agreement”), among Holdings, the Company, the Subsidiary Guarantors and Wells Fargo Bank, National Association as Collateral Agent. Accordingly, the parties hereto agree as follows: 

Section 1. Terms. Capitalized terms used in this Agreement and not otherwise defined herein have the meanings specified in the
Security Agreement. The rules of construction specified in Article I of the Indenture also apply to this Agreement. 
 Section 2.
Grant of Security Interest. As security for the payment or performance, as the case may be, in full of the Obligations, each Grantor, pursuant to and in accordance with the Security Agreement, did and hereby does grant to the Collateral
Agent, its successors and assigns, for the benefit of the Secured Parties, a security interest in, all right, title and interest in or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor
or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the “Trademark Collateral”); provided that no security interest shall attach to any such Trademark Collateral if
and for so long as the grant of such security interest would result in the abandonment, invalidation, unenforceability or termination of such Trademark Collateral; and provided further that such security interest shall attach immediately at such
time as the condition causing such abandonment, invalidation, unenforceability or termination shall be remedied: 
 (a) all trademarks,
service marks, trade names, corporate names, trade dress, logos, designs, fictitious business names, other source or business identifiers, now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all registration
and recording applications filed in connection therewith, including registrations and registration applications in the USPTO or any similar offices in any State of the United States or any other country or any political subdivision thereof, and all
extensions or renewals thereof, as well as any unregistered trademarks and service marks used by a Grantor, and (b) all goodwill connected with the use of and symbolized thereby. 

It is the intent of the parties that this Agreement grants a security interest in the Trademark Collateral and is not intended to be, and shall not be deemed
to be, an assignment of the Trademark Collateral. 

 Section 3. Termination. This Agreement is made to secure the satisfactory
performance and payment of the Obligations. This Agreement and the security interest granted hereby shall terminate with respect to all of a Grantor’s Obligations and any Lien arising therefrom shall be automatically released upon termination
of the Security Agreement or release of such Grantor’s obligations thereunder. The Collateral Agent shall, in connection with any termination or release herein or under the Security Agreement, execute and deliver to any Grantor as such Grantor
may request, an instrument in writing releasing the security interest in the Trademark Collateral acquired under this Agreement. Additionally, upon such satisfactory performance or payment, the Collateral Agent shall reasonably cooperate with any
efforts made by a Grantor to make of record or otherwise confirm such satisfaction including, but not limited to, the release and/or termination of this Agreement and any security interest in, to or under the Trademark Collateral. 

Section 4. Supplement to the Security Agreement. The security interests granted to the Collateral Agent herein are granted in
furtherance, and not in limitation of, the security interests granted to the Collateral Agent pursuant to the Security Agreement. Each Grantor hereby acknowledges and affirms that the rights and remedies of the Collateral Agent with respect to the
Trademark Collateral are more fully set forth in the Security Agreement, the terms and provisions of which are hereby incorporated herein by reference as if fully set forth herein. In the event of any conflict between the terms of this Agreement and
the Security Agreement, the terms of the Security Agreement shall govern. 
 Section 5. Representations and Warranties. Holdings
and the Company jointly and severally represent and warrant, as to themselves and the other Grantors, to the Collateral Agent and the Secured Parties, that a true and correct list of all of the existing material Trademark Collateral consisting of
Trademark registrations or applications registered or filed with the USPTO owned by the Grantor, in whole or in part, is set forth in Schedule I. 

Section 6. Miscellaneous. The provisions of Article VII of the Security Agreement are hereby incorporated by reference. 

NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE LIEN AND SECURITY INTEREST GRANTED TO THE COLLATERAL AGENT, FOR THE BENEFIT OF THE SECURED PARTIES,
PURSUANT TO THIS AGREEMENT AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE COLLATERAL AGENT AND THE OTHER SECURED PARTIES HEREUNDER ARE SUBJECT TO THE PROVISIONS OF THE INTERCREDITOR AGREEMENT. IN THE EVENT OF ANY CONFLICT OR INCONSISTENCY BETWEEN
THE PROVISIONS OF THE INTERCREDITOR AGREEMENT AND THIS AGREEMENT, THE PROVISIONS OF THE INTERCREDITOR AGREEMENT SHALL CONTROL. 

[Signatures on following page] 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and
year first above written. 
  

			
	SABRE HOLDINGS CORPORATION,
	 as Holdings

		
	By:	 	
                     

		 	Name:
		 	Title:
	
	SABRE GLBL INC.,
	 as the Company

		
	By:	 	  

		 	Name:
		 	Title:
	
	AS SUBSIDIARY GUARANTOR:
	
	[SUBSIDIARY GUARANTOR]
		
	By:	 	
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Trademark Security Agreement Short Form] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	 as Collateral Agent

			
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Trademark Security Agreement Short Form] 

 Schedule I 

UNITED STATES TRADEMARKS, SERVICE MARKS AND TRADEMARK 

APPLICATIONS 
  

																									
	 No.
	  	MARK	 	  	SERIAL
NO	 	  	REG NO	 	  	FILE DT	 	  	REG DT	 	  	OWNER	 
		  				  				  				  				  				  			

 EXHIBIT V 

Form of Copyright Security Agreement 

 FORM OF COPYRIGHT SECURITY AGREEMENT 

(SHORT-FORM) 

COPYRIGHT SECURITY AGREEMENT (this “Agreement”), dated as of [    ], among SABRE HOLDINGS CORPORATION
(“Holdings”), SABRE GLBL INC. (the “Company”), the Subsidiary Guarantors (each of the foregoing, including the Company, a “Grantor”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Collateral Agent
for the Secured Parties (as defined below). 
 Reference is made to the Pledge and Security Agreement dated as of August 27, 2020 (as
amended, supplemented or otherwise modified from time to time, the “Security Agreement”), among Holdings, the Company, the Subsidiary Guarantors and WELLS FARGO BANK, NATIONAL ASSOCIATION as Collateral Agent. Accordingly, the
parties hereto agree as follows: 
 Section 1. Terms. Capitalized terms used in this Agreement and not otherwise defined herein
have the meanings specified in the Security Agreement. The rules of construction specified in Article I of the Indenture also apply to this Agreement. 

Section 2. Grant of Security Interest. As security for the payment or performance, as the case may be, in full of the Obligations,
each Grantor, pursuant to and in accordance with the Security Agreement, did and hereby does grant to the Collateral Agent, its successors and assigns, for the benefit of the Secured Parties, a security interest in, all right, title and interest in
or to any and all of the following assets and properties now owned or at any time hereafter acquired by such Grantor or in which such Grantor now has or at any time in the future may acquire any right, title or interest (collectively, the
“Copyright Collateral”): 
 (a) all copyright rights in any work subject to the copyright laws of the United States or any
other country, whether as author, assignee, transferee or otherwise, and (b) all registrations and applications for registration of any such copyright in the United States or any other country, including registrations, recordings, supplemental
registrations and pending applications for registration in the USCO. 
 Section 3. Termination. This Agreement is made to secure
the satisfactory performance and payment of the Obligations. This Agreement and the security interest granted hereby shall terminate with respect to all of a Grantor’s Obligations and any Lien arising therefrom shall be automatically released
upon termination of the Security Agreement or release of such Grantor’s obligations thereunder. The Collateral Agent shall, in connection with any termination or release herein or under the Security Agreement, execute and deliver to any Grantor
as such Grantor may request, an instrument in writing releasing the security interest in the Copyright Collateral acquired under this Agreement. Additionally, upon such satisfactory performance or payment, the Collateral Agent shall reasonably
cooperate with any efforts made by a Grantor to make of record or otherwise confirm such satisfaction including, but not limited to, the release and/or termination of this Agreement and any security interest in, to or under the Copyright Collateral.

 Section 4. Supplement to the Security Agreement. The security interests granted
to the Collateral Agent herein are granted in furtherance, and not in limitation of, the security interests granted to the Collateral Agent pursuant to the Security Agreement. Each Grantor hereby acknowledges and affirms that the rights and remedies
of the Collateral Agent with respect to the Copyright Collateral are more fully set forth in the Security Agreement, the terms and provisions of which are hereby incorporated herein by reference as if fully set forth herein. In the event of any
conflict between the terms of this Agreement and the Security Agreement, the terms of the Security Agreement shall govern. 

Section 5. Representations and Warranties. Holdings and the Company jointly and severally represent and warrant, as to themselves
and the other Grantors, to the Collateral Agent and the Secured Parties, that a true and correct list of all of the existing material Copyright Collateral consisting of Copyright registrations or applications registered or filed with the USCO owned
by the Grantor, in whole or in part, is collectively set forth in Schedule I. 
 Section 6. Miscellaneous. The provisions
of Article VII of the Security Agreement are hereby incorporated by reference. 
 NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, THE LIEN AND SECURITY
INTEREST GRANTED TO THE COLLATERAL AGENT, FOR THE BENEFIT OF THE SECURED PARTIES, PURSUANT TO THIS AGREEMENT AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE COLLATERAL AGENT AND THE OTHER SECURED PARTIES HEREUNDER ARE SUBJECT TO THE PROVISIONS OF THE
INTERCREDITOR AGREEMENT. IN THE EVENT OF ANY CONFLICT OR INCONSISTENCY BETWEEN THE PROVISIONS OF THE INTERCREDITOR AGREEMENT AND THIS AGREEMENT, THE PROVISIONS OF THE INTERCREDITOR AGREEMENT SHALL CONTROL. 

[Signatures on following page] 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and
year first above written. 
  

			
	SABRE HOLDINGS CORPORATION,
	 as Holdings

 
			
		
	By:	 	  

		 	Name:
		 	Title:

 
			
	
	SABRE GLBL INC.,
	 as the Company

 
			
		
	By:	 	  

		 	Name:
		 	Title:

 
			
	
	AS SUBSIDIARY GUARANTOR:
	
	[SUBSIDIARY GUARANTOR]

 
			
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Copyright Security Agreement Short Form] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	 as Collateral Agent

			
		
	By:	 	  

		 	Name:
		 	Title:

 [Signature Page to Copyright Security Agreement Short Form] 

 Schedule I 

Short Particulars of U.S. Copyright Collateral 
  

																	
	 No.
	  	TITLE	 	  	REG NO	 	  	REG DATE	 	  	OWNERExhibit 10.1

     

   

    

  
    EXECUTION VERSION

     

   
   

    

   
  

    
    

    

    

    

    

    

    INVESTMENT AGREEMENT

    

    

    by and among

    

    

    NUTANIX, INC.

    and

    

    

    BCPE NUCLEON (DE) SPV, LP

    

    

     

      

    

    

    

    

    Dated as of August 26, 2020

    

    

    

    

    

    

    

    

    
      
        

    

    
    Table of Contents

    

    

    	  

          	 Page
	ARTICLE I DEFINITIONS	 1
	Section 1.01. 

          	Definitions 

          	 1
	Section 1.02. 

          	General Interpretive Principles 

          	 12
	ARTICLE II SALE AND PURCHASE OF THE NOTES 

          	12 

          
	Section 2.01. 

          	Sale and Purchase of the Notes 

          	 12
	Section 2.02. 

          	Closing 

          	 12
	Section 2.03. 

          	Termination 

          	15 

          
	ARTICLE III REPRESENTATIONS AND WARRANTIES  

          	 15
	Section 3.01. 

          	Representations and Warranties of the Company 

          	 15
	Section 3.02. 

          	Representations and Warranties of the Purchaser 

          	 22
	ARTICLE IV ADDITIONAL AGREEMENTS 

          	26 

          
	Section 4.01. 

          	Taking of Necessary Action 

          	 26
	Section 4.02. 

          	Restricted Period; Non-Conversion 

          	 27
	Section 4.03. 

          	Standstill 

          	 28
	Section 4.04. 

          	Securities Laws 

          	 32
	Section 4.05. 

          	Lost, Stolen, Destroyed or Mutilated Securities 

          	 32
	Section 4.06. 

          	Antitrust Approval 

          	 32
	Section 4.07. 

          	Board Nomination Rights 

          	 33
	Section 4.08. 

          	VCOC Letters 

          	 37
	Section 4.09. 

          	Financing Cooperation 

          	 37
	Section 4.10. 

          	Certain Tax Matters 

          	 38
	Section 4.10. 

          	Section 16 Matters 

          	 38
	Section 4.12. 

          	D&O Indemnification / Insurance Priority Matters 

          	 39
	Section 4.13. 

          	Conversion Price Matters 

          	 40
	Section 4.14. 

          	Transfers of Sponsor Global Note 

          	 40
	Section 4.15. 

          	Par Value 

          	 40
	Section 4.16. 

          	Voting 

          	 40
	Section 4.17. 

          	Indenture Amendments and Supplements 

          	 41
	Section 4.18. 

          	Information Rights 

          	 41
	Section 4.19. 

          	Equity Financing 

          	 41
	Section 4.20. 

          	Last Interest Payment 

          	 42

    

    

    
      i

      
        

    

    

    

    	ARTICLE V REGISTRATION RIGHTS  

          	 42
	Section 5.01. 

          	Registration Statement 

          	 42
	Section 5.02. 

          	Registration Limitations and Obligations 

          	 44
	Section 5.03. 

          	Registration Procedures 

          	 46
	Section 5.04. 

          	Expenses 

          	 50
	Section 5.05. 

          	Registration Indemnification 

          	 50
	Section 5.06. 

          	Facilitation of Sales Pursuant to Rule 144 

          	 53
	ARTICLE VI MISCELLANEOUS  

          	 54
	Section 6.01. 

          	Survival of Representations and Warranties 

          	 54
	Section 6.02. 

          	Notices 

          	 54
	Section 6.03. 

          	Entire Agreement; Third Party Beneficiaries; Amendment 

          	 55
	Section 6.04. 

          	Counterparts 

          	 55
	Section 6.05. 

          	Public Announcements 

          	 55
	Section 6.06. 

          	Expenses	 56
	Section 6.07. 

          	Successors and Assigns 

          	 56
	Section 6.08. 

          	Governing Law; Jurisdiction; Waiver of Jury Trial 

          	 57
	Section 6.09.	Severability 

          	58 

          
	Section 6.10. 

          	Specific Performance 

          	 58
	Section 6.11. 

          	Headings 

          	 58
	Section 6.12. 

          	Non-Recourse 

          	 58

    

    

    

    Exhibit A: Form of Indenture

    

    

    Exhibit B: Form of Joinder

    

    

    Exhibit C: Form of Issuer Agreement

    

    

    Exhibit D: Schedule of Exceptions

    

    

    
      ii

      
        

    

    
    INVESTMENT AGREEMENT

    This INVESTMENT AGREEMENT (this “Agreement”), dated as of August 26, 2020, is by and among Nutanix, Inc., a
      Delaware corporation (together with any successor or assign pursuant to Section 6.07, the “Company”), and BCPE Nucleon (DE) SPV, LP, a Delaware limited partnership (together with its successors and any respective Affiliates thereof
      that become a Purchaser party hereto in accordance with Section 4.02 and Section 6.07, each, a “Purchaser”). Capitalized terms not otherwise defined where used shall have the meanings ascribed thereto in Article I.

    WHEREAS, the Purchaser desires to purchase from the Company, and the Company desires to issue and sell to the
      Purchaser, $750,000,000 (seven hundred and fifty million) aggregate principal amount of the Company’s 2.5% Convertible Notes due 2026 (referred to herein as the “Note” or the “Notes”) in the form attached to the Indenture (as defined
      below) and to be issued in accordance with the terms and conditions of the Indenture and this Agreement;

    WHEREAS, prior to the execution hereof, the Board of Directors (as defined below) approved and authorized the
      execution and delivery of this Agreement (including Section 4.07(e) hereof) and the other Transaction Agreements (as defined below) and the consummation of the transactions contemplated hereby and thereby; and

    WHEREAS, the Company and the Purchaser desire to set forth certain agreements herein.

    NOW, THEREFORE, in consideration of the premises and the representations, warranties and agreements herein contained
      and intending to be legally bound hereby, the parties hereby agree as follows:

    
      ARTICLE I

      

      

      

      DEFINITIONS

    

    
      
        Section

            1.01. Definitions. As used in this Agreement, the following terms shall
            have the meanings set forth below:

      

    

    “Affiliate” shall mean, with respect to any Person, any other Person which directly or indirectly controls or
      is controlled by or is under common control with such Person. Notwithstanding the foregoing, (i) the Company and the Company’s Subsidiaries shall not be considered Affiliates of the Purchaser or any of the Purchaser’s Affiliates and (ii) for purposes
      of the definitions of “Beneficially Own”, “Registrable Securities”, “Bain Group”, “Standstill Period” and “Third Party” and Section 3.02(d), Section 3.02(f), Section 4.02, Section 4.03, Section 4.06 and Section

        4.07, neither any Bain Excluded Entity, nor Bain Capital Investors, LLC, nor any of their respective Affiliates shall be deemed an Affiliate of the Purchaser and its other Affiliates so long as such Bain Excluded Entity (x) has not been
      directed, encouraged, instructed, assisted, advised or supported by, or coordinated with, the Purchaser or any of its Affiliates or any Bain Affiliated Director in carrying out any act prohibited by this Agreement or the subject matter of Section
        4.03, (y) is not a member of a group (as such term is defined in Section 13(d)(3) of the Exchange Act) with either the Purchaser or any of its Affiliates with respect to any securities of the Company, and (z) has not received from the Purchaser
      or any Affiliate of the Purchaser or any Bain Affiliated Director, directly or indirectly, any Confidential Information concerning the Company or its business. As used in this definition, “control” (including its correlative meanings, “controlled by”
      and “under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or
      otherwise).

    
      1

      
        

    

    “Agreement” shall have the meaning set forth in the preamble hereto.

    “Anti-Corruption Laws” shall mean (i) the U.S. Foreign Corrupt Practices Act (as amended), (ii) the UK Bribery
      Act (as amended), and (iii) any other applicable law, rule, regulation, or order relating to bribery or corruption (governmental or commercial).

    “Associate” shall have the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act; provided
      that (i) the Company and the Company’s Subsidiaries will not be considered Associates of the Purchaser or any of its Affiliates and (ii) no portfolio company of the Purchaser or its other Affiliates will be deemed Associates of the Purchaser or any
      of its other Affiliates.

    “Available” means, with respect to a Registration Statement, that such Registration Statement is effective and
      there is no stop order with respect thereto and such Registration Statement does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light
      of the circumstances under which they were made, not misleading, such that such Registration Statement will be available for the resale of Registrable Securities.

    “Bain Affiliate” means any Affiliate of Bain Capital Investors, LLC or Bain Capital Private Equity, LP that
      serves as general partner of, or manages or advises, any investment fund affiliated with Bain Capital Investors, LLC that has a direct or indirect investment in the Company.

    “Bain Affiliated Director” means each Bain Designee and any other person that is a managing director, officer,
      advisor or employee of Bain Capital Private Equity, LP or a successor thereto or another Bain Affiliate that is serving on the Board of Directors.

    “Bain Designee” means an individual then serving on the Board of Directors pursuant to the exercise of the
      Purchaser’s nomination rights pursuant to Section 4.07(a) and/or the Purchaser’s rights pursuant to Section 4.07(e), together with any designee of the Purchaser who is then standing for election to the Board of Directors pursuant to Section

        4.07(a) and (b) or who is being proposed for election by the Purchaser pursuant to Section 4.07(e).

    “Bain Excluded Entity” means (a) any leveraged finance investment fund or any other investment fund associated
      or affiliated with Bain Capital Investors, LLC, the primary purpose of which is to invest in loans or debt securities, or (b) any hedge fund associated or affiliated with Bain Capital Investors, LLC.

    “Bain Group” means the Purchaser, together with its Affiliates, including Bain Affiliates.

    
      2

      
        

    

    “Bain Indemnitors” shall have the meaning set forth in Section 4.12.

    “Beneficially Own”, “Beneficially Owned” or “Beneficial Ownership” and “Beneficial Owner”
      shall have the meaning set forth in Rule 13d-3 of the rules and regulations promulgated under the Exchange Act, except that for purposes of this Agreement the words “within sixty days” in Rule 13d-3(d)(1)(i) shall not apply, to the effect that a
      person shall be deemed to be the Beneficial Owner of a security if that person has the right to acquire beneficial ownership of such security at any time. Solely for purposes of determining the number of shares of Company Common Stock issuable upon
      conversion of the Notes Beneficially Owned by the Purchaser and its Affiliates, the Notes shall be treated as if upon conversion the only settlement option under the Notes and Indenture were solely Physical Settlement (as defined in the Indenture) of
      Company Common Stock. For the avoidance of doubt, for purposes of this Agreement, the Purchaser (or any other person) shall at all times be deemed to have Beneficial Ownership of shares of Company Common Stock issuable upon conversion of the Notes
      directly or indirectly held by them, irrespective of any non-conversion period specified in the Notes or this Agreement or any restrictions on transfer or voting contained in this Agreement.

    “Blackout Period” means (i) the Company’s regular quarterly restricted trading period during which directors
      and executive officers of the Company are not permitted to trade under the insider trading policy of the Company then in effect and which is not longer than the regular quarterly restricted period that has been in effect historically consistent with
      past practice in all material respects and/or (ii) in the event that the Company determines in good faith that any registration or sale pursuant to any registration statement could reasonably be expected to materially adversely affect or materially
      interfere with any bona fide financing of the Company or any bona fide material transaction under consideration by the Company or would require disclosure of
      information that has not been, and is not otherwise then required to be, disclosed to the public, the premature disclosure of which would adversely affect the Company in any material respect, or the registration statement is otherwise not Available
      for use (in each case as determined by the Company in good faith after consultation with outside counsel), a period of up to sixty (60) days; provided that a Blackout Period described in this clause (ii) may not be called by the Company more
      than twice in any period of twelve (12) consecutive months and may not be called by the Company in consecutive fiscal quarters.

    “Board of Directors” shall mean the board of directors of the Company.

    “Bookings Policy” shall mean the bookings policy of the Company.

    “Business Day” shall mean any day, other than a Saturday, Sunday or a day on which banking institutions in the
      City of New York, New York are authorized or obligated by law or executive order to remain closed.

    “Cash Settlement” has the meaning set forth in the Indenture.

    “Change in Control” shall mean the occurrence of any of the following events: (i) there occurs a sale,
      transfer, conveyance or other disposition of all or substantially all of the consolidated assets of the Company, (ii) any Person or “group” (as such term is used in Section 13 of the Exchange Act) (in each case excluding any member of the Bain Group
      or any of their respective Affiliates or any of their respective controlled portfolio companies), directly or indirectly, obtains Beneficial Ownership of 50% or more of the outstanding Company Common Stock, (iii) the Company consummates any merger,
      consolidation or similar transaction, unless the stockholders of the Company immediately prior to the consummation of such transaction continue to hold (in substantially the same proportion as their ownership of the Company Common Stock immediately
      prior to the transaction, other than changes in proportionality as a result of any cash/stock election provided under the terms of the definitive agreement regarding such transaction) more than 50% of all of voting power of the outstanding shares of
      Voting Stock of the surviving or resulting entity in such transaction immediately following the consummation of such transaction or (iv) a majority of the Board of Directors is no longer composed of (x) directors who were directors of the Company on
      the Closing Date and (y) directors who were nominated for election or elected or appointed to the Board of Directors with the approval of a majority of the directors described in subclause (x) together with any incumbent directors previously elected
      or appointed to the Board of Directors in accordance with this subclause (y).

    
      3

      
        

    

    “Class A Common Stock” shall mean the Class A common stock, par value $0.000025 per share, of the Company.

    “Class B Common Stock” shall mean the Class B common stock, par value $0.000025 per share, of the Company.

    “Closing” shall have the meaning set forth in Section 2.02(a).

    “Closing Date” shall have the meaning set forth in Section 2.02(a).

    “Company” shall have the meaning set forth in the preamble hereto.

    “Company Common Stock” shall mean the Class A Common Stock and Class B Common Stock.

    “Company Data” shall have the meaning set forth in Section 3.01(r).

    “Company Reports” shall have the meaning set forth in Section 3.01(g)(i).

    “Confidential Information” has the meaning ascribed to “Confidential Information” in the Confidentiality
      Agreement.

    “Confidentiality Agreement” shall mean the mutual nondisclosure agreement entered into by the Company, on the one hand, and Bain Capital Private Equity, LP, on the other hand, dated as of July 10, 2020.

    “Conversion Date”
        has the meaning set forth in the Indenture.

    “Conversion Price” has the meaning set forth in the Indenture.

    “Conversion Rate” has the meaning set forth in the Indenture.

    “Covered Persons” shall have the meaning set forth in Section 4.07(f).

    
      4

      
        

    

    “DGCL” shall mean the Delaware General Corporation Law.

    
      “Director Policy Change” shall have the meaning set forth in Section 4.07(d).

    

    “Enforceability Exceptions” shall have the meaning set forth in Section 3.01(c).

    “Enforcement Costs” shall have the meaning set forth in Section 6.10(b).

    “Equity Commitment Letter” shall mean that certain Equity Commitment Letter between the Purchaser and Bain
      Capital Fund XII, L.P., a Cayman Islands limited partnership, dated as of the date hereof, a copy of which has been delivered to the Company concurrently with the execution of this Agreement.

    “Equity Financing” shall have the meaning set forth in Section 3.02(g)(i).

    “Equity Plan” shall have the meaning set forth in Section 3.01(b).

    “Equity Provider” shall have the meaning set forth in Section 3.02(g)(i).

    “ESPP” shall have the meaning set forth in Section 3.01(b).

    “Exchange Act” shall mean the U.S. Securities Exchange Act of 1934, as amended.

    “Free Writing Prospectus” shall have meaning set forth in Section 5.03(a)(v).

    “GAAP” shall mean U.S. generally accepted accounting principles.

    “Global Note” has the meaning set forth in the Indenture.

    “Goldman Sachs” shall mean Goldman Sachs & Co. LLC.

    “Global Trade Laws” shall mean (i) the U.S. Export Administration Regulations administered by the U.S.
      Commerce Department’s Bureau of Industry and Security, (ii) the U.S. International Traffic in Arms Regulations administered by the U.S. State Department’s Directorate of Defense Trade Controls, (iii) the import laws administered by U.S. Customs and
      Border Protection, (iv) the economic sanctions rules and regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Control, (v) European Union regulations on export controls and sanctions, (vi) United Nations sanctions
      policies, (vii) all relevant regulations made under any of the foregoing, and (viii) other applicable economic sanctions, export control, or import laws.

    “Governmental Entity” shall mean any court, administrative agency or commission or other governmental
      authority or instrumentality, whether federal, state, local or foreign, and any applicable industry self-regulatory organization, or any arbitrator or arbitral body.

    “Guarantee” of or by any Person (the “guarantor”) means any obligation, contingent or otherwise, of the
      guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of the guarantor,
      direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof,
      (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity capital or any other financial statement
      condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or
      obligation; provided, that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business, or customary indemnification obligations entered into in connection with any acquisition or disposition
      of assets or of other entities (other than to the extent that the primary obligations that are the subject of such Guarantee would be considered Indebtedness hereunder).

    
      5

      
        

    

    “HSR Act” shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and
      regulations promulgated thereunder.

    “Indebtedness” of any Person at any date means, without duplication, (a) all indebtedness of such Person for
      borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (other than intercompany or current trade payables incurred in the ordinary course of such Person’s business), (c) all obligations of such
      Person evidenced by notes, bonds, debentures or other similar instruments, (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights
      and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all capital lease obligations of such Person, (f) all obligations of such Person, contingent or otherwise, as
      an account party or applicant under or in respect of acceptances, letters of credit, surety bonds or similar arrangements, (g) the liquidation value of all redeemable preferred capital stock of such Person, (h) all Guarantees of such Person in
      respect of obligations of the kind referred to in clauses (a) through (g) above, (i) all obligations of the kind referred to in clauses (a) through (h) above secured by (or for which the holder of such obligation has an existing right, contingent or
      otherwise, to be secured by) any lien on property (including accounts and contract rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation.

    “Indemnified Persons” shall have the meaning set forth in Section 5.05(a).

    “Indenture” shall mean an indenture in the form attached hereto as Exhibit A, as amended, supplemented
      or otherwise modified from time to time with the consent of the Purchaser and the Company prior to the Closing, it being agreed that the Company and the Purchaser shall consent to any changes required by the Trustee or by The Depository Trust Company
      that do not adversely affect the Company or the Purchaser, or the Purchaser’s financing sources, including with respect to timing and mechanics of transfers and exchanges of Subject Securities and interests therein, in any material respect.

    “Initial Conversion Rate” shall have the meaning set forth in Section 4.13.

    “Initiating Holder” shall have the meaning set forth in Section 5.02(a).

    
      6

      
        

    

    “Intellectual Property” shall have the meaning set forth in Section 3.01(p).

    “Interest Payment Date” has the meaning set forth in the Indenture.

    “Interest Record Date” has the meaning set forth in the Indenture.

    “Issuer Agreement” shall have the meaning set forth in Section 4.09.

    “Joinder” shall mean, with respect to any Person permitted to sign such document in accordance with the terms
      hereof, a joinder executed and delivered by such Person, providing such Person to have all the rights and obligations of the Purchaser under this Agreement, in the form and substance substantially as attached hereto as Exhibit B or such other
      form as may be agreed to by the Company and the Purchaser.

    “Losses” shall have the meaning set forth in Section 5.05(a).

    “Management Agreement” shall have the meaning set forth in Section 2.02(c)(viii).

    “Marketed Underwritten Offering” shall mean an Underwritten Offering involving reasonable and customary
      marketing efforts not to exceed twenty-four (24) hours by the Company and the underwriters.

    “Material Adverse Effect” shall mean any events, changes or developments that, individually or in the
      aggregate, have a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole, other than any event, change or development resulting from or arising out of the following:
      (a) events, changes or developments generally affecting the economy, the financial or securities markets, or political, legislative or regulatory conditions, in each case in the United States or elsewhere in the world, (b) events, changes or
      developments in the industries in which the Company or any of its Subsidiaries conducts its business, (c) any adoption, implementation, promulgation, repeal, modification, reinterpretation or proposal of any rule, regulation, ordinance, order,
      protocol or any other law of or by any national, regional, state or local Governmental Entity, or market administrator, (d) any changes in GAAP or accounting standards or interpretations thereof, (e) epidemics, pandemics, earthquakes, any
      weather-related or other force majeure event or natural disasters or outbreak or escalation of hostilities or acts of war or terrorism, (f) the announcement or the existence of, compliance with or performance under, this Agreement or the transactions
      contemplated hereby (including the contents of the press releases to be issued by the Company publicly announcing the execution of this Agreement and the Company’s financial results for fiscal year 2020 and any other events to be announced
      contemporaneously therewith) (provided that this clause (f) shall not exclude any impact resulting from a breach of Section 3.01(f)), (g) any taking of any action at the request of the Purchaser, (h) any failure by the Company to meet any
      financial projections or forecasts or estimates of revenues, earnings or other financial metrics for any period (provided that the exception in this clause (h) shall not prevent or otherwise affect a determination that any event, change, effect or
      development underlying such failure has resulted in a Material Adverse Effect so long as it is not otherwise excluded by this definition) or (i) any changes in the share price or trading volume of the Company Common Stock or in the Company’s credit
      rating (provided that the exception in this clause (i) shall not prevent or otherwise affect a determination that any event, change, effect or development underlying such change has resulted in a Material Adverse Effect so long as it is not
      otherwise excluded by this definition); except, in each case with respect to subclauses (a) through (e), to the extent that such event, change or development materially and disproportionately affects the Company and its Subsidiaries, taken as a
      whole, relative to other similarly situated companies in the industries in which the Company and its Subsidiaries operate.

    
      7

      
        

    

    “Material Indebtedness” shall mean (i) the Indebtedness of the Company under any notes issued pursuant to the
      Indenture, dated as of January 22, 2018, between the Company and U.S. Bank National Association, as trustee, relating to the Company’s 0% convertible senior notes due 2023 (the “Other Notes”) and (ii) any other Indebtedness (other than the
      Notes) of, collectively, any one or more of the Company and its Subsidiaries in an aggregate principal amount exceeding $50,000,000.

    “Maturity Date” has the meaning set forth in the Indenture.

    “NASDAQ” shall mean the NASDAQ Global Select Market.

    “Note” or “Notes” shall have the meaning set forth in the preamble hereto.

    “Permitted Loan” shall have the meaning set forth in Section 4.02(a).

    “Permitted Transfers” shall have the meaning set forth in Section 4.02(a).

    “Person” or “person” shall mean an individual, corporation, limited liability or unlimited liability
      company, association, partnership, trust, estate, joint venture, business trust or unincorporated organization, or a government or any agency or political subdivision thereof, or other entity of any kind or nature.

    “Personal Data” means any information that, alone or in combination with other information held by the Company or
      its Subsidiaries, allows the identification of or contact with a Person or can be used to identify a Person and any other information that constitutes personal information under any applicable law.

    “PIK Note” has the meaning set forth in the Indenture.

    “Prohibited Transfers” shall have the meaning set forth in Section 4.02(a).

    “Purchase Price” shall have the meaning set forth in Section 2.01.

    “Purchaser” shall have the meaning set forth in the preamble hereto.

    “Purchaser Affiliates” shall have the meaning set forth in Section 4.03(a).

    “Registrable Securities” shall mean the Subject Securities; provided that any Subject Securities will
      cease to be Registrable Securities when (a) such Subject Securities have been sold or otherwise disposed of pursuant to an effective Registration Statement or in compliance with Rule 144, (b) such Subject Securities are held or Beneficially Owned by
      any Person (other than the Purchaser or any of its Affiliates) that together with its Affiliates Beneficially Own less than 1.0% of the outstanding shares of Company Common Stock as of such time (assuming any Subject Securities Beneficially Owned by
      such Person and its Affiliates are converted on a fully physical settlement basis), (c) such Subject Securities are held or Beneficially Owned by any of the Purchaser or any of its Affiliates and the Purchaser and its Affiliates collectively
      Beneficially Own less than 1.0% of the outstanding shares of Company Common Stock as of such time, when such Subject Securities may be offered and sold without volume limitations or other restrictions on transfer under Rule 144 (including without
      application of paragraphs (d), (e), (f) and (h) of Rule 144) (assuming any Subject Securities Beneficially Owned by such Person and its Affiliates are converted on a fully physical settlement basis), or (d) such Subject Securities cease to be
      outstanding; provided, further, that any security that has ceased to be Registrable Securities in accordance with the foregoing definition shall not thereafter become Registrable Securities and any security that is issued or
      distributed in respect of securities that have ceased to be Registrable Securities are not Registrable Securities.

    
      8

      
        

    

    “Registration Date” shall have the meaning set forth in Section 5.01(a).

    “Registration Expenses” shall mean all expenses incurred by the Company in complying with Article V,
      including all registration, filing and listing fees, printing expenses, fees and disbursements of counsel (including local counsel if required) and independent public accountants for the Company and of a single counsel for the holders of Registrable
      Securities, fees and expenses incurred by the Company in connection with complying with state securities or “blue sky” laws, fees of the Financial Industry Regulatory Authority, Inc., all the Company’s internal expenses, transfer taxes, and fees of
      transfer agents and registrars, but excluding any underwriting discounts and commissions, agency fees, brokers’ commissions and transfer taxes, in each case to the extent applicable to the Registrable Securities of the selling holders; provided
      that Registration Expenses shall not include more than $60,000 per offering of fees and disbursements of counsel and other advisors for the holders of Registrable Securities.

    “Registration Statement” shall mean any registration statement of the Company filed or to be filed with the
      SEC under the rules and regulations promulgated under the Securities Act, including the related prospectus, amendments and supplements to such registration statement, and including pre- and post-effective amendments, and all exhibits and all material
      incorporated by reference in such registration statement.

    “Registration Termination Date” shall have the meaning set forth in Section 5.01(b).

    “Restricted Period” shall mean the period commencing on the Closing Date and ending on the earlier of (i) the
      date that is twelve (12) months following the Closing Date and (ii) the consummation of any Change in Control or entry into a definitive agreement for a transaction that, if consummated, would result in a Change in Control or Fundamental Change (as
      defined in the Indenture).

    “Rule 144” shall mean Rule 144 promulgated by the SEC pursuant to the Securities Act, as such rule may be
      amended from time to time.

    “Rule 405” shall mean Rule 405 promulgated by the SEC pursuant to the Securities Act, as such rule may be
      amended from time to time.

    
      9

      
        

    

    “Scheduled Trading Day” has the meaning set forth in the Indenture.

    “SEC” shall mean the U.S. Securities and Exchange Commission.

    “Securities Act” shall mean the U.S. Securities Act of 1933, as amended.

    “Selling Holders” shall have the meaning set forth in Section 5.03(a)(i).

    “Software” means computer software programs and databases, including all source code, object code, firmware,
      specifications, designs and documentation therefor.

    “Specified Guidelines” shall have the meaning set forth in Section 4.07(c).

    “Sponsor Global Note” has the meaning set forth in the Indenture.

    “Standstill Period” shall mean the period commencing on the Closing Date and ending on the earliest of (i) the
      later of (A) the date on which no Bain Designee is serving on the Board of Directors (and as of such time the Purchaser no longer has board nomination rights pursuant to this Agreement or otherwise irrevocably waives in a writing delivered to the
      Company all of such rights) and (B) the two (2) year anniversary of the Closing Date, (ii) the consummation of a Change in Control and (iii) the failure of the stockholders of the Company to elect a Bain Designee nominated in accordance with Section

        4.07.

    “Subject Securities” shall mean (i) the Notes or any Other Notes; (ii) the shares of Company Common Stock
      issuable or issued upon conversion or repurchase by the Company of the Notes; (iii) any other shares of Company Common Stock or Other Notes acquired by the Purchaser after the effective date of this Agreement at a time when the Purchaser or its
      Affiliates hold other Registrable Securities and (iv) any securities issued as or pursuant to (or issuable upon the conversion, exercise or exchange of any warrant, right or other security that is issued as or pursuant to) a dividend, stock split,
      combination or any reclassification, recapitalization, merger, consolidation, exchange or any other distribution or reorganization with respect to, or in exchange for, or in replacement of, the securities referenced in clause (i), (ii) or (iii)
      (without giving effect to any election by the Company regarding settlement options upon conversion) above or this clause (iv).

    “Subsidiary” shall mean, with respect to any Person, any other Person of which 50% or more of the shares of
      the voting securities or other voting interests are owned or controlled, or the ability to select or elect 50% or more of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries, or
      by such first Person, or by such first Person and one or more of its Subsidiaries.

    “Systems” means all networks, servers, switches, endpoints, Software, platforms, electronics, websites,
      storage, firmware, hardware, and related information technology or outsourced services, and all electronic connections between them, that are owned, operated, or used by the Company or its Subsidiaries.

    “Take-Down Notice” shall have the meaning set forth in Section 5.02(a).

    
      10

      
        

    

    “Tax” or “Taxes” shall mean all federal, state, local, and foreign income, excise, gross receipts,
      gross income, ad valorem, profits, gains, property, capital, sales, transfer, use, payroll, employment, severance, withholding (including backup withholding), duties, intangibles, franchise, escheat, abandoned or unclaimed property, value-added, and
      other taxes imposed by a Governmental Entity, together with all interest, penalties and additions to tax imposed with respect thereto.

    “Tax Return” shall mean a report, return or other document (including any amendments thereto) required to be
      supplied to a Governmental Entity with respect to Taxes.

    “Third Party” shall mean with respect to the Purchaser, a Person other than the Purchaser or any Affiliate of
      the Purchaser.

    “Third Party Tender/Exchange Offer” shall have the meaning set forth in Section 4.02(a).

    “Tier I Minimum Ownership Threshold” shall mean collective Beneficial Ownership by Bain Group of Company
      Common Stock issuable or issued upon conversion of the Notes Beneficially Owned by the Bain Group representing at least 50% of the shares of Company Common Stock Beneficially Owned by the Bain Group issuable upon conversion of the Notes Beneficially
      Owned by the Bain Group at the Closing.

    “Tier II Minimum Ownership Threshold” shall mean collective Beneficial Ownership by Bain Group of Company
      Common Stock then outstanding issuable or issued upon conversion of the Notes Beneficially Owned by the Bain Group representing at least 25% of the shares of Company Common Stock Beneficially Owned by the Bain Group issuable upon conversion of the
      Notes Beneficially Owned by the Bain Group at the Closing.

    “Transaction Agreements” shall have the meaning set forth in Section 3.01(c).

    “Transactions” shall have the meaning set forth in Section 3.01(c).

    “Trustee” shall mean U.S. Bank National Association, or another institutional trustee selected by the Company
      with the consent of the Purchaser, which consent shall not be unreasonably withheld or delayed.

    “Underwritten Offering” shall mean a sale of Registrable Securities to an underwriter or underwriters for
      reoffering to the public, including in a block trade offered and sold through an underwriter or underwriters.

    “Union” shall mean a labor union, trade union, works council or other employee representative body.

    “VCOC Letter” shall have the meaning set forth in Section 4.08.

    “Voting Stock” shall mean securities of any class or kind having the power to vote generally for the election
      of directors, managers or other voting members of the governing body of the Company or any successor thereto.

    
      11

      
        

    

    “WKSI” means a “well known seasoned issuer” as defined under Rule 405.

    Section 1.02. General Interpretive
          Principles.  Whenever used in this Agreement, except as otherwise expressly provided or unless the context otherwise requires, any noun or pronoun shall be deemed to include the plural as well as the singular and to cover all genders. The
        name assigned to this Agreement and the section captions used herein are for convenience of reference only and shall not be construed to affect the meaning, construction or effect hereof. Whenever the words “include,” “includes,” or “including” are
        used in this Agreement, they shall be deemed to be followed by the words “without limitation.” Unless otherwise specified, the terms “hereto,” “hereof,” “herein” and similar terms refer to this Agreement as a whole (including the exhibits,
        schedules and disclosure statements hereto), references to “the date hereof” refer to the date of this Agreement and references herein to Articles or Sections refer to Articles or Sections of this Agreement. For the avoidance of doubt,
        notwithstanding anything in this Agreement to the contrary, none of the Notes will have any right to vote, or, except as expressly set forth in Section 14.04 of the Indenture, any right to receive any dividends or other distributions that are made
        or paid to the holders of the shares of Company Common Stock.

    ARTICLE II

        

        SALE AND PURCHASE OF THE NOTES

    
      
        Section

            2.01. Sale and Purchase of the Notes. Subject to the terms and
            conditions of this Agreement, at the Closing, the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase and acquire from the Company, $750,000,000 (seven hundred and fifty million) aggregate principal amount of Notes
            for a purchase price equal to the principal amount of the Notes (such price, the “Purchase Price”).

      

    

    Section 2.02. Closing.

    
      
        (a) The closing (the “Closing”) of the purchase and sale of the Notes hereunder shall take place
          electronically at 8:00 a.m. San Francisco time on the date that is one Business Day after the conditions set forth in Section 2.02(c) and (d) have been satisfied or waived (other than those conditions that by their terms are to be
          satisfied at the Closing, but subject to the satisfaction or waiver thereof at the Closing) or at such other place, time or date as may be mutually agreed upon in writing by the Company and the Purchaser; provided that the Closing will not occur
          prior to September 24, 2020, without the prior written consent of the Purchaser (the date on which the Closing actually occurs, the “Closing Date”).

      

    

    
      
        (b) To effect the purchase and sale of Notes, upon the terms and subject to the conditions set forth in this
          Agreement, at the Closing:

      

    

    
      
        (i) the Company shall execute and deliver, and shall instruct the Trustee to, execute and deliver the Indenture.
          The Company shall deliver the fully executed Indenture to the Purchaser at the Closing, against payment in full by or on behalf of the Purchaser of the Purchase Price for the Notes;

        
          12

          
            

        

      

    

    
      
        (ii) the Company shall issue and deliver to the Purchaser the Notes through the facilities of The Depository
          Trust Company, or at the option of the Purchaser, registered in the name of the Purchaser, against payment in full by or on behalf of the Purchaser of the Purchase Price for the Notes;

      

    

    
      
        (iii) the Purchaser shall cause a wire transfer to be made in same day funds to an account of the Company
          designated in writing by the Company to the Purchaser in an amount equal to the Purchase Price for the Notes; and

      

    

    
      
        (iv) the Purchaser shall deliver to the Company a duly completed and executed IRS Form W-9 (or a substantively
          equivalent form).

      

    

    
      
        (c) The obligations of the Purchaser to purchase the Notes to be purchased by it hereunder are subject to the
          satisfaction or waiver by the Purchaser of the following conditions as of the Closing:

      

    

    
      
        (i) the purchase and sale of the Notes pursuant to Section 2.02(b) shall not be prohibited or enjoined
          by any court of competent jurisdiction;

      

    

    
      
        (ii) the Company and the Trustee shall have executed the Indenture and delivered the Indenture to the Purchaser,
          and the Company shall have executed and delivered the Notes to the Purchaser;

      

    

    
      
        (iii) the Company shall have executed the Issuer Agreement and delivered it to the Purchaser and, if requested
          by the Purchaser, the Company shall have executed and delivered a VCOC Letter to the Purchaser in a form acceptable to the Company;

      

    

    
      
        (iv) (A) the representations and warranties of the Company set forth in Section 3.01(a), the first and second
          sentence of Section 3.01(b), 3.01(c), 3.01(e), 3.01(f), and 3.01(o) shall be true and correct in all material respects at and as of the Closing; (B) the representations and warranties of the Company
          set forth in 3.01(h)(ii) shall be true and correct at and as of the Closing and (C) the representations and warranties of the Company set forth in Section 3.01 (other than those set forth in Section 3.01(a), the first and
          second sentence of Section 3.01(b), 3.01(c), 3.01(e), 3.01(f), 3.01(h)(ii) and 3.01(o)) shall be true and correct at and as of the date hereof (without giving effect to materiality, Material Adverse
          Effect, or similar phrases in the representations and warranties) except where the failure of such representations and warranties referenced in this clause (C) to be so true and correct, individually or in the aggregate, has not had and would not
          reasonably be expected to have a Material Adverse Effect;

      

    

    
      
        (v) the Company shall have delivered to the Trustee, as custodian, the Global Securities registered in the name
          of The Depository Trust Company and such Global Securities shall be eligible for book-entry settlement with The Depository Trust Company;

        
          13

          
            

        

      

    

    
      
        (vi) the Company shall have performed and complied in all material respects with all agreements and obligations
          required by this Agreement to be performed or complied with by it on or prior to the Closing;

      

    

    
      
        (vii) the Purchaser shall have received a certificate, dated the Closing Date, duly executed by an executive
          officer of the Company on behalf of the Company, certifying that the conditions specified in Section 2.02(c)(iv), (vi) and (vii) have been satisfied; and

      

    

    
      
        (viii) the Purchaser shall have received a management agreement in the form agreed to by the parties hereto
          prior to the execution hereof (the “Management Agreement”) duly executed by the Company.

      

    

    
      
        (d) The obligations of the Company to sell the Notes to the Purchaser are subject to the satisfaction or waiver
          of the following conditions as of the Closing:

      

    

    
      
        (i) the purchase and sale of the Notes pursuant to Section 2.02(b) shall not be prohibited or enjoined
          by any court of competent jurisdiction; and

      

    

    
      
        (ii) the Trustee shall have executed and delivered the Indenture to the Company;

      

    

    
      
        (iii) the representations and warranties of the Purchaser set forth in Section 3.02 shall be true and
          correct in all material respects on and as of the Closing;

      

    

    
      
        (iv) the Purchaser shall have performed and complied in all material respects with all agreements and
          obligations required by this Agreement to be performed or complied with by it on or prior to the Closing; and

      

    

    
      
        (v) the Company shall have received a certificate duly executed by the general partner of the Purchaser on
          behalf of the Purchaser, dated as of the Closing Date certifying that the conditions specified in Section 2.02(d)(iii) and (iv) have been satisfied.

      

    

    
      
        Section 2.03. Termination.  If the Closing does not occur on or prior to 5:30 p.m. New York time on
            September 30, 2020, this Agreement shall automatically terminate on the date that is five Business Days following such date and each of the parties hereto shall be relieved of its duties and obligations arising under this Agreement after the
            date of such termination; provided, that this Agreement shall not so terminate and shall continue in full force and effect so long as the Company or the Purchaser is seeking to specifically enforce the other party’s obligation to
            consummate the Closing; provided, further, that no such termination shall relieve any party hereto of liability for any breach or default under this Agreement prior to such termination.

        
          14

          
            

        

      

    

    ARTICLE III

        

        REPRESENTATIONS AND WARRANTIES

     
    
      
        Section 3.01. Representations and Warranties of the Company.  Except as disclosed in the Company
            Reports filed with or furnished to the SEC and publicly available prior to the date hereof (excluding in each case any disclosures set forth in the risk factors or “forward-looking statements” sections of such reports, and any other disclosures
            included therein to the extent they are predictive or forward-looking in nature) or the Schedule of Exceptions attached hereto as Exhibit D, the Company represents and warrants to the Purchaser, as of the date hereof as follows:

      

    

     
    
      
        (a)
          Existence and Power.  The Company is duly organized, validly existing and
            in good standing under the laws of the State of Delaware and has all requisite corporate power and authority to own, operate and lease its properties, rights and assets and to carry on its business as it is being conducted on the date of this
            Agreement, and, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the
            laws of each other jurisdiction in which it owns or leases properties, rights and assets or conducts any business so as to require such qualification. Except as would not, individually or in the aggregate, reasonably be expected to have a
            Material Adverse Effect, each Subsidiary of the Company that is a “significant subsidiary” (as defined in Rule 1.02(w) of the SEC’s Regulation S-X) has been duly organized and is validly existing in good standing (to the extent that the concept
            of “good standing” is recognized by the applicable jurisdiction) under the laws of its jurisdiction of organization.

      

    

     
    
      
        (b)
          Capitalization.

      

    

     
    
      
        (i) The authorized share capital of the Company consists of 1,000,000,000 shares of Class A Common Stock, par value $0.000025 per share and 200,000,000 shares of Class B Common Stock, par value of $0.000025 per share. As of July 31, 2020, there were (i) 186,846,321 shares of Class A Common Stock issued and outstanding and
            15,102,744 shares of Class B Common Stock issued and outstanding, (ii) options to purchase an aggregate of 1,500 shares of Class A Common Stock issued and outstanding under the Nutanix, Inc. 2016 Equity Incentive Plan, as amended (the “2016
              Plan”), (iii) options to purchase an aggregate of 7,544,942 shares of Class B Common Stock issued and outstanding (assuming the performance conditions associated with options that are subject to performance-based vesting are satisfied in
            full) under the Nutanix, Inc. 2010 Stock Plan (the “2010 Plan”) and the Nutanix, Inc. 2011 Stock Plan; (iv) 22,631,557 shares of Class A Common Stock underlying the Company’s restricted and performance stock unit awards (assuming
            performance conditions associated with the awards are satisfied in full) under the 2016 Plan and the 2010 Plan, (v) 11,529,531 shares of Class A Common Stock authorized for issuance under the Nutanix, Inc. Amended and Restated 2016 Employee
            Stock Purchase Plan, as amended (the “ESPP”), of which 9,169,078 are reserved for issuance under the ESPP, and (vi) 12,723,678 shares of Class A Common Stock reserved for issuance under the 2016 Plan.

        
          15

          
            

        

      

    

     
    
      
        (ii) Since July 31, 2020, (i) the Company has only issued options to purchase, and, restricted stock units and performance stock units with respect to, shares of Class A Common Stock in the ordinary course of
            business consistent with past practice and (ii) the only shares of capital stock issued by the Company were pursuant to outstanding options to purchase shares of Class A Common Stock and Class B Common Stock and restricted stock units and
            performance stock units with respect to shares of Class A Common Stock. The only equity or equity-based incentive plans sponsored or maintained by the Company under which stock-based awards may be granted are the Equity Plan and the ESPP. All
            options to purchase Class A Common Stock and Class B Common Stock were granted with a per share exercise price that is no less than the fair market value of the shares of Class A Common Stock or Class B Common Stock, as applicable, on the date
            such option was granted. Each option to purchase Class A Common Stock and Class B Common Stock, and each restricted stock unit and performance stock unit with respect to Class A Common Stock, was granted in all material respects in accordance
            with the term of the applicable Company equity plan and all applicable laws. All outstanding shares of Company Common Stock are duly authorized, validly issued, fully paid and nonassessable, and are not subject to and were not issued in
            violation of any preemptive or similar right, purchase option, call or right of first refusal or similar right. Except as set forth above, the Company has not issued any securities, the holders of which have the right to vote with the
            stockholders of the Company on any matter. Except as provided in this Agreement, the Notes and the Indenture and except as set forth in or contemplated by this paragraph (b), there are no existing options, warrants, calls, preemptive (or
            similar) rights, subscriptions or other rights, agreements or commitments obligating the Company to issue, transfer or sell, or cause to be issued, transferred or sold, any capital stock of the Company or any securities convertible into or
            exchangeable for such capital stock and there are no current outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any of its shares of capital stock.

      

    

     
    
      
        (c)
          Authorization.  The execution, delivery and performance of this Agreement,
            the Indenture, the Notes, the VCOC Letters and the Issuer Agreement (the “Transaction Agreements”) and the consummation of the transactions contemplated herein and therein (collectively, the “Transactions”), have been duly
            authorized by the Board of Directors and all other necessary corporate action on the part of the Company. Assuming this Agreement constitutes the valid and binding obligation of the Purchaser, this Agreement is a valid and binding obligation of
            the Company, enforceable against the Company in accordance with its terms, subject to the limitation of such enforcement by (A) the effect of bankruptcy, insolvency, reorganization, receivership, conservatorship, arrangement, moratorium or
            other laws affecting or relating to creditors’ rights generally or (B) the rules governing the availability of specific performance, injunctive relief or other equitable remedies and general principles of equity, regardless of whether
            considered in a proceeding in equity or at law (the “Enforceability Exceptions”). On the Closing Date, the Indenture will be duly executed and delivered by the Company and, assuming the Indenture will be a valid and binding obligation of
            the Trustee, the Indenture will be a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. If applicable, assuming the VCOC Letters constitute the
            valid and binding obligations of the Purchaser or other Affiliate thereof party thereto, on the Closing Date, the VCOC Letters will be valid and binding obligations of the Company enforceable against the Company in accordance with their terms,
            subject to the Enforceability Exceptions. Pursuant to resolutions previously provided to the Purchaser, the Board of Directors or a committee thereof composed solely of two or more “non-employee directors” as defined in Rule 16b-3 of the
            Exchange Act has approved, and will approve in advance of the Closing, for the express purpose of exempting each such transaction from Section 16(b) of the Exchange Act, pursuant to Rule 16b-3 thereunder, the transactions contemplated by the
            Transaction Agreements, including the acquisition of the Notes, any disposition of such Notes upon the conversion thereof, any acquisition of Company Common Stock upon conversion of the Notes, any deemed acquisition or disposition in connection
            therewith, and all transactions related thereto.

        
          16

          
            

        

      

    

     
    
      
        (d)
          General Solicitation; No Integration.  Other than with respect to the
            Purchaser and its Affiliates, neither the Company nor any other Person or entity authorized by the Company to act on its behalf has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities
            Act) of investors with respect to offers or sales of the Notes. The Company has not, directly or indirectly, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act)
            which, to its knowledge, is or will be integrated with the Notes sold pursuant to this Agreement.

      

    

     
    
      
        (e)
          Valid Issuance.  The Notes have been duly authorized by all necessary
            corporate action of the Company. When issued and sold against receipt of the consideration therefor, the Notes will be valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject to the limitation
            of such enforcement by the Enforceability Exceptions. The Company has available for issuance the maximum number of shares (including make-whole shares) of Company Common Stock initially issuable upon conversion of the Notes if such conversion
            were to occur immediately following Closing (assuming fully physical share settlement). The Company Common Stock to be issued upon conversion of the Notes in accordance with the terms of the Notes has been duly authorized, and when issued upon
            conversion of the Notes, all such Company Common Stock will be validly issued, fully paid and nonassessable and free of pre-emptive or similar rights. As of the date hereof, the Company is a WKSI eligible to file a registration statement on
            Form S-3 under the Securities Act.

      

    

     
    
      
        (f)
          Non-Contravention/No Consents.  The execution, delivery and performance of
            the Transaction Agreements, the issuance of the shares of Company Common Stock upon conversion of the Notes in accordance with their terms and the consummation by the Company of the Transactions, does not conflict with, violate or result in a
            breach of any provision of, or constitute a default under, or result in the termination of or accelerate the performance required by, or result in a right of termination or acceleration under, (i) the certificate of incorporation or bylaws of
            the Company, (ii) any credit agreement, mortgage, note, indenture, deed of trust, lease, license, loan agreement or other agreement binding upon the Company or any of its Subsidiaries with respect to any Material Indebtedness, or (iii) any
            permit, government license, judgment, order, decree, ruling, injunction, statute, law, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, other than in the cases of clauses (ii) and (iii) as would not,
            individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Assuming the accuracy of the representations of the Purchaser set forth herein, other than (A) any required filings or approvals under the HSR Act or
            any foreign antitrust or competition laws, requirements or regulations in connection with the issuance of shares of Company Common Stock upon the conversion of the Notes, (B) the filing of a Supplemental Listing Application with the NASDAQ, (C)
            any required filings pursuant to the Exchange Act or the rules of the SEC or the NASDAQ or (D) as have been obtained, completed or provided prior to the date of this Agreement, no consent, approval, order or authorization of, or registration,
            consultation, declaration or filing with, or notice to any Governmental Entity is required on the part of the Company or any of its Subsidiaries in connection with the execution, delivery and performance by the Company of this Agreement and the
            consummation by the Company of the Transactions (in each case other than the transactions contemplated by Article V), except for any consent, approval, order, authorization, registration, declaration, filing, exemption or review the failure of
            which to be obtained or made, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.

        
          17

          
            

        

      

    

     
    
      
        (g)
          Reports; Financial Statements.

      

    

     
    
      
        (i) The Company has filed or furnished, as applicable, (A) its annual report on Form 10-K for the fiscal year ended July 31, 2019, (B) its proxy statement relating to the annual meeting of the stockholders of
            the Company held in 2019 and (C) all other forms, reports, schedules and other statements required to be filed or furnished by it with the SEC under the Exchange Act or the Securities Act since July 31, 2019 and through the date hereof
            (collectively, the “Company Reports”).

      

    

     
    
      
        (ii) As of its respective date, and, if amended, as of the date of the last such amendment, each Company Report complied in all material respects as to form with the applicable requirements of the Securities Act
            and the Exchange Act, and any rules and regulations promulgated thereunder applicable to such Company Report. As of its respective date, and, if amended, as of the date of the last such amendment, no Company Report contained any untrue
            statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances in which they were made, not misleading.

      

    

     
    
      
        (iii) Each of the consolidated balance sheets, and the related consolidated statements of income, changes in stockholders’ equity and cash flows, included in the Company Reports filed with the SEC under the
            Exchange Act (A) have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries, (B) fairly present in all material respects the consolidated financial position of the Company and its consolidated
            Subsidiaries as of the dates shown and the results of the consolidated operations, changes in stockholders’ equity and cash flows of the Company and its consolidated Subsidiaries for the respective fiscal periods or as of the respective dates
            therein set forth, subject, in the case of any unaudited financial statements, to normal recurring year-end adjustments, (C) have been prepared in accordance with GAAP consistently applied during the periods involved, except as otherwise set
            forth therein or in the notes thereto, and in the case of unaudited financial statements except for the absence of footnote disclosure, and (D) otherwise comply in all material respects with the requirements of the SEC.

        
          18

          
            

        

      

    

     
    
      
        (h)
          Absence of Certain Changes.  Since April 30, 2020 until the date hereof,
            (i) the Company and its Subsidiaries have conducted their respective businesses in all material respects in the ordinary course of business and (ii) no events, changes or developments have occurred that, individually or in the aggregate, have
            had or would reasonably be expected to have a Material Adverse Effect or would require the Company to file a current report on Form 8-K that has not been filed.

      

    

     
    
      
        (i)
          No Undisclosed Liabilities, etc.  As of the date hereof, there are no
            liabilities of the Company or any of its Subsidiaries that would be required by GAAP to be reflected on the face of the balance sheet, except (i) liabilities reflected or reserved against in the financial statements contained in the Company
            Reports, (ii) liabilities incurred since April 30, 2020 in the ordinary course of business, and (iii) liabilities that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

      

    

     
    
      
        (j)
          Compliance with Applicable Law.  As of the date hereof, each of the Company
            and its Subsidiaries has complied in all respects with, and is not in default or violation in any respect of, any law, statute, order, rule, regulation, policy or guideline of any Governmental Entity (including, without limitation, all
            Anti-Corruption Laws and Global Trade Laws) applicable to the Company or such Subsidiary, other than such non-compliance, defaults or violations that, individually or in the aggregate, have not had and would not reasonably be expected to have a
            Material Adverse Effect. The Company and its Subsidiaries have established and maintain internal controls and procedures reasonably designed to ensure compliance with Anti-Corruption Laws and Global Trade Laws.

      

    

     
    
      
        (k)
          Legal Proceedings and Liabilities.  As of the date hereof, neither the
            Company nor any of its Subsidiaries is a party to any, and there are no pending, or to the knowledge of the Company, threatened, legal, administrative, arbitral or other proceedings, claims, charges, actions, mediations or governmental
            investigations of any nature against the Company or any of its Subsidiaries (i) that, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect or (ii) that challenge the validity of or seek to
            prevent the Transactions. As of the date hereof, neither the Company nor any of its Subsidiaries is subject to any order, judgment or decree of a Governmental Entity that, individually or in the aggregate, has had or would reasonably be
            expected to have a Material Adverse Effect. As of the date hereof, except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect, to the knowledge of the Company, there is no
            investigation, or review pending or threatened by any Governmental Entity with respect to the Company or any of its Subsidiaries.

          

        
          19

          
            

        

      

    

     
    
      
        (l)
          Investment Company Act.  The Company is not, and immediately after receipt
            of payment for the Notes will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

      

    

     
    
      
        (m)
          Taxes and Tax Returns.  Except as, individually or in the aggregate, has
            not had and would not reasonably be expected to have a Material Adverse Effect, as of the date hereof:

      

    

     
    
      
        (i) the Company and each of its Subsidiaries has timely filed (taking into account all applicable extensions) all Tax Returns required to be filed by it, and all such Tax Returns were correct and complete in
            all respects, and the Company and each of its Subsidiaries has paid (or has had paid on its behalf) to the appropriate Governmental Entity all Taxes that are required to be paid by it, except with respect to Taxes contested in good faith by
            appropriate proceedings and for which adequate reserves have been established in accordance with GAAP; and

      

    

     
    
      
        (ii) there are no disputes or claims asserted in writing, in respect of Taxes or Tax Returns of the Company or any of its Subsidiaries for which reserves that are adequate under GAAP have not been established.

      

    

     
    
      
        (n)
          No Piggyback or Preemptive Rights.  Other than this Agreement, there are no
            contracts, agreements or understandings between the Company and any person granting such person the right (other than rights which have been waived in writing or otherwise satisfied) to (i) require the Company to include in any Registration
            Statement filed pursuant to Article V any securities other than the Subject Securities or (ii) preemptive rights to subscribe for the Company Common Stock issuable upon conversion of the Notes, except in each case of (i) and (ii), as
            may have been duly waived.

      

    

     
    
      
        (o)
          Brokers and Finders.  The Company has not retained, utilized or been
            represented by, or otherwise become obligated to, any broker, placement agent, financial advisor or finder in connection with the transactions contemplated by this Agreement whose fees the Purchaser would be required to pay.

      

    

     
    
      
        (p)
          Intellectual Property.  Except as, individually or in the aggregate, has
            not had and would not reasonably be expected to have a Material Adverse Effect, to the Company’s knowledge and as of the date hereof, the Company and its Subsidiaries own or possess sufficient rights to use all patents, patent applications,
            inventions, copyrights and copyright applications, know-how, trade secrets, trademarks, service marks, trademarks and service marks applications, trade names, domain names, Software and other technology and intellectual property rights
            (collectively, “Intellectual Property”) used in or necessary for the conduct of their respective businesses as currently conducted. To the Company’s knowledge as of the date hereof, the conduct of the respective businesses of the Company
            and its Subsidiaries does not infringe the Intellectual Property of others, and to the Company’s knowledge as of the date hereof, no third party is infringing any Intellectual Property owned by the Company or any of its Subsidiaries.

        
          20

          
            

        

      

    

     
    
      
        (q)
          Labor Matters.  Except as would not reasonably be expected to have,
            individually or in the aggregate, a Material Adverse Effect, as of the date hereof: (i) there are no strikes or other material labor disputes or Union organizing efforts pending or, to the Company’s knowledge, threatened, against the Company or
            any of its Subsidiaries,(ii) the Company and each of its Subsidiaries is in compliance with applicable agreements with any Union and (iii) hours worked by and payment made based on hours worked to employees of each of the Company and its
            Subsidiaries have not been in violation of the Fair Labor Standards Act or any other applicable laws dealing with wage and hour matters.

      

    

     
    
      
        (r)
          Cybersecurity. To the Company’s knowledge, as of the date hereof, except as
            would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no Person has gained unauthorized access to or made any unauthorized use of any Personal Data, confidential information or trade secret
            maintained by or on behalf of the Company or its Subsidiaries (collectively, “Company Data”). The Company and its Subsidiaries have implemented and maintain an information security program that is comprised of reasonable and appropriate
            organizational, physical, administrative, and technical safeguards designed to protect the security, confidentiality, integrity and availability of its Systems including any Company Data that are consistent in all material respects with all
            laws and contracts applicable to the Company or a Subsidiary.

      

    

     
    
      
        (s)
          Bookings Policy.  Prior to the execution hereof, the Company has provided a
            true and complete copy of the Bookings Policy as in effect on the date hereof to the Purchaser.

      

    

     
    
      
        (t)
          No Additional Representations.

      

    

     
    
      
        (i) The Company acknowledges that the Purchaser makes no representation or warranty as to any matter whatsoever except as expressly set forth in Section 3.02 and in any certificate delivered by the
            Purchaser pursuant to this Agreement, and the Company has not relied on or been induced by such information or any other representations or warranties (whether express or implied or made orally or in writing) not expressly set forth in Section

              3.02 and in any certificate delivered by the Purchaser pursuant to this Agreement.

      

    

     
    
      
        (ii) The Company acknowledges and agrees that, except for the representations and warranties expressly set forth in Section 3.02 and in any certificate delivered by the Purchaser pursuant to this
            Agreement, (i) no person has been authorized by the Purchaser to make any representation or warranty relating to the Purchaser or otherwise in connection with the transactions contemplated hereby, and if made, such representation or warranty
            must not be relied upon by the Company as having been authorized by the Purchaser, and (ii) any materials or information provided or addressed to the Company or any of its Affiliates or representatives are not and shall not be deemed to be or
            include representations or warranties of the Purchaser unless any such materials or information are the subject of any express representation or warranty set forth in Section 3.02 of this Agreement and in any certificate delivered by
            the Purchaser pursuant to this Agreement.

        
          21

          
            

        

      

    

     
    Section 3.02. Representations

          and Warranties of the Purchaser.  The Purchaser represents and warrants to, and agrees with, the Company, as of the date hereof, as follows:

     
    
      
        (a)
          Organization; Ownership.  The Purchaser is a limited partnership, duly
            organized, validly existing and in good standing under the laws of the jurisdiction of the Purchaser’s formation and has all requisite limited partnership power and authority to own, operate and lease its properties and to carry on its business
            as it is being conducted on the date of this Agreement.

      

    

     
    
      
        (b)
          Authorization; Sufficient Funds; No Conflicts.

      

    

     
    
      
        (i) The Purchaser has full partnership power and authority to execute and deliver this Agreement and to consummate the Transactions to which it is a party. The execution, delivery and performance by the
            Purchaser of this Agreement and the consummation of the Transactions to which it is a party have been duly authorized by all necessary partnership action on behalf of the Purchaser. No other proceedings on the part of the Purchaser are
            necessary to authorize the execution, delivery and performance by the Purchaser of this Agreement and consummation of the Transactions. This Agreement has been duly and validly executed and delivered by the Purchaser. Assuming this Agreement
            constitutes the valid and binding obligation of the Company, this Agreement is a valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, subject to the limitation of such enforcement by the
            Enforceability Exceptions.

      

    

     
    
      
        (ii) At the Closing, assuming receipt of the funds under the Equity Commitment Letter, the Purchaser will have available funds necessary to consummate the Closing and pay the Purchase Price on the terms and
            subject to the conditions contemplated in this Agreement.

      

    

     
    
      
        (iii) The execution, delivery and performance of this Agreement by the Purchaser, the consummation by the Purchaser of the Transactions to which it is a party and the compliance by the Purchaser with any of the
            provisions hereof and thereof will not conflict with, violate or result in a breach of any provision of, or constitute a default under, or result in the termination of or accelerate the performance required by, or result in a right of
            termination or acceleration under, (A) any provision of the Purchaser’s organizational documents, (B) any mortgage, note, indenture, deed of trust, lease, license, loan agreement or other agreement binding upon the Purchaser (C) any permit,
            government license, judgment, order, decree, ruling, injunction, statute, law, ordinance, rule or regulation applicable to the Purchaser or any of its Affiliates, other than in the cases of clauses (B) and (C) as would not reasonably be
            expected to materially and adversely affect or delay the consummation of the Transactions to which it is a party.

      

    

     
    
      
        (c)
          Consents and Approvals.  No consent, approval, order or authorization of,
            or registration, declaration or filing with, or exemption or review by, any Governmental Entity is required on the part of the Purchaser in connection with the execution, delivery and performance by the Purchaser of this Agreement and the
            consummation by the Purchaser of the Transactions to which it is a party, except for any required filings or approvals under the HSR Act or any foreign antitrust or competition laws, requirements or regulations in connection with the issuance
            of shares of Company Common Stock upon the conversion of the Notes and any consent, approval, order, authorization, registration, declaration, filing, exemption or review the failure of which to be obtained or made, individually or in the
            aggregate, would not reasonably be expected to adversely affect or delay the consummation of the Transactions to which it is a party by the Purchaser.

        
          22

          
            

        

      

    

     
    
      
        (d)
          Securities Act Representations.

      

    

     
    
      
        (i) The Purchaser is an accredited investor (as defined in Rule 501 of the Securities Act), and is aware that the sale of the Notes is being made in reliance on a private placement exemption from registration
            under the Securities Act. The Purchaser is not an underwriter within the meaning of Section 2(a)(11) of the Securities Act. The Purchaser is acquiring the Notes (and any shares of Company Common Stock issuable upon conversion of the Notes) for
            its own account, and not with a view toward, or for sale in connection with, any distribution thereof in violation of any federal or state securities or “blue sky” law, or with any present intention of distributing or selling such Notes (or any
            shares of Company Common Stock issuable upon conversion of the Notes) and agrees not to reoffer or resell the Notes in violation of the Securities Act. The Purchaser has sufficient knowledge and experience in financial and business matters so
            as to be capable of evaluating the merits and risks of its investment in such Notes (and any shares of Company Common Stock issuable upon conversion of the Notes) and is capable of bearing the economic risks of such investment. The Purchaser
            has been provided a reasonable opportunity to undertake and has undertaken such investigation and has been provided with and has evaluated such documents and information as it has deemed necessary to enable it to make an informed and
            intelligent decision with respect to the execution, delivery and performance of this Agreement.

      

    

     
    
      
        (ii) Neither the Purchaser nor any of its Affiliates is acting in concert, and neither the Purchaser nor any of its Affiliates has any agreement or understanding, with any Person that is not an Affiliate of the
            Purchaser, and is not otherwise a member of a “group” (as such term is used in Section 13(d)(3) of the Exchange Act), with respect to the Company or its securities, in each case, other than with respect to any bona

              fide loan from one or more financial institutions.

      

    

     
    
      
        (e)
          Brokers and Finders.  The Purchaser has not retained, utilized or been
            represented by, or otherwise become obligated to, any broker, placement agent, financial advisor or finder in connection with the transactions contemplated by this Agreement whose fees the Company would be required to pay.

      

    

     
    
      
        (f)
          Ownership of Shares.  None of the Purchaser or its Affiliates Beneficially
            Own any shares of Company Common Stock (without giving effect to the issuance of the Notes hereunder) other than any shares of Company Common Stock that may be Beneficially Owned by managing directors, officers or other employees of any member
            of the Bain Group.

        
          23

          
            

        

      

    

     
    
      
        (g) Financing.

      

    

     
    
      
        (i)
          Equity Commitment Letter. As of the date hereof, the Purchaser
            has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to which Bain Capital Fund XII, L.P., a Cayman Islands limited partnership (“Equity Provider”), has committed, subject only to the terms and
            conditions thereof, to invest the amounts set forth therein (the “Equity Financing”).  The Equity Commitment Letter provides that (A) the Company is an express third party beneficiary thereof; and (B) the Purchaser and Equity Provider
            will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason
            at law or in equity in connection with the exercise of such third party beneficiary rights.

      

    

     
    
      
        (ii)
          No Amendments. As of the date hereof, (i) the Equity
            Commitment Letter and the terms of the Equity Financing have not been amended or modified as of the date hereof and as of the date of the Closing; (ii) no such amendment or modification is contemplated; and (iii) the respective commitments
            contained therein have not been withdrawn, terminated or rescinded in any respect. There are no other contracts, agreements, side letters or arrangements to which the Purchaser is a party relating to the funding or investing, as applicable,
            that would reasonably be expected to adversely affect the availability or conditionality of the Equity Financing, other than as expressly set forth in the Equity Commitment Letter. Other than as set forth in the Equity Commitment Letter, there
            are no conditions precedent related to the funding or investing, as applicable, of the full amount of the Equity Financing.

      

    

     
    
      
        (iii)

          Sufficiency of Equity Financing. The net proceeds of the
            Equity Financing, when funded in accordance with the Equity Commitment Letter, will be, in the aggregate, sufficient to pay the Purchase Price on the terms and subject to the conditions contemplated in this Agreement. The Company acknowledges
            (x) the separate corporate existence of the Purchaser and (y) that the sole asset of the Purchaser is cash in a de minimis amount and its rights under this Agreement and the Equity Commitment Letter, in
            each case in accordance with, and subject to, the terms and conditions set forth herein and therein and that no additional funds will be contributed to the Purchaser unless and until the Closing occurs pursuant to the terms and conditions of
            this Agreement.

      

    

     
    
      
        (iv)
          Validity. As of the date hereof, the Equity Commitment Letter
            (in the form delivered by the Purchaser to the Company) is in full force and effect and constitutes the legal, valid and binding obligations of the Purchaser and Equity Provider, as applicable, enforceable against the Purchaser and Equity
            Provider, as applicable, in accordance with their terms, except as such enforceability (i) may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting or relating to creditors’ rights
            generally; and (ii) is subject to general principles of equity. Assuming the accuracy of the representations and warranties set forth in Article III in all respects as of the date of this Agreement, no event has occurred that, with
            notice or lapse of time or both, would, or would reasonably be expected to, constitute a default or breach on the part of the Purchaser or Equity Provider pursuant to the Equity Commitment Letter. Subject to the Company’s compliance with this
            Agreement and the satisfaction (or waiver) of the conditions set forth in Section 2.02(c), as of the date hereof, the Purchaser has no reason to believe that it will be unable to satisfy on a timely basis any term or condition of the
            Equity Financing to be satisfied by it, whether or not such term or condition is contained in the Equity Commitment Letter. As of the date of the Closing the Purchaser has fully paid, or caused to be fully paid, all commitment or other fees
            that are due and payable on or prior to the date hereof, in each case pursuant to and in accordance with the terms of the Equity Commitment Letter.

        
          24

          
            

        

      

    

     
    
      
        (h) No Additional Representations.

      

    

    
      
        (i) The Purchaser acknowledges that the Company does not make any representation or warranty as to any matter whatsoever except as expressly set forth in Section 3.01 and in any certificate delivered by
            the Company pursuant to this Agreement, and specifically (but without limiting the generality of the foregoing), that, except as expressly set forth in Section 3.01 and in any certificate delivered by the Company pursuant to this
            Agreement, the Company makes no representation or warranty with respect to (A) any matters relating to the Company, its business, financial condition, results of operations, prospects or otherwise, (B) any projections, estimates or budgets
            delivered or made available to the Purchaser (or any of its Affiliates, officers, directors, employees or other representatives) of future revenues, results of operations (or any component thereof), cash flows or financial condition (or any
            component thereof) of the Company and its Subsidiaries or (C) the future business and operations of the Company and its Subsidiaries, and the Purchaser has not relied on or been induced by such information or any other representations or
            warranties (whether express or implied or made orally or in writing) not expressly set forth in Section 3.01 and in any certificate delivered by the Company pursuant to this Agreement.

      

    

     
    
      
        (ii) The Purchaser has conducted its own independent review and analysis of the business, operations, assets, liabilities, results of operations, financial condition and prospects of the Company and its
            Subsidiaries and acknowledges the Purchaser has been provided with sufficient access for such purposes, has been furnished with all other materials that it considers relevant to an investment in the Notes, and has had a full opportunity to ask
            questions of and receive answers from the Company or any person or persons acting on behalf of the Company concerning the terms and conditions of an investment in the Notes. The Purchaser acknowledges and agrees that, except for the
            representations and warranties expressly set forth in Section 3.01 and in any certificate delivered by the Company pursuant to this Agreement, (i) no person has been authorized by the Company to make any representation or warranty
            relating to itself or its business or otherwise in connection with the transactions contemplated hereby, and if made, such representation or warranty must not be relied upon by the Purchaser as having been authorized by the Company, and the
            Purchaser is not relying upon, and has not relied upon, any statement, representation or warranty made by Goldman Sachs, any of its affiliates or any of its or their control persons, officers, directors or employees, in making its investment or
            decision to invest in the Company and (ii) any estimates, projections, predictions, data, financial information, memoranda, presentations or any other materials or information provided or addressed to the Purchaser or any of its Affiliates or
            representatives are not and shall not be deemed to be or include representations or warranties of the Company unless any such materials or information are the subject of any express representation or warranty set forth in Section 3.01
            of this Agreement and in any certificate delivered by the Company pursuant to this Agreement.

        
          25

          
            

        

      

    

     
     
      
        (iii) The Purchaser agrees that none of Goldman Sachs, any of its affiliates or any of its or their control persons, officers, directors or employees shall be liable to any
            purchaser in connection with its purchase of the Notes.

      

    

    ARTICLE IV

        

        ADDITIONAL AGREEMENTS

     
    
      
        Section 4.01. Taking of Necessary Action. Each of the parties hereto agrees to use its reasonable
            efforts promptly to take or cause to be taken all action, and promptly to do or cause to be done all things necessary, proper or advisable under applicable laws and regulations to consummate and make effective the sale and purchase of the Notes
            hereunder, subject to the terms and conditions hereof and compliance with applicable law. In case at any time before or after the Closing any further action is necessary or desirable to carry out the purposes of the sale and purchase of the
            Notes, the proper officers, managers and directors of each party to this Agreement shall take all such necessary action as may be reasonably requested by, and the sole expense of, the requesting party.

        
          26

          
            

        

      

    

     
    Section 4.02. Restricted

          Period; Non-Conversion.

     
    
      
        (a) During the Restricted Period, notwithstanding any rights provided in Article V, the Purchaser shall not, without the Company’s prior written consent, directly or indirectly, (x) sell, offer, transfer,
            assign, mortgage, hypothecate, gift, pledge or dispose of, enter into or agree to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, pledge, mortgage, hypothecation, gift, assignment or
            similar disposition of (any of the foregoing, a “transfer”), any of the Notes or any shares of Company Common Stock issuable or issued upon conversion or repurchase by the Company of any of the Notes or (y) enter into or engage in any
            hedge, swap, short sale, derivative transaction or other agreement or arrangement that transfers to any Third Party, directly or indirectly, in whole or in part, any of the economic consequences of ownership of the Notes or any shares of
            Company Common Stock issuable or issued upon conversion of any of the Notes (such actions in clauses (x) and (y), “Prohibited Transfers”), other than Permitted Transfers. “Permitted Transfers”, in each case, shall mean any (i)
            transfer to the Purchaser’s Affiliate that executes and delivers to the Company a Joinder becoming a Purchaser party to this Agreement and the Confidentiality Agreement and a duly completed and executed IRS Form W-9 (or a substantially
            equivalent form), (ii) transfer to the Company or any of its Subsidiaries, (iii) transfer to a Third Party for cash solely to the extent that all of the net proceeds of such sale are solely used to satisfy a bona

              fide margin call (i.e. posted as collateral) pursuant to a Permitted Loan, or repay a Permitted Loan to the extent necessary to satisfy a bona fide margin call on such Permitted Loan or avoid a
            bona fide margin call on such Permitted Loan, (iv) transfer with the prior written consent of the Company; or (v) tender of any Company Common Stock into a Third Party Tender/Exchange Offer, as defined
            below, (and any related conversion of Notes to the extent required to effect such tender or exchange) and any transfer effected pursuant to any merger, consolidation or similar transaction consummated by the Company (for the avoidance of doubt,
            if such Third Party Tender/Exchange Offer does not close for any reason, the restrictions on transfer contained herein shall continue to apply to any Company Common Stock received pursuant to the conversion of any Notes that had previously been
            converted to participate in any such tender or exchange offer). “Third Party Tender/Exchange Offer” shall mean any tender or exchange offer made to all of the holders of Company Common Stock by a Third Party for a number of outstanding
            shares of Voting Stock that, if consummated, would result in a Change in Control solely to the extent that (x) the Board of Directors has recommended such tender or exchange offer in a Schedule 14D-9 under the Exchange Act or (y) such tender or
            exchange offer is either (I) a tender or exchange offer for less than all of the outstanding shares of Company Common Stock or (II) part of a two-step transaction and the consideration to be received in the second step of such transaction is
            not identical in the amount or form of consideration (or the election of the type of consideration available to holders of Company Common Stock is not identical in the second-step of such transaction) as the first step of such transaction. Any
            purported Prohibited Transfer in violation of this Section 4.02 shall be null and void ab initio. Notwithstanding the foregoing, the Purchaser (or a controlled Affiliate of the Purchaser) shall be permitted to mortgage, hypothecate,
            and/or pledge the Notes and/or the shares of Company Common Stock issuable or issued upon conversion or repurchase by the Company of the Notes in respect of one or more bona fide purpose (margin) or bona fide non-purpose loans (each, a “Permitted Loan”). Except with the Company’s prior written consent, any Permitted Loan entered into by the Purchaser or its controlled Affiliates shall be with one
            or more financial institutions and nothing contained in this Agreement shall prohibit or otherwise restrict the ability of any lender (or its securities’ affiliate) or collateral agent or trustee to foreclose upon and sell, dispose of or
            otherwise transfer the Notes and/or shares of Company Common Stock (including shares of Company Common Stock received upon conversion or repurchase by the Company of the Notes following foreclosure on a
              Permitted Loan) mortgaged, hypothecated and/or pledged to secure the obligations of the borrower following an event of default under a Permitted Loan. Notwithstanding the foregoing or anything to the contrary herein, in the event that
            any lender or other creditor under a Permitted Loan transaction (including any agent or trustee on their behalf) or any affiliate of the foregoing exercises any rights or remedies in respect of the Notes or the shares of Company Common Stock
            issuable or issued upon conversion or repurchase by the Company of the Notes or any other collateral for any Permitted Loan, no lender, creditor, agent or trustee on their behalf or affiliate of any of the foregoing (other than, for the
            avoidance of doubt, the Purchaser or any of its Affiliates) shall be entitled to any rights or have any obligations or be subject to any transfer restrictions or limitations hereunder (including, without limitation, the rights or benefits
            provided for in Section 4.06 and Section 4.07) except and to the extent for those expressly provided for in Article V.

        
          27

          
            

        

      

    

     
    
      
        (b) Notwithstanding anything in this Agreement or elsewhere to the contrary, any sale of Notes or Company Common Stock pursuant to Article V shall be subject to any applicable limitations set forth in
            this Section 4.02 and Article V but shall not be subject to any policies, procedures or limitations (other than any applicable federal securities laws and any other applicable laws) otherwise applicable to the Bain Affiliated
            Directors with respect to trading in the Company’s securities (other than as set forth in clause (i) of the definition of “Blackout Period” at such time as a Bain Affiliated Director is serving on the Board of Directors) and the Company
            acknowledges and agrees that such policies, procedures or limitations applicable to the Bain Affiliated Directors shall not be violated by any such transfer pursuant to Article V, other than any applicable federal securities laws and
            any other applicable laws.

      

    

     
    
      
        (c) Notwithstanding anything in the Notes or in the Indenture to the contrary, during the Restricted Period, the Purchaser (including any Third Party that signs a Joinder) shall not, without the Company’s prior
            written consent, convert (or give notice of conversion of) any of the Notes, irrespective of whether such conversion is permitted pursuant to the terms of the Notes or the Indenture, except in connection with a transfer of shares of Company
            Common Stock issuable upon conversion of such Notes that is (i) not prohibited pursuant to this Section 4.02 and (ii) not to an Affiliate of the Purchaser; provided, that notwithstanding the foregoing, following an event of
            default under a Permitted Loan, the applicable lenders may convert the Notes (including in the name of the Purchaser) in accordance with the terms and conditions set forth in the Indenture.

      

    

     
    Section 4.03. Standstill.

     
    
      
        (a) The Purchaser agrees that, during the Standstill Period, it shall not, and shall cause each of its Affiliates (collectively and individually, the “Purchaser Affiliates,”) not to, directly or indirectly, in any manner, alone
            or in concert with others, take any of the following actions without the prior consent of the Company (acting through a resolution of the Company’s directors not including, in respect of any consent to actions taken or proposed to be taken by
            the Purchaser or its Affiliates, any Bain Affiliated Director):

      

    

     
    
      
        (i) make, engage in, or in any way participate in, directly or indirectly, any “solicitation” of proxies (as such terms are used in the proxy rules of the SEC but without regard to the exclusion set forth in
            Rule 14a-1(l)(2)(iv)) or consents to vote, or seek to advise, encourage or influence any person with respect to the voting of any securities of the Company for the election of individuals to the Board of Directors or to approve any proposals
            submitted to a vote of the stockholders of the Company that have not been authorized and approved, or recommended for approval, by the Board of Directors, or become a “participant” in any contested “solicitation” (as such terms are defined or
            used under the Exchange Act) for the election of directors with respect to the Company, other than a “solicitation” or acting as a “participant” in support of all of the nominees of the Board of Directors at any stockholder meeting, or make or
            be the proponent of any stockholder proposal (pursuant to Rule 14a-8 under the Exchange Act or otherwise);

        
          28

          
            

        

      

    

     
    
      
        (ii) form, join, encourage, influence, advise or in any way participate in any “group” (as such term is defined in Section 13(d)(3) of the Exchange Act) with any persons who are not Purchaser Affiliates with
            respect to any securities of the Company or otherwise in any manner agree, attempt, seek or propose to deposit any securities of the Company or any securities convertible or exchangeable into or exercisable for any such securities in any voting
            trust or similar arrangement, or subject any securities of the Company to any arrangement or agreement with respect to the voting thereof, except as expressly permitted by this Agreement;

      

    

     
    
      
        (iii) acquire, offer or propose to acquire, or agree to acquire, directly or indirectly, whether by purchase, tender or exchange offer, through the acquisition of control of another person, by joining a
            partnership, limited partnership, syndicate or other group (including any group of persons that would be treated as a single “person” under Section 13(d) of the Exchange Act), through swap or hedging transactions or otherwise, any securities of
            the Company or any rights decoupled from the underlying securities that would result in the Purchaser (together with the Purchaser Affiliates) having Beneficial Ownership of more than 19.9% in the aggregate of the shares of the Company Common
            Stock outstanding at such time (assuming all the Notes are converted on a fully physical settlement basis), excluding any issuance by the Company of shares of Company Common Stock or options, warrants or other rights to acquire Company Common
            Stock (or the exercise thereof) to any Bain Affiliated Director as compensation for their membership on the Board of Directors; provided that nothing herein will require any Notes or shares of Company Common Stock to be sold to the
            extent the Purchaser and the Purchaser Affiliates, collectively, exceed the ownership limit under this paragraph as the result of a share repurchase or any other Company actions that reduces the number of outstanding shares of Company Common
            Stock. For the avoidance of doubt, this Section 4.03(a) shall not restrict conversion of the Notes and provided further that nothing herein will prevent Purchaser from making proposals to acquire securities of the Company if Purchaser
            does not make any public announcement or disclosure of such proposal and such proposal would not reasonably be expected to require public announcement or disclosure by the Company. For purposes of this Section 4.03(a), no securities
            Beneficially Owned by a portfolio company of the Purchaser or its Affiliates will be deemed to be Beneficially Owned by the Purchaser or any of its Affiliates only so long as (x) such portfolio company is not an Affiliate of the Purchaser for
            purposes of this Agreement, (y) neither the Purchaser nor any of the Purchaser Affiliates has encouraged, instructed, directed, supported, assisted or advised, or coordinated with, such portfolio company with respect to the acquisition, voting
            or disposition of securities of the Company by the portfolio company and (z) neither the Purchaser or any of its Affiliates is a member of a group (as such term is defined in Section 13(d)(3) of the Exchange Act) with that portfolio
            company with respect to any securities of the Company.

        
          29

          
            

        

      

    

     
    
      
        (iv) effect or seek to effect, offer or propose to effect, cause or participate in, or in any way assist or facilitate any other person to effect or seek, offer or propose to effect or participate in, any tender
            or exchange offer, merger, consolidation, acquisition, scheme of arrangement, business combination, recapitalization, reorganization, sale or acquisition of all or substantially all assets, liquidation, dissolution or other extraordinary
            transaction involving the Company or any of its Subsidiaries or joint ventures or any of their respective securities (each, an “Extraordinary Transaction”), or make any public statement with respect to an Extraordinary Transaction; provided,
            however, that this clause shall not preclude the tender by such Purchaser or its Purchaser Affiliates of any securities of the Company into any Third Party Tender/Exchange Offer (and any related conversion of Notes to the extent required to
            effect such tender) or the vote by such Purchaser or its Purchaser Affiliates of any voting securities of the Company with respect to any Extraordinary Transaction in accordance with the recommendation of the Board of Directors;

      

    

     
    
      
        (v) (A) call or seek to call any meeting of stockholders of the Company, including by written consent, (B) seek representation on the Board of Directors, except as expressly set forth herein, (C) seek the
            removal of any member of the Board of Directors (other than a Bain Affiliated Director in accordance with Section 4.07), (D) solicit consents from stockholders or otherwise act or seek to act by written consent with respect to the Company, (E)
            conduct a referendum of stockholders of the Company or (F) make a request for any stockholder list or other Company books and records, whether pursuant to Section 220 of the DGCL or otherwise;

      

    

     
    
      
        (vi) take any action in support of or make any proposal or request that constitutes: (A) controlling or changing the Board of Directors or management of the Company, including any plans or proposals to change
            the number or term of directors or to fill any vacancies on the Board of Directors, (B) any material change in the capitalization or dividend policy of the Company, (C) any other material change in the Company’s management, business or
            corporate structure, (D) seeking to have the Company waive or make amendments or modifications to the Company’s certificate of incorporation or bylaws, or other actions that may impede or facilitate the acquisition of control of the Company by
            any person, (E) causing a class of securities of the Company to be delisted from, or to cease to be authorized to be quoted on, any securities exchange; or (F) causing a class of equity securities of the Company to become eligible for
            termination of registration pursuant to Section 12(g)(4) of the Exchange Act (except in each case pursuant to any action or transaction permitted by clause (y) of Section 4.03(a)(iv) and Section 4.03(a)(v));

      

    

     
    
      
        (vii) make any public disclosure, announcement or statement regarding any intent, purpose, plan or proposal with respect to the Board of Directors, the Company, its management, policies or affairs, any of its
            securities or assets or this Agreement that is inconsistent with the provisions of this Agreement; or

        
          30

          
            

        

      

    

     
    
      
        (viii) enter into any discussions, negotiations, agreements or understandings with any Third Party with respect to any of the foregoing, or advise, assist, knowingly encourage or seek to persuade any Third Party
            to take any action or make any statement with respect to any of the foregoing.

      

    

     
    
      
        (b) Nothing in this Section 4.03 shall limit any action that may be taken by any Bain Affiliated Director acting solely as a director of the Company consistent with his fiduciary duties as a director of
            the Company if such action does not include any public announcement or disclosure by such Bain Affiliated Director or by Purchaser and its Purchaser Affiliates.

      

    

     
    
      
        (c) The provisions of Section 4.03(a) shall not be deemed to prohibit the Purchaser or any Purchaser Affiliates or their respective directors, executive officers, partners, employees, managing members,
            advisors or agents (acting in such capacity) from communicating privately with the Company’s directors, officers or advisors so long as such communications are not intended to, and would not reasonably be expected to, require any public
            disclosure of such communications.

      

    

     
    
      
        (d) Notwithstanding anything in Section 4.03(a) to the contrary, if (i) the Company enters into a definitive agreement providing for a transaction that, if consummated, would result in a Change in
            Control and (ii) the Company had not, reasonably prior to entering into such definitive agreement, provided the Purchaser with a written notice inviting the Purchaser and Purchaser Affiliates to make one or more proposals or offers to effect a
            transaction that would result in a Change in Control, then after the announcement of such transaction and prior to the earlier of any termination of such definitive agreement or Company stockholder approval of such definitive agreement, nothing
            in Section 4.03(a) will prevent the Purchaser or any Purchaser Affiliate (A) from submitting to the Board of Directors one or more bona fide proposals or offers for an alternative transaction
            involving, directly or indirectly, the Purchaser or one or more of Purchaser Affiliates, (B) pursuing and entering into any such alternative transaction with the Company and (C) taking any actions in furtherance of the foregoing, including
            actions relating to obtaining equity and/or debt financing for the alternative transaction as long as (x) any proposal or offer is conditioned on the proposed transaction being approved by the Board of Directors and (y) the Purchaser and the
            Purchaser Affiliates do not make any public announcement or disclosure of such proposal, offer or actions other than any filings and disclosures that may be required in filings with the SEC.

      

    

     
    
      
        Section 4.04. Securities Laws. 
            The Purchaser acknowledges and agrees that, as of the Closing Date, the Notes (and the shares of Company Common Stock that are issuable upon conversion or repurchase by the Company of the Notes) have not been registered under the Securities Act
            or the securities laws of any state and that they may be sold or otherwise disposed of only in one or more transactions registered under the Securities Act and, where applicable, such laws, or as to which an exemption from the registration
            requirements of the Securities Act and, where applicable, such laws, is available. The Purchaser acknowledges that, except as provided in Article V with respect to shares of Company Common Stock and the Notes, the Purchaser has no right
            to require the Company or any of its Subsidiaries to register the Notes or the shares of Company Common Stock that are issuable upon conversion or repurchase by the Company of the Notes.

        
          31

          
            

        

      

    

     
    
      
        Section 4.05. Lost, Stolen, Destroyed or Mutilated Securities.  Upon receipt of evidence
            satisfactory to the Company of the loss, theft, destruction or mutilation of any certificate for any security of the Company and, in the case of loss, theft or destruction, upon delivery of an undertaking by the holder thereof to indemnify the
            Company (and, if requested by the Company, the delivery of an indemnity bond sufficient in the judgment of the Company to protect the Company from any loss it may suffer if a certificate is replaced), or, in the case of mutilation, upon
            surrender and cancellation thereof, the Company will issue a new certificate or, at the Company’s option, a share ownership statement representing such securities for an equivalent number of shares or another security of like tenor, as the case
            may be.

      

    

     
    
      
        Section 4.06. Antitrust Approval.  The Company and the Purchaser acknowledge that one or more
            filings under the HSR Act or foreign antitrust laws may be necessary in connection with the issuance of shares of Company Common Stock upon conversion of the Notes. The Purchaser will promptly notify the Company if any such filing is required
            on the part of the Purchaser. To the extent reasonably requested, the Company, the Purchaser and any other applicable Affiliate of the Purchaser will use reasonable efforts to cooperate in timely making or causing to be made all applications
            and filings under the HSR Act or any foreign antitrust requirements in connection with the issuance of shares of Company Common Stock upon conversion of Notes held by the Purchaser or any Affiliate of the Purchaser in a timely manner and as
            required by the law of the applicable jurisdiction; provided that, notwithstanding anything in this Agreement to the contrary, the Company shall not have any responsibility or liability for failure of the Purchaser or any of its Affiliates to
            comply with any applicable law. For as long as there are Notes outstanding and owned by the Purchaser or its Affiliates, the Company shall as promptly as reasonably practicable provide (no more than four (4) times per calendar year) such
            information regarding the Company and its Subsidiaries as the Purchaser may reasonably request in order to determine what foreign antitrust requirements may exist with respect to any potential conversion of the Notes and the Company shall
            provide such information at the time of issuing any redemption notice pursuant to the Indenture. To the extent that any filings are necessary under the HSR Act or foreign antitrust laws in connection with the Company’s redemption of the Notes,
            the Company, the Purchaser and any other applicable Affiliate of the Purchaser will use reasonable efforts to cooperate in timely making or causing to be made all applications and filings as required by the law of the applicable jurisdiction.
            Except as provided in Section 6.06, the Purchaser shall be responsible for the payment of the filing fees associated with any such applications or filings.

      

    

     
    Section 4.07. Board

          Nomination Rights.

     
    
      
        (a) The Company agrees to appoint the two initial Bain Designees selected in accordance with Section 4.07(c) to the Board of Directors (one Bain Designee to be appointed as a Class II director with term
            expiring at the 2021 annual meeting of the Company’s stockholders and the other Bain Designee to be appointed as a Class III director with term expiring at the 2022 annual meeting of the Company’s stockholders) by taking all necessary action to
            increase the size of the Board of Directors unless there otherwise is a vacancy in the Board of Directors and in either event filling the vacancy thereby created with such individuals as soon as practicable after the Closing. The Company agrees
            that, subject to Section 4.07(c), the Purchaser shall have the right to nominate at each meeting or action by written consent at which a Bain Designee’s term as a director expires (or, if the stockholders of the Company fail to elect a
            Bain Designee standing for election to the Board of Directors, the next meeting of the Company’s stockholders at which directors are nominated for election following the expiration of such Bain Designee’s term) a nominee of the Purchaser. The
            Purchaser shall have a right to nominate two members to the Board of Directors for so long as the Bain Group collectively Beneficially Owns a number of shares of Company Common Stock equal to or greater than the Tier I Minimum Ownership
            Threshold and shall have the right to nominate one member to the Board of Directors for so long as the Bain Group collectively Beneficially Owns a number of shares of Company Common Stock that is less than Tier I Minimum Ownership Threshold but
            equal to or greater than the Tier II Minimum Ownership Threshold. The Purchaser shall not have a right to nominate any member to the Board of Directors during any such time as the Bain Group’s collective Beneficially Ownership of Company Common
            Stock is less than the Tier II Minimum Ownership Threshold. Upon ceasing to satisfy the Tier I Minimum Ownership Threshold or the Tier II Minimum Ownership Threshold, as applicable, the Purchaser shall cause the applicable Bain Designee to
            offer his or her resignation to the Board of Directors and upon taking office each Bain Designee shall execute an irrevocable resignation effective upon acceptance by the Board of Directors under such circumstances. Further, after the Closing,
            the Company shall appoint the Bain Affiliated Directors to the committees and sub-committees of the Board of Directors in the discretion of the Board of Directors. At any time when the Purchaser is entitled to nominate a member of the Board of
            Directors, the Purchaser may, in its sole discretion, appoint a Bain Designee as an observer to the Board of Directors (in lieu of nominating a director).

        
          32

          
            

        

      

    

     
    
      
        (b) Subject to the terms and conditions of this Section 4.07 and applicable law, the Company agrees to include each Bain Designee in its slate of nominees for election as directors of the Company at
            each of the Company’s meetings of stockholders or action by written consent at which such Bain Designee’s term as a director expires (or, if the stockholders of the Company fail to elect any Bain Designee standing for election to the Board of
            Directors, the next meeting of the Company’s stockholders at which directors are nominated for election following the expiration of such Bain Designee’s term) and to use its reasonable efforts to cause the election of each such Bain Designee to
            the Board of Directors (for the avoidance of doubt, the Company will be required to use substantially the same level of efforts and provide substantially the same level of support as is used and/or provided for the other director nominees of
            the Company with respect to the applicable meeting of stockholders or action by written consent). For the avoidance of doubt, failure of the stockholders of the Company to elect any Bain Designee to the Board of Directors shall not affect the
            right of the Purchaser to nominate directors for election pursuant to this Section 4.07 in any future election of directors. For their services to the Company, each Bain Affiliated Director shall receive compensation from the Company
            that is consistent (in the aggregate amount and structure of the compensation package as well as the opportunities to participate in benefit plans) with the compensation for other non-employee directors of the Company. Further, the Company
            shall reimburse each Bain Designee (whether designated as a board observer or elected as a Bain Affiliated Director) for its reasonable, documented out-of-pocket fees, costs, expenses and disbursements in connection with attending meetings
            (including participation in telephonic meetings) of the Board of Directors and of its committees or in the performance of services as requested by the Company or any of its Subsidiaries in accordance with the Company’s expense reimbursement
            policy applicable to all members of the Board of Directors.

        
          33

          
            

        

      

    

     
    
      
        (c) Each Bain Designee must be either (i) a managing director of Bain Capital Private Equity, LP or another Bain Affiliate management entity or (ii) another individual selected by the Purchaser that is approved
            by the Nominating and Corporate Governance Committee of the Board of Directors (or any successor thereto). As a condition to any Bain Designee’s appointment to the Board of Directors and nomination for election as a director of the Company at
            the Company’s annual meetings of stockholders (A) the Purchaser and each Bain Designee must in all material respects provide to the Company (1) all information reasonably requested by the Company that is required to be or customarily disclosed
            for directors, candidates for directors, and their affiliates and representatives in a proxy statement or other filings under applicable law or regulation or stock exchange rules or listing standards, in each case, relating to their nomination
            or election as a director of the Company or the Company’s operations in the ordinary course of business and (2) information reasonably requested by the Company in connection with assessing eligibility, independence and other criteria applicable
            to directors or satisfying compliance and legal or regulatory obligations, in each case, relating to their nomination or election as a director of the Company or the Company’s operations in the ordinary course of business, with respect to the
            Purchaser, its Affiliates and the applicable Bain Designee, and (B) each Bain Designee must be qualified to serve as a director of the Company under the DGCL to the same extent as all other directors of the Company. The Company will make all
            information requests pursuant to this Section 4.07(c) in good faith in a timely manner that allows the Purchaser and each Bain Designee a reasonable amount of time to provide such information, and will cooperate in good faith with the
            Purchaser and each Bain Designee in connection with their efforts to provide the requested information and (C) each Bain Designee (other than a Bain Designee who is a managing director of Bain Capital Private Equity, LP or another Bain
            Affiliate management entity) must satisfy the requirements set forth in the Company’s Corporate Governance Guidelines, Code of Business Conduct and Ethics and Insider Trading Policy (subject to Section 4.02), in each case as currently
            in effect (the “Specified Guidelines”) with such changes thereto (or such successor policies) as are applicable to all other directors, as are adopted in good faith by the Board of Directors, and do not by their terms adversely impact
            any Bain Designee relative to all other directors and as are consistent with clause (d) below (for the avoidance of doubt, no Bain Designee shall be required to qualify as an independent director under applicable stock exchange rules and
            federal securities laws and regulations; provided, however, if a Bain Designee does not qualify as independent, such Bain Designee shall not serve on any committee of the Board if such service violates applicable stock exchange rules,
            federal securities laws and regulations, and the Company’s Specified Guidelines). 

      

    

     
    
      
        (d) For so long as a Bain Affiliated Director is on the Board of Directors, (i) such Bain Affiliated Director will be subject to the Specified Guidelines, but the Company shall not implement or maintain any
            trading policy, equity ownership guidelines (including with respect to the use of Rule 10b5-1 plans and preclearance or notification to the Company of any trades in the Company’s securities) or similar guideline or policy with respect to the
            trading of securities of the Company that applies to the Purchaser or its Affiliates (including a policy that limits, prohibits or restricts the Purchaser or its Affiliates from entering into any hedging or derivative arrangements), in each
            case other than with respect to any Bain Affiliated Director solely in his or her individual capacity, except as provided herein, or that imposes confidentiality obligations on any Bain Affiliated Director that are inconsistent with the
            Confidentiality Agreement, (ii) any share ownership requirement for any Bain Designee serving on the Board of Directors will be deemed satisfied by the securities owned by the Bain Group and/or its Affiliates and under no circumstances shall
            any of such policies, procedures, processes, codes, rules, standards and guidelines impose any restrictions on the Bain Group’s or its Affiliates’ transfers of securities pursuant to Article V (except as otherwise provided therein with
            respect to Blackout Periods) and (iii) under no circumstances shall any policy, procedure, code, rule, standard or guideline applicable to the Board of Directors be violated by any Bain Designee (x) accepting an invitation to serve on another
            board of directors of a company whose principal line(s) of business do not compete with the principal line(s) of business of the Company or failing to notify an officer or director of the Company prior to doing so, or (y) receiving compensation
            from the Bain Group or any of its Affiliates, or (z) failing to offer his or her resignation from the Board of Directors except as otherwise expressly provided in this Agreement or pursuant to any majority voting policy adopted by the Board of
            Directors, and, in each case of (i), (ii) and (iii), it is agreed that any such policies in effect from time to time that purport to impose terms inconsistent with this Section 4.07 shall not apply to the extent inconsistent with this Section

              4.07 (but shall otherwise be applicable to the Bain Designee). If the Specified Guidelines are in good faith changed in a manner that results in a Bain Designee (other

            than a Bain Designee who is a managing director of Bain Capital Private Equity, LP or another Bain Affiliate management entity) no longer satisfying the Specified
              Guidelines in all material respects (any such changes to the Specified Guidelines, a “Director Policy Change”), then the Bain Group agrees that it shall not nominate such Bain Designee at the next meeting of stockholders of the Company at which the stockholders of the Company elect the Board of Directors.

        
          34

          
            

        

      

    

     
    
      
        (e) Subject to the terms and conditions of this Section 4.07, if a vacancy on the Board of Directors is created as a result of a Bain Designee’s death, resignation, disqualification or removal, in each
            case for whatever reason, or if the Purchaser desires to nominate a different individual to replace any then-existing Bain Designee, then, at the request of the Purchaser, the Purchaser and the Company (acting through the Board of Directors)
            shall work together in good faith to fill such vacancy or replace such nominee as promptly as reasonably practical with a replacement Bain Designee subject to the terms and conditions hereof, and thereafter such individual shall as promptly as
            reasonably practical be appointed to the Board of Directors to fill such vacancy and/or be nominated as a Company nominee as a “Bain Designee” pursuant to this Section 4.07 (as applicable).

      

    

     
    To the fullest extent permitted by the DGCL and subject to any express agreement that may from time to time be in effect, the Company
      agrees that any Bain Affiliated Director, the Purchaser and any other member of the Bain Group or any portfolio company thereof (collectively, “Covered Persons”) may, and shall have no duty not to, (i) invest in, carry on and conduct, whether
      directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an officer, director, stockholder, equityholder or investor in any person, or as a participant in any syndicate, pool, trust or association, any business
      of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company or any of its Subsidiaries, (ii) do business with any client, customer, vendor or lessor of any of the
      Company or its Affiliates; and/or (iii) make investments in any kind of property in which the Company may make investments. To the fullest extent permitted by the DGCL, the Company renounces any interest or expectancy to participate in any business
      or investments of any Covered Person as currently conducted or as may be conducted in the future, and waives any claim against a Covered Person and shall indemnify a Covered Person against any claim that such Covered Person is liable to the Company
      or its stockholders for breach of any fiduciary duty solely by reason of such person’s participation in any such business or investment. The Company shall pay in advance any expenses incurred in defense of such claim as provided in this provision
      except to the extent that a Covered Person is determined by a final, non-appealable order of a Delaware court having competent jurisdiction (or any other judgement which is not appealed in the applicable time) that such Covered Person is not entitled
      to indemnification under this Section 4.07(e), in which case any such advanced expenses shall be promptly reimbursed to the Company.

    
      35

      
        

    

     
    The Company agrees that in the event that a Covered Person acquires knowledge of a potential transaction or matter which may constitute
      a corporate opportunity for both (x) the Covered Person and (y) the Company or its Subsidiaries, the Covered Person shall not have any duty to offer or communicate information regarding such corporate opportunity to the Company or its Subsidiaries.
      To the fullest extent permitted by the DGCL, the Company hereby renounces any interest or expectancy in any potential transaction or matter of which the Covered Person acquires knowledge, except for any corporate opportunity which is expressly
      offered to a Covered Person in writing stating that such offer is intended solely for such Covered Person in his or her capacity as a member of the Board of Directors, and waives any claim against each Covered Person and shall indemnify a Covered
      Person against any claim, that such Covered Person is liable to the Company or its stockholders for breach of any fiduciary duty solely by reason of the fact that such Covered Person (A) pursues or acquires any corporate opportunity for its own
      account or the account of any Affiliate or other person, (B) directs, recommends, sells, assigns or otherwise transfers such corporate opportunity to another person or (C) does not communicate information regarding such corporate opportunity to the
      Company; provided, that, in each such case, that any corporate opportunity which is expressly offered to a Covered Person in writing stating that such offer is intended solely for such Covered Person in his or her capacity as a member of the
      Board of Directors shall belong to the Company. The Company shall pay in advance any expenses incurred in defense of such claim as provided in this provision, except to the extent that a Covered Person is determined by a final, non-appealable order
      of a Delaware court having competent jurisdiction (or any other judgment which is not appealed in the applicable time) to have breached this Section 4.07(e) in which case any such advanced expenses shall be promptly reimbursed to the Company.

     
    
      
        (f) For the avoidance of doubt, notwithstanding anything in this Agreement or the Notes to the contrary, transferees of the Notes and/or the shares of Company Common Stock (other than Affiliates of the
            Purchaser who sign a Joinder) shall not have any rights pursuant to this Section 4.07.

      

    

     
    
      
        Section 4.08. VCOC Letters.  Upon request by the Purchaser, the Company shall deliver to the
            Purchaser at the Closing and from time to time any Affiliate of the Purchaser to whom the Purchaser’s rights and obligations under this Agreement are assigned in accordance with this Agreement a letter substantially consistent with the form
            thereof furnished by the Purchaser (the “VCOC Letters”).

        
          36

          
            

        

      

    

     
    
      
        Section 4.09. Financing Cooperation.  If requested by the Purchaser, the Company will provide the
            following cooperation in connection with the Purchaser obtaining any Permitted Loan: (i) subject to applicable law, using reasonable efforts to (A) remove any restrictive legends on certificates representing pledged Notes and depositing such
            pledged Notes in book entry form on the books of The Depository Trust Company when eligible to do so or (B) without limiting the generality of clause (A), if such Note is eligible for resale under Rule 144A, depositing such pledged Note in book
            entry form on the books of The Depository Trust Company or other depository with customary restrictive legends, (ii) if so requested by such lender or counterparty, as applicable, using commercially reasonable efforts to re-register the pledged
            Note in the name of the relevant lender, counterparty, custodian or similar party to a Permitted Loan, with respect to Permitted Loans solely as securities intermediary and only to the extent a Purchaser or its Affiliates continues to
            beneficially own such pledged Note, (iii) entering into an issuer agreement (an “Issuer Agreement”) with each lender with respect to such Permitted Loan in the form attached hereto as Exhibit C, and subject to the consent of the
            Company (which will not be unreasonably withheld or delayed), with such changes thereto as are requested by such lender, (iv) entering into customary triparty agreements with the relevant lender and the Purchaser relating to the delivery of the
            Notes to such lender for crediting to the relevant collateral accounts upon funding of the relevant loan and payment of the purchase price of the Purchaser, including a right for such lender as a third party beneficiary with respect to the
            Company’s obligation under Article II hereof to issue the Notes upon payment of the purchase price therefor in accordance with the terms of this Agreement (including satisfaction of the conditions set forth in Section 2.02(d))
            and (v) such other cooperation and assistance as the Purchaser may reasonably request that will not unreasonably disrupt the operation of the Company’s business. Anything in the preceding sentence to the contrary notwithstanding, the Company’s
            obligation to deliver an Issuer Agreement is conditioned on (x) the Purchaser delivering to the Company a copy of the loan agreement for the Permitted Loan to which the Issuer Agreement relates and (y) the Purchaser certifying to the Company in
            writing that (A) the loan agreement with respect to which the Issuer Agreement is being delivered constitutes a Permitted Loan being entered into in accordance with this Agreement, the Purchaser has pledged the Notes and/or the underlying
            shares of Company Common Stock as collateral to the lenders under such Permitted Loan and that the execution of such Permitted Loan and the terms thereof do not violate the terms of this Agreement, (B) to the extent applicable, whether the
            registration rights under Article V are being assigned to the lenders under that Permitted Loan and (C) the Purchaser acknowledges and agrees that the Company will be relying on such certificate when entering into the Issuer Agreement
            and any inaccuracy in such certificate will be deemed a breach of this Agreement. The Purchaser acknowledges and agrees that the statements and agreements of the Company in an Issuer Agreement are solely for the benefit of the applicable
            lenders party thereto and that in any dispute between the Company and the Purchaser under this Agreement, the Purchaser shall not be entitled to use the statements and agreements of the Company in an Issuer Agreement against the Company. Upon
            request by the Purchaser, the Company shall consider in good faith any amendments to this Agreement, the Indenture or the Notes proposed by the Purchaser necessary to facilitate the consummation of a Permitted Loan transaction, and the Company
            shall consent to any such amendment that is not adverse in any respect to the interests of the Company (as determined in good faith by the Company), it being acknowledged that registration of the Notes for resale by the Registration Date is not
            adverse to the interests of the Company.

        
          37

          
            

        

      

    

     
    Section 4.10. Certain

          Tax Matters.

     
    
      
        (a) Notwithstanding anything herein to the contrary, the Company shall have the right to deduct and withhold from any payment or distribution made with respect to the Notes (or the issuance of shares of Company
            Common Stock upon conversion or repurchase by the Company of the Notes) such amounts as are required to be deducted or withheld with respect to the making of such payment or distribution (or issuance) under any applicable Tax law. To the extent
            that any amounts are so deducted or withheld, such deducted or withheld amounts shall be treated for all purposes of this Agreement as having been paid to the person in respect of which such deduction or withholding was made. In the event the
            Company previously remitted any amounts to a Governmental Entity on account of Taxes required to be deducted or withheld in respect of any payment or distribution (or deemed distribution) on any Notes, the Company shall be entitled to offset
            any such amounts against any amounts otherwise payable in respect of such Notes (or the issuance of shares of Company Common Stock upon conversion or repurchase by the Company of the Notes).

      

    

     
    
      
        (b) The Company agrees, unless otherwise required by a change in law or as required by a taxing authority following an audit or examination, (i) to treat the Notes as indebtedness for U.S. federal income tax
            purposes (and applicable state and local tax purposes), (ii) not to treat the Notes as a “contingent payment debt instrument” or as governed by the rules set out in Treasury Regulations Section 1.1275-4, and (iii) not to file any Tax Return or
            otherwise take any position inconsistent with the foregoing.

      

    

     
    
      
        Section 4.11. Section 16 Matters.  If the Company becomes a party to a consolidation, merger or other similar transaction, or if there is any event or circumstance that may result in the Purchaser, its Affiliates and/or any Bain
            Affiliated Director being deemed to have made a disposition or acquisition of equity securities of the Company or derivatives thereof for purposes of Section 16 of the Exchange Act, and if any Bain Affiliated Director is serving on the Board of
            Directors at such time or has served on the Board of Directors during the preceding six months (i) the Board of Directors or a committee thereof composed solely of two or more “non-employee directors” as defined in Rule 16b-3 of the Exchange
            Act will pre-approve such acquisition or disposition of equity securities of the Company or derivatives thereof for the express purpose of exempting the Purchaser’s, its Affiliates’ and any Bain Affiliated Director’s interests (to the extent
            such persons may be deemed to be “directors by deputization”) in such transaction from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder and (ii) if the transaction involves (A) a merger or consolidation to which the Company
            is a party and the Company Common Stock is, in whole or in part, converted into or exchanged for equity securities of a different issuer, (B) a potential acquisition or deemed acquisition, or disposition or deemed disposition, by the Purchaser,
            its Affiliates and/or any Bain Affiliated Director of equity securities of such other issuer or derivatives thereof and (C) an Affiliate or other designee of the Purchaser or its Affiliates will serve on the board of directors (or its
            equivalent) of such other issuer pursuant to the terms of an agreement to which the Company is a party (or if the Purchaser notifies the Company of such service a reasonable time in advance of the closing of such transactions), then if the
            Company requires that the other issuer pre-approve any acquisition of equity securities or derivatives thereof for the express purpose of exempting the interests of any director or officer of the Company or any of its subsidiaries in such
            transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder, the Company shall require that such other issuer pre-approve any such acquisitions of equity securities or derivatives thereof for the express purpose of
            exempting the interests of the Purchaser’s, its Affiliates’ and any Bain Affiliated Director’s (to the extent such persons may be deemed to be “directors by deputization” of such other issuer) in such transactions from Section 16(b) of the
            Exchange Act pursuant to Rule 16b-3 thereunder.

        
          38

          
            

        

      

    

     
    
      
        Section 4.12. D&O Indemnification / Insurance Priority Matters.  The Company shall enter into an
            indemnification agreement consistent with the form on file with the SEC with each Bain Affiliated Director. The Company acknowledges and agrees that any Bain Affiliated Directors who are partners, members, employees, advisors or consultants of
            any member of the Bain Group may have certain rights to indemnification, advancement of expenses and/or insurance provided by the applicable member of the Bain Group (collectively, the “Bain Indemnitors”). The Company acknowledges and
            agrees that the Company shall be the indemnitor of first resort with respect to any indemnification, advancement of expenses and/or insurance provided in the Company’s certificate of incorporation, bylaws and/or indemnification agreement
            (including Section 5.05 hereof) to any Bain Affiliated Director in his or her capacity as a director of the Company or any of its subsidiaries (such that the Company’s obligations to such indemnitees in their capacities as directors are
            primary and any obligation of the Bain Indemnitors to advance expenses or to provide indemnification or insurance for the same expenses or liabilities incurred by such indemnitees are secondary). Such indemnitees shall, in their
            capacities as directors, be entitled to all the rights to indemnification, advancement of expenses and entitled to insurance to the extent provided under (i) the certificate of incorporation and/or bylaws of the Company as in effect from time
            to time and/or (ii) such other agreement (including Section 5.05 hereof), if any, between the Company and such indemnitees, without regard to any rights such indemnitees may have against the Bain Indemnitors. No advancement or payment
            by the Bain Indemnitors on behalf of such indemnitees with respect to any claim for which such indemnitees have sought indemnification, advancement of expenses or insurance from the Company in their capacities as directors shall affect the
            foregoing and the Bain Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such indemnitees against the Company.

      

    

     
    
      
        Section 4.13. Conversion Price Matters.  The Conversion Rate on the Closing Date (the “Initial
              Conversion Rate”) shall be 36.0360; provided, that if any event shall occur between the date hereof and the Closing Date (inclusive) that would have resulted in an adjustment to the Conversion Rate pursuant to Article 14 or
            Exhibit C of the Indenture if the Notes had been issued and outstanding since the date hereof, the Initial Conversion Rate and the share amounts in the table set forth in Section 14.03(e) of the Indenture shall be adjusted in the same manner as
            would have been required by Article 14 or Exhibit C (as applicable) of the Indenture if the Notes had been issued and outstanding since the date hereof and the Conversion Price, Initial Conversion Rate and the share amounts in the table set
            forth in Section 14.03(e) of the Indenture shall reflect such adjustment.

        
          39

          
            

        

      

    

     
    
      
        Section 4.14. Transfers of Sponsor Global Note. The Purchaser agrees that (i) except in the case of
            a foreclosure under a Permitted Loan pursuant to which the lender thereunder is obligated to convert the foreclosed interest in the Sponsor Global Note or exchange the foreclosed interest in the Sponsor Global Note for a Global Note other than
            the Sponsor Global Note, the Purchaser and its Affiliates will only transfer their interests in the Sponsor Global Note to a Third Party if such Person receives such transferred interest in a Global Note other than the Sponsor Global Note in an
            integral multiple of $1,000 and (ii) the Purchaser and its Affiliates may only transfer an interest in the Sponsor Global Note to an Affiliate of the Purchaser if such Affiliate continues to hold such transferred interest in the Sponsor Global
            Note and not any other Global Note.

      

    

     
    
      
        Section 4.15. Par Value. While the Purchaser owns any Notes, the Company will not, without the
            consent of the Purchaser, increase the par value per share of the Company Common Stock to above $0.000025 per share.

      

    

     
    
      
        Section 4.16. Voting.  The Purchaser agrees with the Company that, except with the Company’s prior
            written consent (a) for so long as the Purchaser is entitled to nominate at least one Bain Designee to the Board of Directors pursuant to Section 4.07, the Purchaser shall take such action (including, if applicable, through the
            execution of one or more written consents if stockholders of the Company are requested to vote through the execution of an action by written consent in lieu of any such annual or special meeting of stockholders of the Company) at each meeting
            of the stockholders of the Company as may be required so that all shares of issued and outstanding Company Common Stock Beneficially Owned, directly or indirectly, by it and/or by any of the Purchaser Affiliates are voted in the same manner
            (“for,” “against,” “withheld,” “abstain” or otherwise) as recommended by the Board of Directors to the other holders of Company Common Stock (including with respect to director elections); provided, notwithstanding the foregoing, this Section

              4.16 shall not in any way restrict or otherwise limit the Purchaser or any Purchaser Affiliates from voting, directly or indirectly, any Company Common Stock Beneficially Owned “for” the election of a Bain Designee to the Board of
            Directors, and (b) the Purchaser shall, and shall (to the extent necessary to comply with this Section 4.16) cause the Purchaser Affiliates to, be present, in person or by proxy, at all meetings of the stockholders of the Company so
            that all shares of issued and outstanding Company Common Stock Beneficially Owned by it or them from time to time may be counted for the purposes of determining the presence of a quorum and voted in accordance with the preceding clause (a) at
            such meetings (including at any adjournments or postponements thereof). The foregoing provision shall also apply to the execution by such Persons of any written consent in lieu of a meeting of holders of shares of Company Common Stock.
            Notwithstanding anything to the contrary herein, nothing in this Section 4.16 shall require the Purchaser to convert its Notes.

      

    

     
    
      
        Section 4.17. Indenture Amendments and Supplement.  For so long as the Bain Group collectively
            Beneficially Owns at least 50% of the Notes Beneficially Owned by the Bain Group immediately following the Closing, the Company shall not make an amendment or supplement to the Indenture or the Notes (as defined in the Indenture) of a type to
            which the first sentence of Section 10.02 of the Indenture applies, without the written consent of the Purchaser.

        
          40

          
            

        

      

    

     
    
      
        Section 4.18. Information Rights.  For so long as the Bain Group Beneficially Owns Notes
            representing at least 50% of the aggregate principal amount of the Notes, the Company shall:

      

    

     
    
      
        (a)  provide the Purchaser, its Affiliates and the representatives of the foregoing with (i) the right to visit any of the offices and properties of the Company and its Subsidiaries and inspect the books and
            records of the Company and its Subsidiaries, in each case upon reasonable notice and at such reasonable times and as often as the Purchaser may reasonably request and (ii) such other information reasonably requested by the Purchaser in the
            Company’s possession related to the business, operations and financial condition of the Company and its Subsidiaries (including any projections or financial analysis prepared by or on behalf of the Company) (it being understood that the Company
            shall not be required to create any new projections or analyses or other reports in response to a request pursuant to this clause (ii)) ; and

      

    

     
    
      
        (b) make appropriate officers, advisors and representatives of the Company and its Subsidiaries available periodically and at such times as reasonably requested by the Purchaser for consultation with the
            Purchaser, its Affiliates and the representatives of the foregoing with respect to matters relating to the business, operations and affairs of the Company and its Subsidiaries; provided that in case of clause (a) and (b) the Company shall not
            be obligated to provide materials, documents or information that it reasonably and in good faith considers to be a trade secret or the disclosure of which would reasonably be likely to jeopardize the attorney-client privilege between the
            Company and its counsel or violate applicable law.

      

    

     
    Section 4.19. Equity

          Financing.

     
    
      
        (a)
          No Amendments to Equity Commitment Letter. Subject to the
            terms and conditions of this Agreement and the Equity Commitment Letter, the Purchaser will not permit any amendment or modification to be made to, or any waiver of any provision or remedy pursuant to, the Equity Commitment Letter if such
            amendment, modification or waiver would, or would reasonably be expected to, (i) reduce the aggregate amount of the Equity Financing; (ii) impose new or additional conditions or other terms or otherwise expand, amend or modify any of the
            conditions to the receipt of the Equity Financing or any other terms to the Equity Financing in a manner that would reasonably be expected to (A) delay or prevent the Closing; or (B) make the timely funding of the Equity Financing, or the
            satisfaction of the conditions to obtaining the Equity Financing, less likely to occur in any respect; or (iii) adversely impact the ability of the Purchaser or the Company, as applicable, to enforce its rights against Equity Provider under the
            Equity Commitment Letter. Any reference in this Agreement to (1) the “Equity Financing” will include the financing contemplated by the Equity Commitment Letter as amended or modified in compliance with this Section 4.19; and (2) “Equity
            Commitment Letter” will include such document as amended or modified in compliance with this Section 4.19.

      

    

     
    
      
        (b)
          Taking of Necessary Actions. Subject to the terms and
            conditions of this Agreement, the Purchaser will use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper and advisable to arrange and obtain the Equity Financing on the
            terms and conditions not less favorable to the Company than described in the Equity Commitment Letter, including (i) maintain in effect the Equity Commitment Letter in accordance with the terms and subject to the conditions thereof;
            (ii) satisfy on a timely basis all conditions to funding that are applicable to the Purchaser and are within Purchaser’s control that are contained in the Equity Commitment Letter; (iii) upon the satisfaction of such conditions set forth in Section

              2.02(c), consummate the Equity Financing at or prior to the Closing; (iv) comply with its obligations pursuant to the Equity Commitment Letter; and (v) enforce its rights pursuant to the Equity Commitment Letter.

      

    

     
    
      
        
          41

          
            

        

        Section 4.20. Last Interest Payment.  If all or any portion of a Sponsor Note is converted during
            the period beginning on the Interest Record Date immediately preceding the Maturity Date, any Fundamental Change Repurchase Date or the Redemption Date and ending on the Scheduled Trading Day immediately preceding the Maturity Date, Redemption
            Date or such Fundamental Change Repurchase Date, as applicable, the Company shall pay the holder of the Sponsor Note an amount in cash equal to the difference between (a) the amount the holder would have received if interest on the Sponsor
            Notes submitted for conversion had been paid in the form of a PIK Note, the holder had converted the PIK Note on the Conversion Date for such Sponsor Notes and the Company had satisfied the related Conversion Obligation for such PIK Notes by
            Cash Settlement and (b) the amount of cash interest paid to the holder on the Maturity Date, Fundamental Change Repurchase Date or Redemption Date, as applicable, in respect of such Sponsor Notes for the period from the Interest Payment Date
            immediately preceding the Maturity Date, Fundamental Change Repurchase Date or Redemption Date to the Maturity Date, Fundamental Change Repurchase Date or Redemption Date, as applicable.

      

    

     
    
      
        Section 4.21. Legends.  Unless otherwise requested in writing by the Purchaser, the Company shall
            cause the legend required to be affixed on each certificate evidencing a Note pursuant to Section 2.04 of the Indenture not to be removed from such certificate until the one year anniversary of the last date on which a Sponsor Note was
            outstanding.

      

    

     
    ARTICLE V

        

        REGISTRATION RIGHTS

     
    Section 5.01. Registration

          Statement.

     
    
      
        (a) The Company will use reasonable efforts to prepare and file and use reasonable efforts to cause to be declared effective or otherwise become effective pursuant to the Securities Act, (x) for the
            registration of resales of the Company Common Stock, as soon as reasonably practicable following the Closing Date and (y) for all other registration requests, as soon as reasonably practicable following a written request of the Purchaser, a
            Registration Statement or post-effective amendment to an existing Registration Statement pursuant to the Securities Act in order to provide for resales of Registrable Securities to be made on a delayed or continuous basis pursuant to Rule 415
            under the Securities Act, which Registration Statement will (except to the extent the SEC objects in written comments upon the SEC’s review of such Registration Statement) include such plan of distribution requested by Purchaser. The Company
            shall not register the resale of the Notes unless and until requested in writing by the Purchaser. If such Registration Statement or the post-effective amendment to an existing Registration Statement is not effective upon filing, the Company
            shall use commercially reasonable efforts to cause such Registration Statement or post-effective amendment to be declared effective or otherwise become effective pursuant to the Securities Act (such date, the “Registration Date”). In
            addition, the Company will from time to time, after the initial Registration Statement has been declared effective, use reasonable efforts to file such additional Registration Statements to cover resales of any Registrable Securities that are
            not registered for resale pursuant to a pre-existing Registration Statement and will use its reasonable efforts to cause such Registration Statement to be declared effective or otherwise to become effective under the Securities Act and, subject
            to Section 5.02, will use its reasonable efforts to keep the Registration Statement continuously effective under the Securities Act at all times until the Registration Termination Date. Any Registration Statement filed pursuant to this Article

              V shall cover only Registrable Securities, shall be on Form S-3 (or a successor form) if the Company is eligible to use such form and shall be an automatically effective Registration Statement if the Company is a WKSI (in which case, the
            Registration Statement may request registration of an unspecified amount of Registrable Securities to be sold by unspecified holders).

        
          42

          
            

        

      

    

     
    
      
        (b) Subject to the provisions of Section 5.02 and further subject to the availability of a Registration Statement on Form S-3 (or any successor form thereto) to the Company pursuant to the Securities
            Act and the rules and interpretations of the SEC, the Company will use its reasonable efforts to keep the Registration Statement (or any replacement Registration Statement) continuously effective until the earlier of (such earlier date, the “Registration

              Termination Date”): (i) the date on which all Registrable Securities covered by the Registration Statement have been sold thereunder in accordance with the plan and method of distribution disclosed in the prospectus included in the
            Registration Statement and (ii) there otherwise cease to be any Registrable Securities.

      

    

     
    
      
        (c)
          From and after the date hereof until the Registration Termination Date, the Company shall use its reasonable efforts to maintain eligibility to be able to file and
            use a Registration Statement on Form S-3 (or any successor form thereto). Notwithstanding anything herein to the contrary, during such period of time from and after the Registration Date that the Company ceases to be eligible to file or use a
            Registration Statement on Form S-3 (or any successor form thereto), upon the written request of any holder or holders of Registrable Securities, the Company shall use its reasonable efforts to file a Registration Statement on Form S-1 (or any
            successor form) under the Securities Act covering the Registrable Securities of the requesting party or parties, as applicable, and use reasonable efforts to cause such Registration Statement to be declared effective pursuant to the Securities
            Act as soon as reasonably practicable after filing thereof and file and cause to become effective such amendments thereto as are necessary in order to keep such Registration Statement continuously available. Each such written request must
            specify the amount and intended manner of disposition of such Registrable Securities; provided, that the minimum amount of such Registrable Securities shall be $75,000,000. When the Company regains the ability to file a Registration
            Statement on Form S-3 covering the Registrable Securities it shall as promptly as practicably do so in accordance with Section 5.01(a).

      

    

     
    Section 5.02. Registration

          Limitations and Obligations.

     
    
      
        (a) Subject to Section 5.01, the Company will use reasonable efforts to prepare such supplements or amendments (including a post-effective amendment), if required by applicable law, to each applicable
            Registration Statement and file any other required document so that such Registration Statement will be Available at all times during the period for which such Registration Statement is, or is required pursuant to this Agreement to be,
            effective; provided, that no such supplement, amendment or filing will be required during a Blackout Period. In order to facilitate the Company’s determination of whether to initiate a Blackout Period, the Purchaser shall give the
            Company notice of a proposed sale of Registrable Securities pursuant to the Registration Statement at least two (2) Business Days (or, if two Business Days is not practicable, one (1) Business Day) prior to the proposed date of sale (which
            notice shall not bind the Purchaser to make any sale).

        
          43

          
            

        

      

    

     
    
      
        (b) Notwithstanding anything to the contrary contained in this Agreement, the Company shall be entitled, from time to time, by providing written notice to the holders of Registrable Securities, to require such
            holders of Registrable Securities to suspend the use of the prospectus for sales of Registrable Securities under the Registration Statement during any Blackout Period; provided, if the Purchaser and/or any of its Affiliates is or are
            the only party or parties with rights under this Article V and a Bain Affiliated Director is serving on the Board of Directors, then no notice shall be required for a Blackout Period described in clause (i) of the definition thereof and
            all holders of Registrable Securities shall be deemed to have knowledge of such Blackout Period; provided, further, for purposes of this Section 5.02, the Company shall only be obligated to provide written notice to any
            holder or Beneficial Owner of Registrable Securities of any such Blackout Period, or the certificate described in the following sentence, if such holder or Beneficial Owner has specified in writing (including by electronic mail) to the Company
            for purposes of receiving such notice such holder’s or Beneficial Owner’s address (including electronic mail), contact and fax number information. No sales may be made under the applicable Registration Statement during any Blackout Period (with
            respect to clause (ii) of the definition thereof, of which the holders of Registrable Securities have or are deemed to have received notice). In the event of a Blackout Period under clause (ii) of the definition thereof, the Company shall (x)
            deliver to the holders of Registrable Securities a certificate signed by the chief executive officer, chief financial officer or general counsel of the Company confirming that the conditions described in clause (ii) of the definition of
            Blackout Period are met (but which certificate need not specify the nature of the event causing such conditions to have been met), which certificate shall contain an approximation of the anticipated delay, and (y) notify each holder of
            Registrable Securities promptly upon each of the commencement and the termination of each Blackout Period, which notice of termination shall be delivered to each holder of Registrable Securities no later than the close of business of the last
            day of the Blackout Period. In connection with the expiration of any Blackout Period and without any further request from a holder of Registrable Securities, the Company to the extent necessary and as required by applicable law shall as
            promptly as reasonably practicable prepare supplements or amendments, including a post-effective amendment, to the Registration Statement or the prospectus, or any document incorporated therein by reference, or file any other required document
            so that the Registration Statement will be Available. A Blackout Period described in clause (ii) of the definition thereof shall be deemed to have expired when the Company has notified the holders of Registrable Securities that the Blackout
            Period is over and the Registration Statement is Available. Notwithstanding anything in this Agreement to the contrary, the absence of an Available Registration Statement at any time from and after the Registration Date shall be considered a
            Blackout Period described in clause (ii) of the definition thereof and subject to the limitations therein, except to the extent such absence occurs during (and does not extend beyond) a Blackout Period described in clause (i) of the definition
            thereof. For avoidance of doubt, upon expiration of a Blackout Period described in clause (i) of the definition thereof, any additional duration of a Blackout Period will be deemed to a Blackout Period described in clause (ii) of the definition
            thereof and subject to the limitations therein.

        
          44

          
            

        

      

    

     
    
      
        (a) At any time that a Registration Statement is effective and prior to the Registration Termination Date, if a holder of Registrable Securities (an “Initiating Holder”) delivers a notice to the Company
            (a “Take-Down Notice”) stating that it intends to sell at least $75,000,000 of Registrable Securities held by such holder (provided that, if the Purchaser and its Affiliates do not own at least $75,000,000 of Registrable Securities, they
            shall be permitted to deliver a Take-Down Notice to sell all of the Registrable Securities held by them (but such amount may not in any case be less than $25,000,000 of Registrable Securities)), in each case, pursuant to the Registration
            Statement, then, the Company shall amend or supplement the Registration Statement as may be necessary and to the extent required by law so that the Registration Statement remains Available in order to enable such Registrable Securities to be
            distributed in an Underwritten Offering or in such other manner as requested by the Purchaser. In connection with any Underwritten Offering of Registrable Securities for which a holder delivers a Take-Down Notice and satisfies the dollar
            thresholds set forth in the first sentence above and the Take-Down Notice contemplates a Marketed Underwritten Offering, the Company will use reasonable efforts to cooperate and make its senior officers available for participation in such
            marketing efforts (which marketing efforts will not, for the avoidance of doubt, include a “road show” requiring such officers to travel outside of the city in which they are primarily located). The Initiating Holder shall have the right
            hereunder to, in its sole discretion: (i) select the underwriter(s) for each Underwritten Offering, (ii) determine the pricing of the Registrable Securities offered pursuant to any such Registration Statement, including the underwriting
            discount and fees payable to the underwriters in such Underwritten Offering, as well as any other financial terms, (iii) determine the timing of any such registration and sale and (iv) determine the total number of Registrable Securities that
            can be included in such Underwritten Offering in consultation with the managing underwriters (collectively, the “Offering Terms”). Without the consent of the applicable holder of Registrable Securities subject to an Underwritten
            Offering, no Underwritten Offering pursuant to this Agreement shall include any securities other than Registrable Securities.

      

    

     
    
      
        (b) In addition to the registration rights provided in Section 5.01(c) and the indemnification provisions in Section 5.05, holders of the Notes shall have analogous rights to indemnification and
            to sell such securities in a marketed offering under Rule 144A under the Securities Act through one or more initial purchasers, using procedures that are substantially equivalent to those specified in Section 5.02, Section 5.03
            and Section 5.05, as applicable. The Company agrees to use its reasonable efforts to cooperate to effect any such sales under such Rule 144A. Nothing in this Section 5.02(b) shall impose any additional or more burdensome
            obligations on the Company than would apply under Section 5.02 and Section 5.03, in each case, mutatis mutandis in respect of a registered Underwritten Offering, or require that the
            Company take any actions that it would not be required to take in an Underwritten Offering of such Notes.

      

    

     
    
      
        (c) Notwithstanding anything herein to the contrary, (i) if holders of Registrable Securities engage or propose to engage in a “distribution” (as defined in Regulation M under the Exchange Act) of Registrable
            Securities, such holders shall discuss the timing of such distribution with the Company reasonably prior to commencing such distribution, and (ii) such distribution must not be for less than $75,000,000 of Registrable Securities held by such
            holders (provided that, if collectively the Purchaser and its Affiliates do not own at least $75,000,000 of Registrable Securities, they shall be permitted to engage in such distribution with respect to all of the Registrable Securities held by
            them (for so long as they hold collectively at least $25,000,000 of Registrable Securities)).

        
          45

          
            

        

      

    

     
    
      
        (d) In connection with a distribution of Registrable Securities in which a holder of Registrable Securities is selling at least $100,000,000 of Registrable Securities including pursuant to Rule 144A, the
            Company shall and shall cause each of its officers and directors, to the extent requested by Purchaser, the managing underwriter(s) or initial purchasers, as applicable, of such a distribution, be subject to a restricted period of the same
            length of time as such holder agrees with the managing underwriter(s) (but not to exceed 30 days) during which the Company and its officers and directors may not offer, sell or grant any option to purchase Company Common Stock (in the case of
            an offering of Company Common Stock or securities convertible or exchangeable for Company Common Stock) and any debt securities (in the case of an offering of debt securities) of the Company, subject to customary carve-outs that include, but
            are not limited to, (i) issuances pursuant to the Company’s employee or director stock plans and issuances of shares upon the exercise of options or other equity awards under such stock plans and (ii) in connection with acquisitions, joint
            ventures and other strategic transactions.

      

    

     
    Section 5.03. Registration

          Procedures.

     
    
      
        (a) In connection with the registration of any Registrable Securities under the Securities Act and in connection with any distribution of Registrable Securities pursuant thereto as contemplated by this
            Agreement (including any sale referred to in any Take Down Notice), or any analogous Rule 144A offering pursuant to Section 5.02(b), the Company shall as promptly as reasonably practicable, subject to the other provisions of this
            Agreement:

      

    

     
    
      
        (i) subject to the provisions of Section 5.01(a), use reasonable efforts to prepare and file with the SEC a Registration Statement to effect such registration in accordance with the intended method or
            methods of distribution of such securities and thereafter use reasonable efforts to cause such Registration Statement to become and remain effective pursuant to the terms of this Article V; provided, however, that the
            Company may discontinue any registration of its securities which are not Registrable Securities at any time prior to the effective date of the Registration Statement relating thereto; provided, further, that before filing such
            registration statement or any amendments or supplements thereto, including any prospectus supplements in connection with a sale referred to in a Take-Down Notice (but excluding amendments and supplements that do nothing more than name Selling
            Holders (as defined below) and provide information with respect thereto), the Company will furnish to the holders which are including Registrable Securities in such registration (“Selling Holders”) and the lead managing underwriter(s),
            if any, copies of all such documents proposed to be filed, which documents will be subject to the review and reasonable comment (which comments will be considered in good faith by the Company) of the counsel (if any) to such holders and counsel
            (if any) to such underwriter(s), and other documents reasonably requested by any such counsel, including any comment letters from the SEC, and, if requested by any such counsel, provide such counsel and the lead managing underwriter(s), if any,
            reasonable opportunity to participate in the preparation of such Registration Statement and each prospectus (including any prospectus supplement) included or deemed included therein and such other opportunities to conduct a customary and
            reasonable due diligence investigation (in the context of a registered underwritten offering) of the Company, including reasonable access to (including responses to any reasonable inquiries by the lead managing underwriter(s) and their counsel)
            the Company’s books and records, officers, accountants and other advisors, provided that the same occurs during normal business hours after reasonable notice and is not disruptive to the business of the Company; provided that
            such persons shall first agree in writing with the Company that any information that is reasonably designated by the Company as confidential at the time of delivery shall be kept confidential by such persons subject to customary exceptions;

        
          46

          
            

        

      

    

     
    
      
        (ii) at or before any Registration Statement is declared or otherwise becomes effective, upon request by the Purchaser, qualify the Indenture under the Trust Indenture Act of 1939, as amended, and appoint a new
            trustee under the Indenture to the extent such qualification requires the appointment of a new trustee thereunder;

      

    

     
    
      
        (iii) subject to Section 5.02, prepare and file with the SEC such amendments and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary and to the
            extent required by applicable law to keep such Registration Statement effective and Available pursuant to the terms of this Article V;

      

    

     
    
      
        (iv) if requested by the lead managing underwriter(s), promptly include in a prospectus supplement or post-effective amendment such information as the lead managing underwriter(s), if any, and such holders may
            reasonably request in order to permit the intended method of distribution of such securities and make all required filings of such prospectus supplement or such post-effective amendment as soon as reasonably practicable after the Company has
            received such request; provided, however, that the Company shall not be required to take any actions under this Section 5.03(a)(iv) that are not, in the opinion of counsel for the Company, in compliance with applicable
            law;

      

    

     
    
      
        (v) furnish to the Selling Holders and each underwriter, if any, of the securities being sold by such Selling Holders such number of conformed copies of such Registration Statement and of each amendment and
            supplement thereto, such number of copies of the prospectus and any prospectus supplement contained in or deemed part of such Registration Statement (including each preliminary prospectus supplement) and each free writing prospectus (as defined
            in Rule 405 of the Securities Act) (a “Free Writing Prospectus”) utilized in connection therewith and any other prospectus filed under Rule 424 under the Securities Act, in conformity with the requirements of the Securities Act, and such
            other documents as such Selling Holders and underwriter(s), if any, may reasonably request in order to facilitate the public sale or other disposition of the Registrable Securities owned by such Selling Holders;

        
          47

          
            

        

      

    

     
    
      
        (vi) use reasonable efforts to cause such Registrable Securities to be listed on each securities exchange on which similar securities issued by the Company are then listed, and to apply for any necessary
            “CUSIPs” or analogous codes to identify such securities;

      

    

     
    
      
        (vii) use reasonable efforts to provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by such Registration Statement from and after a date not later than the
            effective date of such Registration Statement;

      

    

     
    
      
        (viii) as promptly as practicable notify in writing the holders of Registrable Securities and the underwriters, if any, of the following events: (A) the filing of the Registration Statement, any amendment thereto,
            the prospectus or any prospectus supplement related thereto or post-effective amendment to such Registration Statement or any Free Writing Prospectus utilized in connection therewith, and, with respect to such Registration Statement or any
            post-effective amendment thereto, when the same has become effective; (B) any request by the SEC or any other U.S. or state governmental authority for amendments or supplements to such Registration Statement or the prospectus; (C) the issuance
            by the SEC of any stop order suspending the effectiveness of such Registration Statement or the initiation of any proceedings by any person for that purpose; (D) the receipt by the Company of any notification with respect to the suspension of
            the qualification of any Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction or the initiation or threat of any proceeding for such purpose; (E) if at any time the representations and warranties of the
            Company contained in any agreement (including any underwriting agreement) related to such registration cease to be true and correct in any material respect; and (F) upon the happening of any event that makes any statement made in such
            Registration Statement or related prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in such registration statement, prospectus or
            documents so that, in the case of such Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not
            misleading, and that in the case of the prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they
            were made, not misleading; provided, in the case of clause (F), that such notice need not include the nature or details concerning such event;

      

    

     
    
      
        (ix) use reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of such Registration Statement, or the lifting of any suspension of the qualification (or exemption from
            qualification) of any of the Registrable Securities for sale in any jurisdiction at the earliest reasonable practicable date, except that the Company shall not for any such purpose be required to (A) qualify generally to do business as a
            foreign corporation or as a dealer in securities in any jurisdiction wherein it would not but for the requirements of this clause (ix) be obligated to be so qualified, (B) subject itself to taxation in any such jurisdiction or (C) file a
            general consent to service of process in any such jurisdiction;

        
          48

          
            

        

      

    

     
    
      
        (x) cooperate with each seller of Registrable Securities and each underwriter or agent participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings
            required to be made with the Financial Industry Regulatory Authority, Inc.; and

      

    

     
    
      
        (xi) prior to any public offering of Registrable Securities, use reasonable efforts to register or qualify or cooperate with the Selling Holders in connection with the registration or qualification (or exemption
            from such registration or qualification) of such Registrable Securities for offer and sale under the applicable state securities or “blue sky” laws of those jurisdictions within the United States as any holder reasonably requests in writing to
            keep each such registration or qualification (or exemption therefrom) effective until the Registration Termination Date; provided, that the Company will not be required to (A) qualify generally to do business as a foreign corporation or
            as a dealer in securities in any jurisdiction wherein it would not but for the requirements of this clause (xi) be obligated to be so qualified, (B) subject itself to taxation in any such jurisdiction or (C) file a general consent to service of
            process in any such jurisdiction;

      

    

     
    
      
        (xii) use reasonable efforts to cooperate with the holders to facilitate the timely preparation and delivery of certificates or book-entry securities representing Registrable Securities to be delivered to a
            transferee pursuant to the Registration Statements, which certificates or book-entry securities shall be free, to the extent permitted by the Indenture and applicable law, of all restrictive legends, and to enable such Registrable Securities to
            be in such denominations and registered in such names as any such holders may request in writing; and in connection therewith, if required by the Company’s transfer agent, the Company will promptly after the effectiveness of the Registration
            Statement cause to be delivered to its transfer agent when and as required by such transfer agent from time to time, any authorizations, certificates, directions and other evidence required by the transfer agent which authorize and direct the
            transfer agent to issue such Registrable Securities without legend upon sale by the holder of such shares of Registrable Securities under the Registration Statement; and

      

    

     
    
      
        (xiii) agrees with each holder of Registrable Securities that, in connection with any Underwritten Offering or other resale pursuant to the Registration Statement in accordance with the terms hereof, it will use
            reasonable efforts to negotiate in good faith and execute all customary indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements (in each case on terms reasonably acceptable
            to the Company), including using reasonable efforts to procure customary legal opinions and auditor “comfort” letters.

        
          49

          
            

        

      

    

     
    
      
        (b) The Company may require each Selling Holder and each underwriter, if any, to (i) furnish the Company in writing such information regarding each Selling Holder or underwriter and the distribution of such
            Registrable Securities as the Company may from time to time reasonably request in writing to complete or amend the information required by such Registration Statement and/or any other documents relating to such registered offering, and (ii)
            execute and deliver, or cause the execution or delivery of, and to perform under, or cause the performance under, any agreements and instruments reasonably requested by the Company to effectuate such registered offering, including, without
            limitation, opinions of counsel and questionnaires. If the Company requests that the holders of Registrable Securities take any of the actions referred to in this Section 5.03(b), such holders shall take such action promptly and as soon
            as reasonably practicable following the date of such request.

      

    

     
    
      
        (c) Each Selling Holder agrees that upon receipt of any notice from the Company of the happening of any event of the kind described in clauses (B), (C), (D), (E) and (F) of Section 5.03(a)(viii), such
            Selling Holder shall forthwith discontinue such Selling Holder’s disposition of Registrable Securities pursuant to the applicable Registration Statement and prospectus relating thereto until such Selling Holder is advised in writing by the
            Company that the use of the applicable prospectus may be resumed, and has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such prospectus. The Company shall use
            reasonable efforts to cure the events described in clauses (B), (C), (D), (E) and (F) of Section 5.03(a)(viii) so that the use of the applicable prospectus may be resumed at the earliest reasonably practicable moment.

      

    

     
    
      
        Section 5.04. Expenses.  The Company shall pay all Registration Expenses in connection with a
            registration pursuant to this Article V; provided that each holder of Registrable Securities participating in an offering shall pay all applicable underwriting discounts and commissions, agency fees, brokers’ commissions and
            transfer taxes, if any, on the Registrable Securities sold by such holder, and similar charges.

      

    

     
    Section 5.05. Registration Indemnification.

     
    
      
        (a) The Company agrees, without limitation as to time, to indemnify and hold harmless, to the fullest extent permitted by law, each Selling Holder and its Affiliates and their respective officers, directors,
            members, shareholders, employees, managers, partners, accountants, attorneys, advisors and agents and each Person who controls (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) such Selling Holder or
            such other indemnified Person and the officers, directors, members, shareholders, employees, managers, partners, accountants, attorneys, advisors and agents of each such controlling Person, each underwriter, if any, and each Person who controls
            (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) such underwriter (collectively, the “Indemnified Persons”), from and against all losses, claims, damages, liabilities, costs, expenses (including
            reasonable expenses of investigation and reasonable attorneys’ fees and expenses), judgments, fines, penalties, charges and amounts paid in settlement (collectively, the “Losses”), as incurred, arising out of, caused by, resulting from
            or relating to any untrue statement (or alleged untrue statement) of a material fact contained in any Registration Statement, prospectus or preliminary prospectus or Free Writing Prospectus, in each case related to such Registration Statement,
            or any amendment or supplement thereto or any omission (or alleged omission) of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading
            and (without limitation of the preceding portions of this Section 5.05(a)) will reimburse each such Selling Holder, each of its Affiliates, and each of their respective officers, directors, members, shareholders, employees, managers,
            partners, accountants, attorneys, advisors and agents and each such Person who controls each such Selling Holder and the officers, directors, members, shareholders, employees, managers, partners, accountants, attorneys, advisors and agents of
            each such controlling Person, each such underwriter and each such Person who controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating and defending or settling any such claim,
            Loss, damage, liability or action, except insofar as the same are caused by any information regarding a holder of Registrable Securities or underwriter furnished in writing to the Company by any such person or any selling holder or underwriter
            expressly for use therein.

        
          50

          
            

        

      

    

     
    
      
        (b) In connection with any Registration Statement in which a Selling Holder is participating, without limitation as to time, each such Selling Holder shall, severally and not jointly, indemnify the Company, its
            directors and officers, and each Person who controls (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) the Company, from and against all Losses, as incurred, arising out of, caused by, resulting from or
            relating to any untrue statement (or alleged untrue statement) of material fact contained in the Registration Statement, prospectus or preliminary prospectus or Free Writing Prospectus or any amendment or supplement thereto or any omission (or
            alleged omission) of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (without limitation of the preceding portions of this
            Section 5.05(b)) will reimburse the Company, its directors and officers and each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) for any legal and any other
            expenses reasonably incurred in connection with investigating and defending or settling any such claim, Loss, damage, liability or action, in each case solely to the extent, but only to the extent, that such untrue statement or omission is made
            in such registration statement, prospectus or preliminary prospectus or Free Writing Prospectus or any amendment or supplement thereto in reliance upon and in conformity with written information regarding the Selling Holder furnished to the
            Company by such Selling Holder for inclusion in such registration statement, prospectus or preliminary prospectus or Free Writing Prospectus or any amendment or supplement thereto.

      

    

     
    
      
        (c) Any Person entitled to indemnification hereunder shall give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification; provided, however,
            the failure to give such notice shall not release the indemnifying party from its obligation, except to the extent that the indemnifying party has been actually and materially prejudiced by such failure to provide such notice on a timely basis.

      

    

     
    
      
        (d) In any case in which any such action is brought against any indemnified party, the indemnified party shall promptly notify in writing the indemnifying party of the commencement thereof, and the indemnifying
            party will be entitled to participate therein, and, to the extent that it may wish, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified
            party of its election so to assume the defense thereof and acknowledging the obligations of the indemnifying party with respect to such proceeding, the indemnifying party will not (so long as it shall continue to have the right to defend,
            contest, litigate and settle the matter in question in accordance with this paragraph) be liable to such indemnified party hereunder for any legal or other expense subsequently incurred by such indemnified party in connection with the defense
            thereof other than reasonable costs of investigation, supervision and monitoring (unless (i) such indemnified party reasonably objects to such assumption on the grounds that there may be defenses available to it which are different from or in
            addition to the defenses available to such indemnifying party or a conflict of interest otherwise exists or (ii) the indemnifying party shall have failed within a reasonable period of time to assume such defense and the indemnified party is or
            would reasonably be expected to be materially prejudiced by such delay, in either event the indemnified party shall be promptly reimbursed by the indemnifying party for the expenses incurred in connection with retaining one separate legal
            counsel (for the avoidance of doubt, for all indemnified parties in connection therewith)). For the avoidance of doubt, notwithstanding any such assumption by an indemnifying party, the indemnified party shall have the right to employ separate
            counsel in any such matter and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such indemnified party except as provided in the previous sentence. An indemnifying party shall not be
            liable for any settlement of an action or claim effected without its consent (which consent shall not be unreasonably withheld, conditioned or delayed). No matter shall be settled by an indemnifying party without the consent of the indemnified
            party (which consent shall not be unreasonably withheld, conditioned or delayed), unless such settlement (x) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such claim or
            proceeding, (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party and (z) is settled solely for cash for which the indemnified party would be entitled to
            indemnification hereunder. The failure of an indemnified party to give notice to an indemnifying party of any action brought against such indemnified party shall not relieve the indemnifying party of its obligations or liabilities pursuant to
            this Agreement, except to the extent such failure adversely prejudices the indemnifying party.

        
          51

          
            

        

      

    

     
    
      
        (e) The indemnification provided for under this Agreement shall survive the sale or other transfer of the Registrable Securities and the termination of this Agreement.

      

    

     
    
      
        (f) If recovery is not available under the foregoing indemnification provisions for any reason or reasons other than as specified therein, any Person who would otherwise be entitled to indemnification by the
            terms thereof shall nevertheless be entitled to contribution with respect to any Losses with respect to which such Person would be entitled to such indemnification but for such reason or reasons, in such proportion as is appropriate to reflect
            the relative fault of the indemnifying party, on the one hand, and such indemnified party, on the other hand, in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable
            considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a
            material fact relates to information supplied by the indemnifying party or by the indemnified party, the Persons’ relative knowledge and access to information concerning the matter with respect to which the claim was asserted, the opportunity
            to correct and prevent any statement or omission, and other equitable considerations appropriate under the circumstances. It is hereby agreed that it would not necessarily be equitable if the amount of such contribution were determined by pro
            rata or per capita allocation that does not take into account the equitable considerations referred to in the immediately preceding sentence. Notwithstanding any other provision of this Agreement, no holder of Registrable Securities shall be
            required to indemnify or contribute, in the aggregate, any amount in excess of its net proceeds from the sale of the Registrable Securities subject to any actions or proceedings over the amount of any damages, indemnity or contribution that
            such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
            shall be entitled to contribution from any Person who was not found guilty of such fraudulent misrepresentation.

        
          52

          
            

        

      

    

     
    
      
        (g) The indemnification and contribution agreements contained in this Section 5.05 are in addition to any liability that the indemnifying party may have to the indemnified party and do not limit other
            provisions of this Agreement that provide for indemnification.

      

    

     
     
      
        Section 5.06. Facilitation of Sales Pursuant to Rule 144.  For as long as the Purchaser or its Affiliates or any lender under any Permitted Loan Beneficially Owns Notes or any Company Common Stock issued or issuable upon conversion thereof, to the
            extent it shall be required to do so under the Exchange Act, the Company shall use reasonable efforts to timely file the reports required to be filed by it under the Exchange Act or the Securities Act (including the reports under Sections 13
            and 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144) and submit all required Interactive Data Files (as defined in Rule 11 of Regulation S-T of the Commission), and shall use reasonable efforts to take such further
            necessary action as any holder of Subject Securities may reasonably request in connection with the removal of any restrictive legend on the Subject Securities being sold, all to the extent required from time to time to enable such holder to
            sell the Subject Securities without registration under the Securities Act within the limitations of the exemption provided by Rule 144.

      

    

    ARTICLE VI

        

        MISCELLANEOUS

    
      
        Section 6.01. Survival of Representations and Warranties.  All covenants and agreements contained
            herein, other than those which by their terms apply in whole or in part after the Closing (which shall survive the Closing), shall terminate as of the Closing; provided nothing herein shall relieve any party of liability for any breach of such
            covenant or agreement before it terminated. Except for the warranties and representations contained in clauses (a), (b), (c), (d), (e) and (f)(i) of Section 3.01 and the representations and warranties contained in Section 3.02, which shall
            survive the Closing indefinitely, the warranties and representations made herein shall survive for one (1) year following the Closing Date and shall then expire; provided that nothing herein shall relieve any party of liability for any
            inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is made in writing prior to such expiration.

        
          53

          
            

        

      

       

     
     
      
        Section 6.02. Notices  All notices and other communications hereunder shall be in writing and shall
            be deemed to have been duly given if delivered personally, by facsimile, sent by overnight courier or sent via email (with receipt confirmed) as follows:

        	 	(a) 

              	If to the Purchaser, to: 

              
	 	 	 
	 	 	c/o Bain Capital Private Equity, LP 

              
	 	 	200 Clarendon Street 

              
	 	 	Boston, Massachusetts 02116 

              
	 	 	
                Attention:  David M. Hutchins

              
	 	 	
                Fax:  [***]

              
	 	 	
                Email:  [***]

              
	 	 	 
	 	 	With a copy (which shall not constitute actual or constructive notice) to: 

              
	 	 	 
	 	 	Ropes & Gray LLP

              
	 	 	
                Three Embarcadero Center

                

                   
	 	 	San Francisco, CA 94111-4006 

              
	 	 	Attention:  Thomas Holden 

              
	 	 	Fax:  +1 (415) 315 4823 

              
	 	 	Email:  Thomas.Holden@ropesgray.com 

              
	 	 	 
	 	(b) 

              	If to the Company, to: 

              
	 	 	 
	 	 	
                Nutanix, Inc.

              
	 	 	1740 Technology Drive, Suite 150 

              
	 	 	San Jose, CA 95110 

              
	 	 	Attention:  Chief Legal Officer and Chief Financial Officer 

              
	 	 	Fax:  (408) 490-2794 

              
	 	 	Phone: (855) 688-2649 

              
	 	 	 
	 	 	With a copy (which shall not constitute actual or constructive notice) to: 

              
	 	 	 
	 	 	
                Wilson Sonsini Goodrich & Rosati

              
	 	 	650 Page Mill Road 

              
	 	 	Palo Alto, CA 94304 

              
	 	 	Attention:  Jeffrey D. Saper 

              
	 	 	Michael A. Occhiolini 

              
	 	 	Bradley L. Finkelstein 

              
	 	 	Email: jsaper@wsgr.com 

              
	 	 	mocchiolini@wsgr.com 

              
	 	 	bfinkelstein@wsgr.com 

              

      

    

    

    
      54

      
        

    

    or to such other address or addresses as shall be designated in writing. All notices shall be deemed effective (a) when delivered
      personally (with written confirmation of receipt, by other than automatic means, whether electronic or otherwise), (b) when sent by facsimile (with written confirmation of receipt, by other than automatic means, whether electronic or otherwise) or
      (c) one (1) Business Day following the day sent by overnight courier.

     
    
      
        Section 6.03. Entire Agreement; Third Party Beneficiaries; Amendment.  This Agreement, together with
            the Confidentiality Agreement, sets forth the entire agreement between the parties hereto with respect to the Transactions, and is not intended to and shall not confer upon any person other than the parties hereto, their successors and
            permitted assigns any rights or remedies hereunder, provided that (i) Section 5.05 shall be for the benefit of and fully enforceable by each of the Indemnified Persons and (ii) Section 6.12 shall be for the benefit of
            and fully enforceable by each of the Specified Persons. Any provision of this Agreement may be amended or modified in whole or in part at any time by an agreement in writing between the parties hereto executed in the same manner as this
            Agreement. No failure on the part of any party to exercise, and no delay in exercising, any right shall operate as a waiver thereof nor shall any single or partial exercise by any party of any right preclude any other or future exercise thereof
            or the exercise of any other right.

      

    

     
    
      
        Section 6.04. Counterparts.  This Agreement may be executed in one or more counterparts, each of
            which shall be deemed to constitute any original, but all of which together shall constitute one and the same document. Signatures to this Agreement transmitted by facsimile transmission, by electronic mail in “portable document format”
            (“.pdf”) form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document will have the same effect as physical delivery of the paper document bearing the original signature.

      

    

     
    
      
        Section 6.05. Public Announcements.  No press release or public announcement related to this
            Agreement or the transactions contemplated herein shall be issued or made by the Purchaser or its Affiliates without the prior written approval of the Company, unless required by law (based on the advice of counsel) in which case the Company
            shall have the right to review and reasonably comment on such press release, announcement or communication prior to issuance, distribution or publication. Notwithstanding the foregoing (but subject to the terms of the Confidentiality
            Agreement), the Purchaser and its Affiliates shall not be restricted from (a) making any filings and disclosures required under applicable laws (including Sections 13 and 16 of the Exchange Act) and (b) communicating with their respective
            investors and potential investors in connection with marketing, informational or reporting activities; provided that in the case of clause (b), the recipient of such information is subject to a customary obligation to keep such
            information confidential. The Company may issue or make one or more press releases or public announcements (in which case the Purchaser shall have the right to review and reasonably comment on such press release, announcement or communication
            prior to issuance, distribution or publication) and may file this Agreement with the SEC and may provide information about the subject matter of this Agreement in connection with equity or debt issuances, share repurchases, or marketing,
            informational or reporting activities.

        
          55

          
            

        

      

    

     
    
      
        Section 6.06. Expenses.  The Company shall reimburse the Purchaser for its reasonable documented
            out-of-pocket fees and expenses, including fees and expenses of Purchaser’s attorneys and other advisors incurred in connection with this Agreement and the Transactions not in excess of an aggregate amount equal to $1,500,000.

      

    

     
    
      
        Section 6.07. Successors and Assigns.  Except as otherwise expressly provided herein, the provisions
            hereof shall inure to the benefit of, and be binding upon, the Company’s successors and assigns and the Purchaser’s successors and assigns, and no other person; provided, that neither the Company nor the Purchaser may assign its
            respective rights or delegate its respective obligations under this Agreement, whether by operation of law or otherwise, and any assignment by the Company or the Purchaser in contravention hereof shall be null and void; provided, that
            (i) prior to the Closing the Purchaser may assign all of its rights and obligations under this Agreement and the Confidentiality Agreement or any portion thereof to one or more Bain Affiliates who execute and deliver to the Company a Joinder
            and any such assignee who executes and delivers to the Company a Joinder shall be deemed a Purchaser hereunder and have all the rights and obligations of a Purchaser; provided that no such assignment will relieve the Purchaser of its
            obligations hereunder or under the Confidentiality Agreement, (ii) any Bain Affiliate who after the Closing Date executes and delivers a Joinder and is a permitted transferee of any Notes or shares of Company Common Stock shall be deemed a
            Purchaser hereunder and have all the rights and obligations of a Purchaser, (iii) if the Company consolidates or merges with or into any Person and the Company Common Stock is, in whole or in part, converted into or exchanged for securities of
            a different issuer in a transaction that does not constitute a Change in Control, then as a condition to such transaction the Company will cause such issuer to assume all of the Company’s rights and obligations under this Agreement in a written
            instrument delivered to the Purchaser, and (iv) the rights of a holder of Registrable Securities under Article V may be transferred but only together with Subject Securities (x) in a transfer of (1) Notes or Other Notes in an aggregate
            principal amount of at least $75,000,000 and (2) Company Common Stock or other Subject Securities issued or issuable upon conversion or repurchase by the Company of at least $75,000,000 in aggregate principal amount of Notes, (y) to an
            Affiliate of the transferor that executes and delivers to the Company a Joinder (subject to 4.02(a)), or (z) to a lender in connection with a Permitted Loan. For the avoidance of doubt, no Third Party to whom any of the Notes or shares of
            Company Common Stock are transferred shall have any rights or obligations under this Agreement except (and then only to the extent of) any rights and obligations under Article V to the extent transferable in accordance with this Section

              6.07. Notwithstanding anything to the contrary set forth herein, the Purchaser may without the consent of any other party grant powers of attorney, operative only upon an event of default of the Company in respect of its obligations under
            Article II to issue the Notes upon payment of the purchase price therefor in accordance with the terms of this Agreement (including satisfaction of the conditions set forth in Section 2.02(d)), to any lender under any Permitted
            Loan to act on behalf of the Purchaser to enforce such obligation.

      

    

     
    Section 6.08. Governing

          Law; Jurisdiction; Waiver of Jury Trial.

     
    
      
        (a) This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of
            Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. In addition, each of the parties hereto irrevocably agrees that any legal action or proceeding with respect
            to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder brought by the other party hereto or its
            successors or assigns, shall be brought and determined exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, solely if the Delaware Court of Chancery declines to accept
            jurisdiction over a particular matter, any state or federal court within the State of Delaware). Each of the parties hereto hereby irrevocably submits with regard to any such action or proceeding for itself and in respect of its property,
            generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement in any court other than the
            aforesaid courts. Each of the parties hereto hereby irrevocably waives, and agrees not to assert as a defense, counterclaim or otherwise, in any action or proceeding with respect to this Agreement, (i) any claim that it is not personally
            subject to the jurisdiction of the above named courts for any reason other than the failure to serve in accordance with this Section 6.08(a), (ii) any claim that it or its property is exempt or immune from the jurisdiction of any such
            court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (iii) to the fullest extent permitted
            by the applicable law, any claim that (A) the suit, action or proceeding in such court is brought in an inconvenient forum, (B) the venue of such suit, action or proceeding is improper or (C) this Agreement, or the subject matter hereof, may
            not be enforced in or by such courts. Each of the parties hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth in Section 6.02 shall be effective service of
            process for any suit or proceeding in connection with this Agreement or the transactions contemplated hereby.

        
          56

          
            

        

      

    

     
    
      
        (b) EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
            TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS SECTION 6.08.

      

    

     
    
      
        Section 6.09. Severability.  If
            any provision of this Agreement is determined to be invalid, illegal or unenforceable, the remaining provisions of this Agreement shall remain in full force and effect provided that the economic and legal substance of, any of the Transactions
            is not affected in any manner materially adverse to any party. In the event of any such determination, the parties agree to negotiate in good faith to modify this Agreement to fulfill as closely as possible the original intent and purpose
            hereof. To the extent permitted by law, the parties hereby to the same extent waive any provision of law that renders any provision hereof prohibited or unenforceable in any respect.

      

    

     
    Section 6.10. Specific

          Performance.

    
      57

      
        

    

     
    
      
        (a) The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
            Accordingly, each party agrees that in the event of any breach or threatened breach by any other party of any covenant or obligation contained in this Agreement, the non-breaching party shall be entitled (in addition to any other remedy that
            may be available to it, whether in law or equity) to obtain (i) a decree or order of specific performance to enforce the observance and performance of such covenant or obligation, and (ii) an injunction restraining such breach or threatened
            breach. Each of the parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance
            is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required
            to provide any bond or other security in connection with any such order or injunction.

      

    

     
    
      
        (b) In the event that any suit or action is instituted to enforce any provisions in this Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and
            expenses of enforcing any right of such prevailing party under or with respect to this Agreement (collectively, the “Enforcement Costs”), including without limitation, such reasonable fees and expenses of attorneys and accountants, which
            shall include, without limitation, all fees, costs and expenses of appeals; provided, however, that in no event shall the amount of the Enforcement Costs reimbursable or recoverable by the prevailing party hereunder exceed
            $1,500,000 in the aggregate.

      

    

     
    
      
        Section 6.11. Headings.  The headings of Articles and Sections contained in this Agreement are for
            reference purposes only and are not part of this Agreement.

      

    

     
     
      
        Section 6.12. Non-Recourse. This Agreement may only be enforced against, and any claim or cause of
            action based upon, arising out of, or related to this Agreement or the transactions contemplated hereby may only be brought against the entities that are expressly named as parties hereto and their respective successors and assigns (including
            any Person that executes and delivers a Joinder). Except as set forth in the immediately preceding sentence, no past, present or future director, officer, employee, incorporator, member, partners, stockholder, Affiliate, agent, attorney,
            advisor or representative of any party hereto (collectively, the “Specified Persons”) shall have any liability for any obligations or liabilities of any party hereto under this Agreement or for any claim based on, in respect of, or by
            reason of, the transactions contemplated hereby.

      

    

    [Remainder of page intentionally left blank.]

    
      58

      
        

    

    IN WITNESS WHEREOF, this Agreement has been executed by the parties hereto or by their respective duly authorized
      officers, all as of the date first above written.

    
      	 	 	 	 
	
               

            	NUTANIX, INC.	 
	
               

            	
               

            	
               

            	 
	
               

            	
               

            	
               

            	 
	
               

            	
              By: 

              

            	
              /s/ Dheeraj Pandey 

              

            	 
	
               

            	
               

            	
              Name:  Dheeraj Pandey 

              

            	 
	
               

            	
               

            	
              Title:  Chief Executive Officer and Chairman 

              

            	 

    

    
       

        

       

        

      
        [Signature Page to Investment Agreement]

           

    

    
      
        

    

    	 	BCPE NUCLEON (DE) SPV, LP 

          	 
	 	 	 
	 	By: BCPE Nucleon (DE) SPV (GP), LLC 

          	 
	 	Its:  General Partner 

          	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By: 

          	/s/ Max de Groen

          	 
	 	 	Name: Max de Groen

          	 
	 	 	Title: Authorized Signatory

          	 

    

    
       

      

      [Signature Page to Investment Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]